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The “wires project” in the Gray group has been focused on characterizing short-
lived intermediates of Fe heme enzyme catalytic cycles by designing and synthesizing  
photosensitizers (wires) that bind to the protein active site with high affinity.  The heart 
of this thesis is on rhenium channel binding and ruthenium surface binding wires for 
inducible nitric oxide synthase (iNOS).  Binding and inhibition studies were conducted, 
electron transfer (ET) kinetics were studied, and iNOS catalytic activity was assayed for 
nitric oxide (NO) production.   
Both channel and surface binding wires bind to iNOS with low micro molar 
affinity.  Channel binding wires bind at the active site, closely interacting with the 
protoporphyrin IX iron heme (Fe heme).  Characteristic spectral shifts of Fe heme 
perturbation were observed.  The surface binding wires bind presumably at the 
hydrophobic patch of the oxygenase domain where the reductase domain was proposed to 
dock during electron transfer processes.  The surface binding wire interacts closely with 
the Fe heme from the surface of the protein, but still close to where spectral shifts of the 
Fe heme were observed; however, the surface binding wire does not displace other 
channel binding wires, indicative of a second binding site. 
Upon photo-excitation of all rhenium wires, the resting state Fe(III) heme is 
reduced to Fe(II) heme in less than 10 ns, characterized by transient absorption 
spectroscopy.  This ET rate is orders of magnitude faster than Fe(III) reduction by the 
reductase domain (kET = 1 s-1) under biological conditions.  In some cases, the wires were 
observed to ligate the Fe(II), creating a six-coordinate Fe(II) complex.  The fully 
 x
coordinated Fe(II) species is prevented from binding oxygen, and the catalytic 
mechanism is terminated.  Another electron cannot be injected, and there is no production 
of NO.  In the cases where the wire was shorter, ligation of the Fe(II) species was not 
observed.  The Fe(II) remains five-coordinate, leaving room for oxygen to bind and for 
the mechanism to continue.  In this case, NOS catalytic activity was assayed for the 
production of NO by photo-excitation of the wires.  Complications of 
photodecomposition of NO indicators presented a challenge in data analysis.  It is 
possible that a very small amount of NO was produced by photo-excitation of the wire; 
unfortunately, nothing definitely can be concluded.  A new method to assay for NOS 
catalytic activity was proposed. 
 Both channel and surface binding wires led to many insights on substrate binding 
modes at the protein active site and on the surface; ET mechanisms were redefined, 
including amino acid radicals participating in electron transfer processes; and future 
directions for new wire were designed with hopes of accomplishing the long standing 
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L-arginine (arg) :  Natural substrate of NOS,  









Nω-nitroarginine (argNO2) :  Known inhibitor of NOS,  










L-citrulline (cit) :  Product of NOS 




Imidazole (imid) :  Known inhibitor of NOS,  












para-methoxy-N,N’-dimethylaniline (pMDA) :  Quencher 
of rhenium wires in Chapter III 
N N
 
tetramethyl-para-benzyldiamine (TMPD) :  Quencher for 
ruthenium wire in Chapter IV  
N N  
4,4’-dimethyl-2,2’-bipyridine (dmbpy) :  Ancillary of 
ruthenium wire in Chapter IV 
N N  









tryptophan (Trp, W) :  Amino acid residues that can 











Iron protoporphyrin IX (Fe heme) :  Chromophore buried 






Dithiothreitol, Cleland’s reagent (DTT) : stabilizes protein 











5,6,7,8-tetrahydrobiopterin (BH4) :  Cofactor of NOS 


















Flavin mononucleotide (FMN) :  Cofactor of the reductase 


































Flavin adenine dinucleotide (FAD) :  Cofactor of the 


































Nicotinamide adenine dinucleotide (NADPH) :  Cofactor 





















(DAF-FMT) : resulting compound from direct reaction of 




Sulfanilamide :  First Greiss reagent, nitric oxide indicator, 





Napthylethylenediamine : Second Greiss reagent, reacts 











Azo product of the Greiss reagent: coupling of 


























(ReC8argNO2) : channel binding wire of iNOS, Kd = 3μM, 





















[Re(CO)3(dmp)(imidC3arginine)][BF4] (ReC3arg) : channel 




























(ReC3argNO2) : channel binding wire of iNOS, Kd = 7μM, 






















nonafluorobiphenyl)][PF6]2 (RuphenF9bp) : surface 
















[Re(CO)3(dmp)(imidF9bp)][BF4] (ReF9bp) : channel 
binding wire of iNOS, Kd = 5μM for Δ114, Kd = 1.4μM for 

















[Re(CO)3(dmp)(imidF8bpimid)][BF4] (ReF8bpimid) : 
channel binding wire of iNOS, Kd = 100nM for Δ114, Kd = 

















[Re(CO)3(dmp)(imidC3F9bp)][BF4] (ReC3F9bp) : channel 


















[Re(CO)3(dmp)(imidC3F8bpimid)][BF4] (ReC3F8bpimid) : 
channel binding wire of iNOS, Kd < 10μM for Δ65, 




























































































































































Electron transfer (ET) reactions are involved in several biological functions, 
participating in processes such as photosynthesis, aerobic respiration, DNA damage and 
repair, drug metabolism, and enzymatic catalysis.1,2  ET is facilitated by conformational 
changes and nuclear motion in the protein and the surrounding solvent, bringing two 
electronic states close together for reaction to occur.3  Owing to the importance of 
electron transfer in metalloproteins, there has been extensive research on understanding 
electron transfer rates and pathways, characterizing high-valent intermediates, and 
studying electrochemical properties of these redox states.   
To study these electron transfer processes, the “wires project” in the Gray group 
introduces photoactive small molecules tethered to a substrate to probe heme enzyme 
active sites with a focus on binding and inhibition studies, characterization of short-lived 
intermediates, and protein conformational changes induced by substrate binding effects.   
We also focus on using these small molecules to modify the surface of proteins to study 
long-range electron transfer rates and pathways. 
 This thesis comprises the work done on the design and synthesis of sensitizer-
linked substrates (wires) to study the electron transfer processes of heme enzyme 
catalytic cycles.  Based on previous research describing electron transfer processes in 
terms of reorganization energies, electronic coupling and potentials, and protein 
environment and solvent effects of ruthenium-modified proteins, such as azurin,4,5 
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myoglobin,6,7 and cytochrome c,8,9 we were able to develop methods of probing enzyme 
active sites by tuning ruthenium/rhenium wires to facilitate direct electron transfer with 
the iron (Fe) heme. 
 
 
1.2  ELECTRON TRANSFER THEORY 
 
A great deal of work has been devoted to understanding the mechanism of long- 
range ET from an electron donor to an electron acceptor mediated by a molecular bridge 
in a donor-bridge-acceptor (DBA) assembly.  In this thesis, the donor is the metal 
complex of the wire, the acceptor is the Fe heme, and the bridge is usually considered the 
substrate tether of the wire or the protein active site environment.  This system is 
sometimes referred to as the donor-substrate-protein assembly (DSP). 
McConnell was the first to formulate that a polymethylene chain bridge mediated 
ET in terms of perturbation theory.10  In the tunneling regime of ET, McConnell theory 
states that the electronic factor can be explicitly related to the electronic structure of the 
bridging molecule.  When designing wires for a specific protein, the bridging molecule 
between the substrate and the metal center is chosen carefully to aid in fast electron 
transfer reactions. 
Long-range electron tunneling in proteins occurs where the electronic interaction 
between redox sites is relatively weak.  The transition states for ET must be formed many 
times before reactants are successfully converted to products.11  In this nonadiabactic 
process, the rate of ET, kET, decays exponentially with increasing distance, R, between 
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donor and acceptor sites (eq 1.0):   
kET ∝ exp(-βR).     (eq 1.0) 
Many synthetic molecules have been prepared specifically to study nonadiabatic ET, 
varying the geometries, energetics, and distances between the donor and acceptor.12  
Various research groups are working on theoretical descriptions of ET processes.13-16 
 
 
Electron and Energy Transfer Processes 
 
In a donor-bridge-acceptor (DBA), or in this case, donor-substrate-protein design 
(DSP), light excitation of the donor (eq 1.1) can be followed by energy (eq 1.2) or 
electron (eq 1.3) transfer processes:   
Excited state formation:         D-B-A + hν   →    D*-B-A ,                                   (eq 1.1) 
Energy transfer:              D*-B-A   →  D-B-A* ,                                     (eq 1.2) 
Electron transfer:                 D*-B-A   →     D+-B-A- .                                   (eq 1.3) 
Instead of going through an intermediate excited state, light excitation can also cause 
DSP complexes to undergo electron transfer directly: 
Optical electron transfer: D-B-A + hν   →    D+-B-A- .                           (eq 1.4) 
In the absence of interactions with other species (such as quencher), energy transfer will 
be followed by the radiative or radiationless decay of the acceptor excited state, 
        D-B-A*   →     D-B-A + hν or heat ,                                         (eq 1.5) 
while photo-induced and optical electron transfer will be followed by a thermal back 
electron transfer process: 
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  D+-B-A-  →     D-B-A .                                            (eq 1.6) 
These processes are schematized in Figure 1.1.  The process that is highlighted in this 
thesis involves the photo-induced excited state (Figure 1.1(2)) of the metal donor 
followed by either energy transfer with the protein or quencher, resulting in electron 





 As stated above, Förster energy transfer (FET) is a radiationless long-range 
resonance coupling between the donor and acceptor dipoles.17  In order for this to occur 
between two sites, the donor emission must overlap with the acceptor absorbance.    This 
process is defined by the interactions of the donor and acceptor dipoles with an inverse 




 ,              (eq 1.7) 
where kE is the rate of energy transfer, ko is the intrinsic decay rate of the donor, r is the 
donor-acceptor distance, and Ro is Förster pair distance, defined as 
               )(108.8
4256 JnxR oo φκ
−−= ,              (eq 1.8) 
where κ2 is the orientation factor of the donor relative to the acceptor (usually 2/3 value is 
used for freely rotating donor or acceptor), n is the index of refraction of the solvent, oφ  



















,              (eq 1.9) 
where λ is the wavelength (nm), Fo is the donor fluorescence emission spectrum, and EA 
is the acceptor absorbance spectrum. 
 A typical Ro value for most macromolecules is within the range of 10 – 60 Å.18  
However, the Ro value will increase with increasing donor luminescence quantum yield 
and increasing J values, the overlap integral.  Therefore, the Ro value can be tailored by 





According to Marcus Theory, the rate constant for ET processes between donor 
and acceptor can be expressed as 
     )/exp( RTGk NET
≠Δ−=  κν  ,                                   (eq 1.10) 
where νN is the effective nuclear frequency factor, κ is the electronic transmission 
coefficient, and 
≠ΔG  is the free activation energy.1,19  The 
≠ΔG  can be expressed by the 


















,                    (eq 1.11) 
where ΔGo is the standard free energy change of the reaction, and λ is the nuclear 



















Figure 1.120:  Potential energy diagram of the relationship between (1) optical, (2 and 3) photo-induced, (4) 


























A                B 
 
Figure 1.2:  (A)  Profile of the potential energy curves of ET processes: I and F indicate the initial and final 
states, respectively.  The dashed curve indicates the final state of the self exchange (isoergonic) process.20  
(B) Driving force dependence of nonadiabatic ET rates.  Potential energy surface for the normal region 








The Marcus equation predicts that for a homogenous series of reactions (for reactions 
having the same λ and κ values), a log (kET) vs. ΔGo plot is a parabolic curve (Figure 
1.2B).  At low driving force (λ > −ΔGo), called the “normal” region, rates increase with 
increasing driving force.  At high driving force (λ < −ΔGo), called the “inverted region,” 
rates decrease with increasing driving force.  At the top of the driving-force curve, there 
is an activationless maximum for λ = −ΔGo.22   
Introduction of quantum mechanical terms in eq 1.10, to account for the electronic 

































 .   (eq 1.12) 
The tunneling matrix element, HAB, is a measure of the electronic coupling between the 
reactants and the products at the transition state.  HAB is considered to decrease 
exponentially with increasing donor-acceptor separation (rAB), as shown by the following 
equation: 
( )[ ]2/exp oABABoABAB rrHH −−= β .                       (eq 1.13) 
o
ABH  is the electronic coupling matrix element when rAB is the closest distance ( )
o
ABr  for 
effective contact between donor and acceptor.23  The parameter β is the distance coupling 
decay constant.  When β is small, the interaction between donor and acceptor does not 
vary much as distance between donor and acceptor increases; and in turn, HAB is not very 
sensitive to the distance.  In contrast, a large β is reflected in strong distance dependence.  
Therefore, the β value is important in ET reactions.   
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Electron Tunneling Timetable  
The timetable for activationless electron tunneling through various media is 
shown in Figure 1.3.24  In a vacuum system, the β values typically fall between 2.9 - 4.0 
Å.  Methyl-THF glass exhibits a β ~ 1.57 - 1.67 Å, aqueous glass a β ~ 1.55 - 1.65 Å, 
ruthenium modified azurin a β ~ 1.1 Å, saturated hydrocarbons β ~ 1.0 Å, xylyl bridges a 
β ~ 0.76 Å, and polyene and phenylenevinylene as low as β ~ 0.04 Å.  Research in our 
laboratory has focused on elucidating the distance dependence of electronic coupling 
between redox states for several ruthenium-modified proteins.  Our studies indicate that a 
large part of the reorganization energy and electron transfer rates are dependent on the 
nuclear reorientation of the protein.  Waldeck has suggested that the dynamics of these 
large scale movements could be slower than most direct electron transfer through bonds 
or solvents and that the solvent relaxation time could be on the order of 200 ns.25  
However, we have demonstrated that four of the ruthenium-modified protein exhibit ET 
time constants < 200 ns (Figure 1.3B).  This is an example of a situation where the ET 
rates exceed the proposed solvent-controlled adiabatic limit.  Reactions at low driving 
force, where ΔGo < λ, require substantial reorganization of the solvent, and ET rates are 
dependent on the solvent relaxation time.  However, in situations where the ET rates of 
activationless (ΔGo = λ) and inverted (ΔGo > λ) reactions, ET rates will be independent of 
the solvent relaxation time, such as the case for our ruthenium-modified protein 
experiments.      
 Electron tunneling times within a protein environment must be within 
milliseconds to microseconds for proteins to function properly, and as a result the 









Figure 1.3.  (A) Activationless electron tunneling timetable for various media: vacuum (black, β = 2.9 - 4.0 
Å-1), methyl-THF (violet, β = 1.57 - 1.67 Å-1), toluene glass (green, β = 1.18 - 1.28 Å-1), xylyl bridge (red, 
β = 0.76 Å-1), alkane bridges (orange, β = 1.0 Å-1), and β strand bridges in ruthenium modified azurin 
(yellow, β = 1.1 Å-1).  (B) Tunneling timetable for intraprotein ET in ruthenium modified azurin (blue 
circles), cyt c (red circles), myoglobin (yellow triangles), cyt b562 (green squares), HiPIP (orange 
diamonds), and for interprotein ET Fe : Zn - cyt c crystals (fushia triangles).  Solid lines illustrate the 
tunneling pathway predictions for coupling along β - strands (β = 1.0 Å-1) and α-helices (β = 1.3 Å-1); 
dashed lines illustrates a 1.1 Å-1 distance decay.  Distance decay for electron tunneling through water is 











However, crystal structures of several redox enzymes suggest distances greater than 20 
Å, exceeding a single step electron transfer limit.  One possible explanation is electron 






kPH .   (eq 1.14) 
With optimal positioning of redox centers and fine tuning of redox potentials, electron 
hopping can be realized.  Using the well-defined ET theory and the distance dependence 
of ET through protein based on the ruthenium-modified protein studies, it was calculated 
that electron transport via a hopping mechanism is 104 times faster than a single step 
tunneling mechanism over a distance of 20 Å.24    
 Energy transfer versus electron transfer (either single step or multi-step 
mechanism) will play a vital role in characterizing electron transfer processes in proteins.  
Choosing a donor-acceptor pair that will facilitate electron transfer over energy transfer is 
critical in studying electron transfer mechanisms.   
 
 
Flash Quench Methodology26,27 
 
In the dynamic reductive quenching mechanism, an organic compound, such as 
ascorbate or para-methoxy-N,N’-dimethylaniline (pMDA), is often used as the reductive 
quencher.  Upon irradiation, the donor complex transforms to the excited state (eq 1.15).    
The excited DBA complex collides with quencher (Q), whereby the complex is quenched 
(eq 1.16), and then intramolecular charge separation (eq 1.17) occurs, followed by 
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intermolecular back electron transfer (eq 1.18).   
 
Excited state formation:     D-B-A + hν    →     D*-B-A;  (eq 1.15) 
Excited state quenching:     D*-B-A + Q  →   D- -B-A + Q+ ;       (eq 1.16) 
Electron transfer:      D- -B-A  →     D-B-A- ; and       (eq 1.17) 
Back electron transfer: D-B-A- + Q+   →    D-B-A + Q. (eq 1.18) 
 
An electron transfer reaction for donor (wire) bound to the protein acceptor in the 
presence of quencher (Q) is schematized in Scheme 1.1.   
When a wire binds to protein with high affinity, laser experiments immediately 
follow for ET kinetic studies.  The metal sensitizer, rhenium in this case, is excited.  In 
the presence of reductive quencher, an electron is transferred to the quencher, reducing 
the rhenium and in turn oxidizing the quencher (Scheme 1.1, right half).  The reduced 
rhenium does electron transfer with the Fe heme, reducing the Fe(III) to Fe(II) and 
returning the rhenium to its original redox state.  The reduced Fe is then returned to its 
resting state by the oxidized quencher.  The transient species in this system are 
characterized by transient luminescence and absorption spectroscopy, which are analyzed 






−+=  ;                      (eq 1.19) 















−−− +++=  .                  (eq 1.21) 
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How many species are in the sample participating in electron transfer reactions depends 
on the number of decay fits that are necessary for each trace.  In general, a free wire in 
solution will exhibit a decay rate that is different from the wire-bound to protein.  If 
quencher is present, then its decay rate will present another parameter into the fitting 
process.  By utilizing the redox properties of the wire coupled with known ET rates and 
pathways in proteins, electron transfer reactions of a heme protein catalytic cycle are 

























































B:  Reductive RouteA:  Oxidative Route  
 
 
Scheme 1.1:  Electron transfer scheme between a rhenium wire, quencher, and Fe heme protein.  Rhenium 
is promoted to its excited state with 355 nm laser light, giving an emission intensity centered at 560 nm.  In 
the presence of a reductive quencher (left side), the rhenium excited state is quenched to its rhenium(0) 
oxidation state, followed by electron transfer into the Fe heme, reducing Fe(III) to Fe(II).  The oxidized 
quencher recombines with the reduced Fe to reach its ground state and closes the electron transfer 
mechanism.  The oxidative route is similar except the rhenium, and the Fe heme are oxidized while the 
quencher is reduced.    
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1.3 WIRES PROJECT 
 
Characterization of high-valent intermediates of Fe heme enzyme catalytic cycles 
has been a long standing goal in the Gray group.28-37  Short-lived intermediates present a 
major challenge for characterization, owing to their occurrence after the rate limiting 
steps of protein catalytic cycles.  Although ferryl intermediates for horseradish 
peroxidase38 and microperoxidase - 839 have been characterized, the analogous 
experiment was unsuccessful for cytochrome P450s,40 presumably owing to inefficient 
electron transfer reactions into the buried heme active site.  The P450 catalytic cycle41,42 
is shown in Scheme 1.2.  Intermediates after the slow electron transfer step have not been 
characterized, despite many efforts.43,44  If this electron transfer rate was increased, then 
there is a possibility of a build-up of these short-lived intermediates, where 
characterization might be possible. 
The wires project was then developed to address these inefficient electron transfer 
reactions by providing direct access to the heme active site via a substrate tethered to a 
photoactive metal complex (Figure 1.4).  The metal center (either ruthenium or rhenium) 
sits at the surface of the protein, probing the conformational states at the opening of the 
active site.  The substrate is tethered down the channel, closely interacting with the Fe 
heme (Figure 1.4, green).  When a reductive quencher is present, the metal is reduced, 
followed by electron transfer down the channel via the substrate tether to the Fe heme 
site.  With this method we were able to characterize several novel cytochrome P450 
redox states.33,34  This investigation revealed many key factors affecting substrate binding 





















































Figure1.4. Model of a wire in an active site. 
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The inorganic nature of the metal complex allowed for easy crystallization of the wire-
protein complexes, revealing interesting protein-substrate conformations.  Opened and 
closed conformations of the protein surface were identified upon substrate binding.32,45  
Wires were proven to be useful as fluorescent sensors for protein conformational 
changes, electrochemical sensors for protein redox states, and novel inhibitors of protein 
catalytic activity.   
 This thesis focuses on the wires work accomplished with inducible nitric oxide 
synthase (iNOS), a cytochrome P450-like heme thiolate enzyme.  The wires that were 
designed and synthesized for iNOS are shown in Figure 1.5.  All of the rhenium-based 
wires are active site channel binders of iNOS, characterized by UV-Vis spectroscopy.  
The one ruthenium wire (Figure 1.5E) is a surface binder, presumably at the oxygenase 
and reductase interface, characterized by UV-Vis spectroscopy and further supported by 
transient luminescence spectroscopy.  Wires D were previously designed for cytochrome 
P450 enzymes.29,30  Owing to structural and functional similarities between cytochrome 
P450 and iNOS, wires D were also tested for binding to iNOS.  Surprisingly, these wires 
bind to iNOS with high affinity.   
More substrate-based wires were designed, keeping the same rhenium metal 
complex (Figure 1.5A-C).  All of these wires bind to iNOS with high affinity.  
Intermediates of the NOS catalytic cycle were characterized by ultrafast electron transfer 
rates, leading to many new proposals for electron transfer pathways and protein domain 
interactions, which in turn have opened new doors for further wire designs for NOS 







































































































where n = 0, 3, 4, 6, or 8











1.4 NITRIC OXIDE SYNTHASE 
 
 
Nitric oxide (NO) is an important secondary signaling molecule that has diverse 
biological functions, such as neurotransmission, blood pressure regulation, and immune 
response.46  Isoforms of homodimeric nitric oxide synthase (NOS) (inducible, 
endothelial, and neuronal)47 catalyze the reaction between L-arginine and dioxygen to 



































Scheme 1.3.  Summary of NOS catalytic cycle. 
 
eNOS participates in the regulation of blood pressure, organ blood flow distribution, and 
inhibition of platelet aggregation.  nNOS produces low NO concentrations for 
neurotransmission; high concentrations of NO leads to neuropathology.  Both eNOS and 
nNOS are calcium/calmodulin (CAM) dependent.  iNOS produces high NO 
concentrations to counter pathogens and coordinate T-cell response.  CAM is 
permanently bound to iNOS; therefore it is not calcium/CAM dependent.  The three 
isoforms have 50% primary sequence homology and 81 – 93 % interspecies 
similarities.47,48  Designing inhibitors specific for each isoform has proven very difficult.   
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The N-terminal oxygenase domain contains binding sites for an iron protoporphyrin IX 
(Fe heme), tetrahydrobiopterin (BH4), and substrate;49 is the site for NO synthesis; and is 
responsible for dimerization interactions.  The C-terminal reductase domain contains 
binding sites for flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), and 
nicotinamide adenine dinucleotide phosphate (NADPH) cofactors and is the source of 
electrons during the catalytic cycle.50  At the interface of the two domains is a binding 
site for calmodulin (CAM) which aids in NOS activity.  Without substrates or cofactors, 
NOS exists primarily in its inactive monomeric form.   
The structures of NOS cofactors are shown in Figure 1.7.  Upon binding of BH4, 
the NOS oxygenase domain dimerizes partially and shifts the Fe heme slightly high spin 
(λmax = 390 nm).  In the presence of arginine, the NOS oxygenase domain completely 
dimerizes and becomes active.  In the presence of NADPH, an electron is delivered to the 
FAD cofactor of one reductase domain, then is shuttled to the FMN cofactor where it gets 
delivered into the heme active site of another oxygenase domain.   
Electrons travel trans, from a reductase domain of one monomer to the oxygenase 
domain of the other monomer.51,52  The Fe(III) is reduced to Fe(II), completing the first 
electron transfer process.  The NOS catalytic cycle has two turnovers (Scheme 1.4).53  
The first turnover resembles the cytochrome P450 catalytic cycle.  The second turnover is 
mostly postulated.  Very little is known about the oxidation of the N-hydroxyarginine 
intermediate.  What we know for certain is that all NOS isoforms transform L-arginine 
and two moles of dioxygen into L-citrulline and NO via an N-hydroxyarginine 
intermediate.  The oxygen atom in both NO and L-citrulline are derived from dioxygen.  


































































First turnover Second turnover  




Figure 1.8.  Docking of the oxygenase domain 
on top of the reductase domain (PBD code 
1MMV and 1TLL).  The FMN region is 
colored in red.  The arrow indicates the flipping 
direction of the FMN domain, and the circle 
indicates the hydrophobic patch of the 
oxygenase domain that interacts with the FMN 
domain.  The flexible linker that allows FMN 
to flip up and down is highlighted in green. 
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The second electron transfer is the rate-limiting step.  The mechanism of the 
second turnover, the roles of NOS cofactors during the catalytic cycle, and the specific 
structural interactions of NOS domains are all highly debated.   There are disputes on the 
role of BH4 during the electron transfer processes.54-56  The source of proton for the 
conversion of Fe(III) peroxide to Fe(III) hydroperoxide is not known.57-59  The 
conformational changes and the interactions between the oxygenase and reductase 
domains have led to an interesting argument involving the FMN domain flip.60,61 
The NOS reductase domain is similar to that of NADPH-cytochrome P450 
reductase, both containing essentially two domains: the N-terminal FMN portion and the 
C-terminal FAD and NADPH binding portion (Figure 1.8).62,63  The FMN portion of 
NOS reductase, however, is less positively charged than that of NADPH-cytochrome 
P450 oxidoreductase, indicating that the NOS FMN domain may have a different 
structural interaction with the other domains and even a different mode of regulation in 
the electron-transfer processes.64  There have been implications that the FMN domain 
controls NOS activity by a swinging motion of the entire domain as electrons are 
delivered to the oxygenase domain.61  The FMN domain can be locked in either its 
electron accepting or donating position as an auto-inhibitory method.  These 
conformational swinging motions of the FMN domain will affect the rate of electron 
transfer, which could be different for each of the isoforms.   
The surface-binding wire discussed in this thesis is proposed to dock in this 
hydrophobic patch of the oxygenase domain, where the FMN domain was proposed to 
dock.  A surface inhibitor of this kind has never been characterized before.  This surface-
binding wire has great potential as a structural and mechanistic probe for enzymes 
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containing multi-domains.   
 Both channel and surface binding inhibitors have given us many insights into 
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LONG-LIVED, SIX-COORDINATE FE(II)  
INDUCIBLE NITRIC OXIDE SYNTHASE CREATED BY PHOTO-



















The catalytic mechanism of mammalian inducible nitric oxide synthase (iNOS) 
was investigated by a sensitizer-linked substrate (wire) to characterize intermediates 
produced by laser-induced electron transfer to the active site of the enzyme.  The 
sensitizer core is Re(CO)3(4,7-dimethyl-phenanthroline) linked to an amino-octyl-
imidazolyl-nitro-L-arginine substrate, ReC8argNO2.  Upon addition of ReC8argNO2 to 
phosphate buffer solution containing the oxygenase domain of iNOS (iNOSoxy), the Soret 
absorption in the optical spectrum of the resting state Fe heme shifts from 423 nm to 390 
nm, indicative of partial displacement of the water ligand in the active site, resulting in a 
high spin, five-coordinate Fe(III) heme.  Competitive binding studies with imidazole 
reveal that a Kd for ReC8argNO2 is 3 ± 1 μM, which is smaller than the dissociation 
constants of both L-arginine (Kd = 16 μM) and imidazole (Kd = 12 μM).  Transient 
absorption measurements show that Fe(III) is reduced to Fe(II) in less than 10 ns, orders 
of magnitude faster than reduction by the reductase domain (kET = 1 s-1).  Upon 
production of five-coordinate Fe(II), ReC8argNO2 ligates the Fe heme through the 
terminated nitro group, creating a six-coordinate Fe(II) complex.  The fully coordinated 
Fe(II) species is prevented from binding oxygen, and the catalytic mechanism is 
terminated.  Another electron cannot be injected, and there is no production of nitric 
oxide.  The nitro group ligation to the Fe heme could be mechanistically analogous to the 
N-oxy ligation of N-hydroxyarginine during the second turnover of the catalytic cycle.  
ReC8argNO2 has proven to be a novel fluorescent inhibitor, giving insights into the 
mechanism of the iNOS catalytic cycle. 
 29
2.1  INTRODUCTION 
 
 
Nitric oxide (NO) is an important secondary signaling molecule that has diverse 
biological functions, such as neurotransmission, blood pressure regulation, and immune 
response.1,2  Isoforms of homodimeric nitric oxide synthase (NOS) (inducible, endothelial, 
and neuronal) catalyzes the reaction between L-arginine and dioxygen to produce L-
citrulline and NO (Scheme 2.1).   
The general model for NOS structure, composition, and function during the 
catalytic cycle is represented in Chapter I.3  In summary, the N-terminal oxygenase 
domain (1) contains binding sites for an iron protoporphyrin IX (Fe heme), 
tetrahydrobiopterin (BH4), and L-arginine  substrate, (2) is the site for NO synthesis, and 
(3) is responsible for dimerization interactions.  The C-terminal reductase domain contains 
binding sites for flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), and 
nicotinamide adenine dinucleotide phosphate (NADPH) cofactors and is the source of 
electrons during the catalytic cycle.  At the interface of the two domains is a floppy 
peptide linker containing the binding site for calmodulin (CAM), which aids in NOS 
activity.4  Without substrates or cofactors, NOS exists primarily in its inactive monomeric 
form.   
The catalytic cycle of NOS is predicted to be cytochrome P450-like,5 meaning it 
has two turnovers based on the cytochrome P450 catalytic mechanism; however, the 
second turnover is mostly postulated.  There is very little evidence for the high-valent Fe 















































































A major goal of this project is to design sensitizer-linked substrates (wires) that 
(1) bind with high affinity to the active site channel of iNOSoxy (the oxygenase domain of 
iNOS with the reductase domain cleaved at the CAM linker site), (2) act as the electron 
donor replacing the reductase domain, and (3) turn over arginine and produce NO as a 
product.  The wire discussed in this chapter consists of (1) a rhenium center, (2) ancillary 
phenanthroline and tricarbonyl ligands, and (3) imidazole alkyl-linked nitro-L-arginine 
substrate (Figure 2.1).  The rhenium metal complex was designed to be small enough to 
easily access the opening of the iNOS channel.  The length of the imidazole alkyl linker 
can easily be altered during synthesis for optimal binding and extending down the active 
site channel.  The nitroarginine substrate was introduced at the wire terminus for 
mechanistic studies on the turnover of electron transfer processes induced by photo-
excitation of the rhenium center. 
 
 
2.2  EXPERIMENTALS 
 
General. Escherichia coli JM109 competent cells and pCWori plasmid 
(ampicillin resistance, tac-tac promoter) were a gift from Professor Michael Marletta 
(University of California at Berkeley).  All chemicals used during synthesis were 
purchased from Aldrich, unless otherwise stated.  All tripled Nd:YAG laser experiments 
were carried out in atmosphere controlled, 1 cm path length cuvettes equipped with 
Kontes valves for pump and purge cycles.  UV-Visible absorption spectra were taken on 
an Agilent 8453 UV-Vis spectrometer.  Steady-state emission measurements were 
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measured using a Flurolog Model FL3-11 fluorometer equipped with a Hamamatsu R928 
PMT.   
Expression and Purification of iNOSoxy.  iNOSoxy was expressed in E.coli 
following literature procedures7,8 with the following alterations:  fresh cell pellets from 6 
L of culture were resuspended in two rounds of 40 mL B-Per lysis buffer (Pierce) 
containing 10 μg/mL benzamidine, 5 μg/mL pefabloc, 1 μg/mL of pepstatin, antipain, 
chymostatin, and chyotrypsin each, 100 μg/mL DNAse, 100 μg/mL RNAse, 500 μg/mL 
lysozyme and 20 mM imidazole per liter of cells, and were shaken for one hour at 4oC.  
The supernatant was collected after centrifugation and loaded directly onto a 5 ml His-
Trap nickel column (Amersham).  The column was washed with 20 column volumes of 
20 mM imidazole in 50 mM sodium phosphate and 300 mM sodium chloride buffer at 
pH 8.  The protein was then eluted with a linear gradient of imidazole (20 - 150 mM).  
The protein containing fractions were concentrated to 5 ml over an Amicon Ultra 
filtration device (10,000 MWCO, Millipore) and loaded onto a Superdex 200 gel 
filtration column (HiLoad 26/60, Amersham).  The anion exchange column was omitted 
when 95% purity was confirmed by UV-Vis spectroscopy and gel electrophoresis.  
Imidazole bound iNOSoxy was stored at -80oC.  Detailed procedures are in Appendix B. 
Preparation of iNOSoxy Samples.  Before every experiment, an aliquot of 100 μL 
of 100 μM of iNOSoxy is thawed on ice and filtered through a PD10 desalting column 
(BioRad).  The PD10 column removed any excess imidazole bound in the active site of 
the protein during purification.  The storing buffer was exchanged for a 50/50 mM 
KPi/KCl buffer at pH 7.4 by the same method.  The resulting stock protein sample 
concentration is 20 μM in 1 mL of buffer after the PD10 column.  The concentration was 
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altered according to each experiment.  The extinction coefficient of iNOS Fe heme is 
75,000 M-1cm-1.  A UV-Vis is taken before the desalting column to check for imidazole-
bound active site, exhibiting an Fe heme Soret λmax at 427 nm.  After the desalting 
column, the water bound Fe heme, containing no residual imidazole, exhibits a Soret λmax 
at 423 nm.  All protein samples were used without the reductase domain, arginine, CAM, 
BH4, FMN, FAD, and NADPH, unless otherwise stated. 
Preparation of ReC8argNO2 Samples.  ReC8argNO2 was stored in ethanol at 5 
mM stock concentration.  ReC8argNO2 was titrated straight from the ethanol solution into 
the protein samples, keeping ethanol concentration < 2% for every sample.  The final 
volume changes were also < 2% of the initial volume to prevent changes in sample 
concentrations.  All laser measurements were done in atmosphere-controlled 1 cm path 
length cuvettes equipped with Kontes valves for pump-purge cycles before every laser 
experiments to eliminate any oxidative side reactions. 
Dissociation Constant.  The dissociation constant of ReC8argNO2 affinity for 
iNOSoxy was calculated in the absence of cofactors, such as BH4 or dithiothreitol (DTT), 
which may exhibit cooperative binding effects under biological conditions.  Dissociation 
constants were determined by saturation binding experiments analyzed by three different 
methods: double reciprocal plots from steady-state UV-Vis experiments, Scatchard 
analysis from steady-state fluorescence experiments, and extrapolated free to bound wire 
ratio from transient luminescence decay traces, which were plugged into a derived 
Michaelis-Menten protein-substrate equilibrium equation.   
The Michaelis-Menten equation for enzyme activity has a similar form to the 















 .   (eq 2.2) 
All saturation-binding experiments were analyzed based on eq 2.2.  A saturation-binding 
experiment measures the equilibrium binding of the inhibitor ([L]) at various 
concentrations in order to determine the number of binding sites (Bmax) and the ligand 
affinity (Kd).  A typical competitive-binding experiment is conducted by titrations of the 
inhibitor into samples containing substrate-bound iNOS with a known binding constant. 
Double Reciprocal Plot.  Binding equilibrium calculated by competitive-binding 
studies between imidazole and ReC8argNO2 followed by the method of spectral 
perturbation, were done according to literature procedures.9,10  ReC8argNO2 was titrated 
into a constant concentration of iNOSoxy samples containing various concentrations of 
imidazole that is bound to the active site.  The optical perturbations were analyzed by 
double reciprocal plots.   

















ΔΑ 427−390  ,  (eq 2.3) 
where 28argNOReCdK  is the binding affinity determined for ReC8argNO2, and α = (1+( [imid] 
/ imiddΚ )), which accounts for the concentration of imidazole ([imid]) and the dissociation 
constant for imidazole ( imiddΚ ).  The 
imid
dΚ  is determined to be 12 μM, which was also 
calculated by a saturation curve.  A double reciprocal plot was generated by extrapolating 
the absorbance difference (427 nm – 423 nm) plotted against the inhibitor concentration. 
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 Scatchard Analysis.  Scatchard analysis is a method of linearizing data from a 
saturation-binding experiment in order to determine substrate binding constants and 
number of binding sites the substrates occupy.11,12  The analysis is done by plotting 













 ,    (eq 2.4)   
where [S]b is the concentration of bound substrate, [S]f is the concentration of free 
substrate, [P]T is the total protein concentration, the slope of the line is -1/Kd (Kd is the 
substrate dissociation constant), and n is the number of binding sites.  When there is only 
one binding site, the Scatchard plot is linear with only one slope.  A single Kd can be 
determined.  When there are more than one non-identical binding sites that are 
independent of each other, where binding at one site does not affect binding at the second 
site, there are two separate equilibrium expressions for each sites (a and b), where ka = 
[PaS] / [P][S] and kb = [PbS] / [P][S].  For systems that have two or more binding sites, 
the Scatchard plot will appear curved.  If the binding constants are different from each 
other, then the Scatchard plot will appear to have distinct linear lines with distinct slopes.  
The stronger binding site will dominate at lower concentrations, and the weaker binding 
site will dominate at higher concentrations. 
A Scatchard analysis was conducted on steady-state fluorescence data of this 
system.  Assuming that bound wire has no fluorescence, any fluorescence intensity 
measurements of wire in the presence of iNOSoxy was concluded to be contributed to free 
wire in solution.  A ratio of bound and free wire can be determined by calculating the 
areas underneath the fluorescence curves. 
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Transient Luminescence and Absorbance Spectroscopy.  Transient 
luminescence and absorbance decay traces were measured using a frequency-tripled 
Nd:YAG laser (λex = 355 nm).13,14  The instrument has a response limit of approximately 
10 ns.  Transient luminescence decay were fit using a nonlinear least-squares algorithm 






 ,   (eq 2.5)
 
where n = 1 - 3 for mono-, bi-, and tri-exponential decays, respectively; kn is the 
luminescence decay rate constant for the bound and free wire at time t; and cn is the 
amplitude of bound and free wire.  The amplitudes of the decay traces were used to 
determine the ratio of bound wire and free wire (cn/cn+1).  The binding constant was then 










 ,   (eq 2.6) 
where [P] is the initial concentration of protein, and [W] is the initial concentration of 
ReC8argNO2.   
Resonance Raman Spectroscopy.  Samples for resonance Raman measurements 
were prepared in glass capillary tubes of roughly 20 μM iNOSoxy and 100 μM 
ReC8argNO2.  Samples were excited at 441.6 nm with a continuous wave He/Cd laser.  
The incident power on the sample was kept under 8 mwatts to prevent sample photo-
degradation.  The scattered light was collected, focused onto an entrance slit (50 μm) on a 
1.25 mm monochromator, and detected by a liquid nitrogen cooled CCD camera.  All 
measurements were made at room temperature.  Typically, several 1 minute spectra were 
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obtained and averaged to improve signal to noise ratios.  The scattered light spectra were 
baseline corrected but not smoothed.  The frequencies of the Raman marker lines were 
calibrated against a cyclohexane standard.  UV-Vis absorption spectra were obtained 
before and after collecting resonance Raman spectra to assure that the He/Cd power did 
not photo-degrade the samples.   
Synthesis.  Synthesis of [Re(CO)3(4,7-dimethylphenanthroline)(THF)][BF4] (1) 
has been described previously (Scheme 2.2).15   
In summary, Re(CO)5Cl was stirred with 4,7-dimethylphenanthroline in toluene 
overnight at 50oC.  A bright yellow solid is collected by gravity filtration and carried onto 
the next step without purification.  The Cl atom is removed with AgBF4 and is replaced 
by a THF molecule from the solvent.  The reaction was run in the dark, for AgCl is 
sensitive to light.   AgCl is filtered off, and the filtrate is concentrated by rotary 
evaporation to collect the product as a bright yellow solid.   
 The ligand synthesis was completed in six steps.  In summary, a deprotonation of 
the phthalamide ligand in the presence of dibromooctane resulted in a bromo-octyl-N-
phthalamide product (Scheme 2.3).  Utilizing a NaH deprotonation reaction of the 
imidazole secondary amine, the bromo-octyl-N-phthalamide is coupled with imidazole to 
produce phthalyl-octyl-imidazole.  The phthalamide moiety is deprotected by hydrazine 
monohydrate, resulting in an amino-octyl-imidazole product.  The alkylimidazole is then 
coupled with Nα-BOC-Nω-nitroarginine by a DCC coupling reaction, followed by a 
deprotection reaction of the BOC group with TFA, leaving the nitro group untouched to 
produce the imidC8argNO2 ligand.  The final step of the synthesis is the metalation 

















































































































































Scheme 2.5.  Synthetic scheme of ReC8argNO2. 
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Re (4,7-dimethyl-1,10-phenanthroline) (tricarbonyl) chloride (Re(CO)3(dmp)Cl).  
Re(CO)5Cl (1.0 g, 2.8 mmol) and 4,7-dimethyl-1,10-phenanthroline (dmp) (0.60 g, 3.0 
mmol) were added to a 100 mL round bottom flask fitted with a stir bar and condenser.  
50 mL of toluene was added to the flask, and the resulting suspension was stirred at 60oC 
overnight.  The suspension was removed from heat.  The solid was collected by vacuum 
filtration, and the solid was washed with toluene to obtain a bright yellow solid as the 
product (1.4 g, 2.8 mmol, 100% yield), which was used without further purification.  1H 
NMR (300 MHz, CDCl3):  δ (ppm) 2.9 (s, 6H); 7.7 (d, 2H); 8.2 (s, 2H); 9.2 (d, 2H).  
ESI/MS (m/z)+: 518.1 (calc. 517.99). 
[Re (4,7-dimethyl-1,10-phenanthroline) (tricarbonyl) (THF)][BF4] 
(Re(CO)3(dmp)(THF)) (1).  Re(CO)3(dmp)Cl (0.50 g, 0.98 mmol) was weighed into a 
sealed, 50 mL, 3-neck round bottom flask and purged with argon for 30 minutes.  30 mL 
anhydrous THF was added, and the yellow suspension was stirred for 15 minutes.  0.90 
equivalents of silver tetrafluoroborate (AgBF4) (170 mg, 0.88 mmol) were transferred 
into the flask under argon flow.  The reaction was sealed and left to stir for 24 hours.  The 
suspension was then vacuum filtered over celite through a filter frit and rinsed with dry 
THF to remove silver chloride.  The bright yellow filtrate was rotary evaporated to 
dryness to obtain a yellow solid as the product (theoretical yield:  0.88 mmol), which was 
carried onto the next step without further purification.  1H NMR (300 MHz, DMSO):  δ 
(ppm) 2.9 (s, 6H); 8.0 (d, 2H); 8.4 (s, 2H); 9.4 (d, 2H).  19F NMR (300 MHz, DMSO):  δ 
(ppm) -160 (s, 4F). ESI/MS (m/z)+: 496.6 [M]+ (calc. 496.5). 
Bromooctylphthalamide (BrC8phth).  1.0 g (6.8mmol) phthalamide was added to a 
flask containing 1.0 g (7.5 mmol) K2CO3 and 10 mL (0.5 M) DMF.  1.4 mL (7.5 mmol) 
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of dibromohexane (Br2C8) was added and stirred overnight (12 hours) at room 
temperature.  The reaction mixture was concentrated by rotary evaporation and purified 
by flash column chromatography (6:1 Hex:EtAc eluent).  1H NMR (300 MHz, CDCl3): δ 
(ppm) 1.2-1.4 (m, 8H), 1.6 (m, 2H), 1.9 (m, 2H), 3.4 (t, 2H), 3.7 (t, 2H), 7.7 (dd, 2H), 7.9 
(dd, 2H).   
Imidazolyl-octyl-pthalamide (2).  200 mg (3.2 mmol) imidazole was stirred in 5.0 mL 
(0.60 M) anhydrous DMF.  78 mg (3.5 mmol) of solid NaH was added to the reaction and 
stirred for 2 hours.  1.0 g (3.2 mmol) BrC8phth was added and stirred overnight at 40oC.  
The reaction mixture was concentrated by rotary evaporation to remove DMF.  50 mL 
water and 20 mL toluene were added to the oil in a separation funnel.  The toluene layer 
was collected, and product was further extracted from the water layer with another 20 mL 
toluene.  This was repeated 3 times.  The organic layer was dried over MgSO4.  MgSO4 
was removed by gravity filtration, and the organic layer was concentrated by rotary 
evaporation, resulting in a pale yellow solid as the product (PhthC8imid) (490 mg, 51% 
yield).   1H NMR (300 MHz, CDCl3): δ (ppm) 1.2-1.4 (m, 8H), 1.6 (m, 2H), 1.8 (m, 2H), 
3.6 (t, 2H), 3.9 (t, 2H), 6.9 (s, 1H), 7.0 (s, 1H), 7.1 (s, 1H), 7.7 (dd, 2H), 7.9 (dd, 2H).   
Imidazolyl-octyl-amine (3). 270 mg (0.83 mmol) phthC8imid and 281 μL (5.8 mmol) 
N2H2 was stirred in 1.0 mL (0.8 M) EtOH for 2 hours.  A white precipitate formed and 
was removed by vacuum filtration through a filter frit.  The solid was washed with more 
EtOH.  The filtrate was collected and concentrated by rotary evaporation.  The product 
(NH2C8imid) was carried onto the next step without further purification (300 mg, 100% 
yield).  1H NMR (300 MHz, CDCl3): δ (ppm) 1.2-1.4 (m, 8H), 1.6 (m, 2H), 1.8 (m, 2H), 
2.6 (t, 2H), 3.9 (t, 2H), 6.9 (s, 1H), 7.0 (s, 1H), 7.1 (s, 1H).   
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Imidazolyl-octyl-BOC-nitroarginine (4).  A one pot synthesis of 1.0 g (3.1 mmol) of 
BOC-nitroarginine and 1.2 g (6.2 mmol) of 3 was stirred with 1.3 g (6.2 mmol) DCC in 
45 mL anhydrous THF at 50oC.  DHU precipitated out as a white solid overnight.  The 
product was collected by removing DHU by vacuum filtration through a filter frit 
containing celite.  The filtrate was concentrated by rotary evaporation and purified by 
flash column chromatography (50:3 CH2Cl2:MeOH).  The product was collected as a 
clear oil (800 mg, 50% yield).  1H NMR (300 MHz, CD3OD): δ (ppm) 1.2-1.8 (m, 18H);  
1.5 (s, 9H);  3.2 (t, 2H); 4.0 (t, 2H);  6.9 (s, 1H); 7.1 (s, 1H); 7.6 (s, 1H).  13C NMR (300 
MHz, CD3OD): δ (ppm) 20-30, 39.9, 40.1, 53, 55, 80, 120, 129, 139, 159, 160, 172.       
Imidazole-octyl-nitroarginine (5).  700 mg (1.4 mmol) imidazole-octyl-BOC-
nitroarginine was chilled to 0oC in 15 mL CH2Cl2.  2.1 mL TFA was added drop wise.  
Once the reaction was completed, an aqueous sodium bicarbonate work up was 
conducted.  The organic layer was collected and concentrated.  Product was purified by 
flash column chromatography (90:1 CH2Cl2:MeOH).  The product was collected as a 
clear oil (200 mg, 48% yield).  1H NMR (300 MHz, CD3CN): δ (ppm) 1.2-1.8 (m, 18H);  
3.1 (t, 2H); 3.9 (t, 2H);  6.9 (s, 1H); 7.1 (s, 1H); 7.5 (s, 1H).    13C NMR (300 MHz, 
CD3OD): δ (ppm) 24.5, 26.9, 27.1, 29.0, 29.2, 29.9, 30.5, 31.9, 32.5, 33.5, 39.9, 51.5, 
120, 126.5, 128, 131, 134.    
[Re(CO)3(4,7-dimethylphenanthroline)(imid-C8-NH-nitroarginine)] [BF4] 
(ReC8argNO2).  145 mg (0.22 mmol) of 1 was stirred with 100 mg (0.25 mmol) of 5 in 
10 mL 1:1 CH2Cl2:THF at 50oC for 2 days.  The yellow precipitate was removed by 
vacuum filtration through a filter frit, and the filtrate was collected and concentrated by 
rotary evaporation.  Product was purified by flash column chromatography (90:1 
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CH2Cl2:MeOH).  The product was collected as a yellow solid (100 mg, 45% yield).  1H 
NMR (300 MHz, CD2Cl2): δ (ppm) 1.0 (broad s, 1H);  1.2-1.8 (m, 18H);  3.0 (s, 6H);  3.2 
(t, 2H);  3.4 (br s, 1H);  3.7 (t, 2H);  6.1 (br s, 1H);  6.4 (s, 1H);  6.7 (s, 1H);  7.3 (s, 1H);  
7.9 (d, 2H);  8.3 (d, 2H);  9.4 (d, 2H).  19F NMR (300 MHz, CD2Cl2): δ (ppm) -151.1 
(4F).  ESI/MS (m/z)+: 880.3 [M]+ (calc 879.3).  
 
 
2.3  RESULTS 
 
Competitive Binding Studies.  To evaluate the spatial relationship between the 
Fe heme and its substrates, the optical spectral changes of the Fe heme was followed 
using UV-Vis spectroscopy.  Addition of L-arginine to iNOSoxy causes a blue shift in the 
Fe heme Soret from λmax = 423 nm six-coordinate, resting-state Fe(III), to λmax = 390 nm 
high-spin, five-coordinate Fe(III), usually considered a type I perturbation; however, the 
addition of imidazole to iNOSoxy causes a red shift of the Fe heme Soret from λmax = 423 
nm to λmax = 427 nm low-spin, six-coordinate Fe(III), called a type II perturbation.16  
This type II perturbation is believed to be a formation of a covalent bond between the 
imidazole ligand with the Fe heme.  The optical changes of iNOSoxy containing 
ReC8argNO2 were studied and compared with the two types of perturbation of the Fe 
heme (Figure 2.2).  The Fe heme Soret band of the protein shifts from λmax = 423 nm to 
λmax = 390 nm, indicative of partial displacement of the water ligand from the active site 































Figure 2.2.  UV-Vis absorption spectra of iNOSoxy in buffer (solid line) and with 1:1 ReC8argNO2 to 
iNOSoxy (dotted line).  The inset is the difference spectrum of the two absorption traces, showing a type I 




Figure 2.3.  Saturation curve of imidazole titrations into 2 μM iNOSoxy sample. 
 























This result, similar to the binding of L-arginine, indicates that ReC8argNO2 does not 
interact covalently with the Fe heme but does bind close enough to the sixth ligand 
binding site of the Fe heme to cause a type I difference spectrum, as shown in Figure 2.2.  
ReC8argNO2 wire does not shift the Fe heme Soret completely high spin at a 1:1 wire to 
protein ratio.  Typically, a full spin shift is observed only with a hundred fold excess of 
arginine to protein.  
The dissociation constant of a substrate can be determined from a saturation curve 
generated by titrations of the substrate into the protein sample.  The double reciprocal 
analysis is conducted by plotting the difference in absorbance intensity, where the 
spectral changes are the largest, against the substrate concentration.  A saturation curve is 
generated for imidazole titration into 2 μM iNOSoxy sample.  The saturation curve is 
generated by taking the difference in absorbance intensity at λmax = 430 minus λmax =  
423 nm plotted against the imidazole concentration (Figure 2.3).  From the saturation 
curve where the protein is half occupied by substrate, the binding constant of imidazole is 
determined to be 12 μM, which is consistent with literature.17,18  A substrate dissociation 
constant can also be quantified by utilizing optical spectral changes caused by an 
inhibitor titrated into a sample containing substrate-bound enzyme, where the substrate 
Kd is known.  The dissociation constant of arginine is determined by competitive binding 
studies against imidazole-bound iNOSoxy.  Arginine is titrated into samples containing 
various concentration of imidazole (10, 20, 50, 100, and 140 μM) bound to iNOSoxy (with 
a constant concentration 2 μM).  A saturation curve is generated (Figure 2.4, only 140 





Figure 2.4.  Saturation curve of arginine titration into (140 μM) imidazole-bound iNOSoxy (2 μM) sample. 
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Figure 2.5.  Double reciprocal plots from UV-Vis competitive binding studies between imidazole and 
ReC8argNO2: 1 / (Abs427 – Abs390) versus 1 / [ReC8argNO2].  iNOSoxy (2μM) was titrated with ReC8argNO2 
at a fixed concentration of imidazole for each sample: square, 5 μM imidazole; diamond, 10 μM imidazole; 
triangle, 30 μM imidazole; circle, 50 μM imidazole.   
 





















titration of arg into
 140uM imid bound iNOSoxy
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In a sample containing 2.0 μM iNOSoxy and 140 μM imidazole, the protein was 
observed to be half occupied by arginine at 200 μM of arginine, indicating that the Kapp 
(arg) = 200 μM.  A Kd of arginine can be determined by accounting for the concentration 
and dissociation constant of imidazole, Kapp = αKd, giving a Kd of 16 μM for arginine 
(see Experimentals), which is also consistent with literature values.19 
A similar competitive binding study of imidazole bound iNOSoxy with titrations of 
ReC8argNO2 was conducted.  Four samples of iNOSoxy containing different 
concentrations of imidazole (5, 10, 30, and 50 μM) were titrated with ReC8argNO2 wire 
from 0 – 100 μM.  Optical spectral changes from λmax = 427 nm to λmax =  390 nm were 
obtained, which is indicative of ReC8argNO2 displacing imidazole from the active site.   
The inverse of the difference in absorption intensity (λmax = 427 nm minus λmax = 
390 nm) was calculated and plotted against the inverse of the concentration of 
ReC8argNO2, creating a double reciprocal plot (Figure 2.5).  The double reciprocal plot 
gave one y-intercept and many x-intercepts, indicative of a competitive binding 
mechanism of ReC8argNO2 with imidazole.  A Kd of 3 ± 0.1 μM for ReC8argNO2 was 
obtained from the average of the slopes of the lines.  This dissociation constant is much 
smaller than both arginine (16 μM) and imidazole (12 μM), indicating that ReC8argNO2 
is a better inhibitor. 
 
Steady-State Fluorescence.  A dissociation constant was also determined for 
ReC8argNO2 by Scatchard analysis of steady-state fluorescence experiments.  When wire 
is bound to iNOSoxy, the emission of the Re(I) excited state (Re(I)*) will decrease in 
intensity compared to the emission intensity of Re(I)* of wire in buffer (Figure 2.6), 
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owing to either energy or electron transfer processes between ReC8argNO2 and the Fe 
heme.  Fluorescence data was measured by exciting into the rhenium MLCT band at 355 
nm.  The PMT is equipped with a 405 nm long pass filter (LPF) to filter any scattered 
laser light during data collection.  There is a slight shift in emission λmax when 
ReC8argNO2 is in a protein environment (λmax = 550 nm) versus when ReC8argNO2 is in 
buffer (λmax = 570 nm).  A decrease in Re(I)* emission intensity implies that either 
fluorescence energy transfer (FET) or electron transfer (ET) is occurring between the 
Re(I)* and a chromophore of the protein, such as the Fe heme or an aromatic amino acid 
residue.   
In order to determine the equivalent of wire-bound to protein, the emission 
intensity of Re(I)* was obtained at various ratios of ReC8argNO2 to protein samples 
(Figure 2.7).  As wire concentration increases, so does the Re(I)* emission intensity.  The 
emission traces of ReC8argNO2 in buffer are shown as dotted lines, and the emission 
traces of ReC8argNO2 in the presence of protein are shown as solid lines.  At 3:1 wire to 
protein concentration (Figure 2.7, third solid line from the bottom), the Re(I)* emission 
intensity overlaps with the emission intensity of Re(I)* of one equivalent of wire in 
buffer (Figure 2.7, first dotted line from the bottom).  Assuming that bound wire has no 
emission, it is inferred that at 3:1 wire to protein concentration, two equivalents of wire 
are bound to protein, and one equivalent is free in solution.  Furthermore, at 4:1 wire to 
protein concentration (Figure 2.7, fourth solid line from the bottom), the Re(I)* emission 
intensity overlaps with the emission intensity of Re(I)* of two equivalents of wire in 
buffer (Figure 2.7, second dotted line from the bottom), also suggesting that two equiv. of 
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Figure 2.6.  Steady-state fluorescence traces of ReC8argNO2 in buffer (solid line) and 1:1 ReC8argNO2 to 
iNOSoxy (dotted line).  A decrease in fluorescence indicates either energy or electron transfer between 





Figure 2.7.  Steady-state fluorescence spectra of ReC8argNO2 titration in buffer (dotted lines) and 
ReC8argNO2 titration into 1 μM iNOSoxy sample.  At 3:1 wire to protein ratio, two equivalents of wire are 
bound to protein while only one equivalent is free in solution, indicative of the fluorescence intensity 























 1uM iNOS + 1uM Re-C8-arg-NO2
 1uM iNOS + 2uM Re-C8-arg-NO2
 1uM iNOS + 3uM Re-C8-arg-NO2
 1uM iNOS + 4uM Re-C8-arg-NO2
 1uM iNOS + 5uM Re-C8-arg-NO2
 1uM iNOS + 6uM Re-C8-arg-NO2









The dissociation constant can be extracted out of the above steady-state 
fluorescence data by a Scatchard analysis.  Using data analysis programs, the area under 
the emission curves can be calculated, a ratio of bound wire to free wire is determined, 
and the ratios are plotted against the initial concentration of wire creating a Scatchard plot 
(Figure 2.8).   
The Scatchard plot shows two distinct lines with two different slopes, suggesting 
two binding modes.  With the slope of the lines, a dissociation constant can be calculated.  
At 4:1 wire to protein ratio, the wire binds mostly in one binding site with a Kd of 2 μM ± 
100 nM, which is consistent with values for UV-Vis competitive binding study with 
imidazole.  This first binding site is assumed to be the active site channel where 
ReC8argNO2 would be competitive with imidazole, shown previously by UV-Vis 
competitive binding studies.  At ratios greater than 4:1 wire to protein, the wire binds at a 
second binding site with a Kd of 12 ± 1 μM.  This second binding site is assumed to be on 
the surface of the protein.  It is concluded that as long as wire to protein ratios are kept 












Figure 2.8.  Scatchard analysis of steady-state fluorescence data.  Assuming that wire-bound to protein 
has no fluorescence, a ratio of bound wire to free wire was calculated.  A plot of [bound wire] / [free 
wire] against [wire] was generated.  The y-intercept = n[P]T / Kd; x-intercept = [S]max; slope = -1 / Kd, 
and n = number of binding sites.  Two distinct lines with two distinct slopes indicates two modes of 

































a = 3.7585 ± 0.387
b = -0.8581 ± 0.141
Kd = -1/slope = 1.17uM
 
[wire] = 4-6uM
a = 0.8175 ± 0.171
b = -0.0785 ± 0.0338
Kd = -1/slope = 12.7uM
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Transient Luminescence.   
 
Transient luminescence traces were measured with a 355 nm excitation 
wavelength and probed at 600 nm.  With transient luminescence spectroscopy, it was 
determined that Re(I)* excited state lifetime has a monoexponential decay rate of 500 ns 
(Figure 2.9).  This lifetime is half the decay rate of other rhenium systems.15,20  
Luminescence decay traces are measured for samples containing ReC8argNO2 in the 
presence of protein.  These decay traces exhibit a biexponential decay (Figure 2.10).  The 
faster lifetime corresponds to the bound ReC8argNO2 (τ = 92 ns), and the slower decay 
rate corresponds to ReC8argNO2 in buffer (τ = 500 ns).  Luminescence decay traces were 
obtained for various ratios of ReC8argNO2 to protein.  From Figure 2.11, traces of 
ReC8argNO2 in buffer are shown as dotted lines, and traces of ReC8argNO2 in the 
presence of protein are shown as solid lines.  As the concentration of wire increases, the 
luminescence intensity of Re(I)* also increases.  All transient luminescence traces of 
ReC8argNO2 in the presence of protein exhibit biexponential decays with a fast rate (τ ~ 
90 ns) and a slow rate (τ ~ 500 ns).   
At 3:1 wire to protein concentration (Figure 2.11, third solid line from the 
bottom), the slower decay rate of the luminescence decay trace overlaps with the 
luminescence decay trace of one equivalent of wire in buffer (Figure 2.11, first dotted 
line from the bottom).  This suggests that at 3:1 wire to protein concentration, two 
equivalents of wire are bound to protein, and one equivalent of wire is free in solution, 
indicating a 2:1 binding mode.  This is consistent with results from steady-state 
fluorescence data.  Furthermore, luminescence decay trace for 4:1 wire to protein 
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concentration (Figure 2.11, fourth solid line from the bottom) overlaps with the 
luminescence decay trace of two equivalents of wire in buffer (Figure 2.11, second dotted 
line from the bottom), indicative of two equivalents of wire bound to protein and two 


































Figure 2.9.  Transient luminescence trace of 2.4 μM ReC8argNO2 (solid line), monoexponential fit (dashed 
line), and residual fit (dotted line above).  The lifetime decay of τ = 500 ns was calculated from the 































 4.8uM ReC8argNO2 + 2.4uM iNOS
 4.8uM ReC8argNO2




Figure 2.10.  Transient luminescence decay traces of 4.8 μM ReC8argNO2 (dotted line), 1:1 ReC8argNO2 : 
iNOSoxy (solid line), biexponential fit (dashed line), and residual fit (dotted line above).  A lifetime decay of 
τ (1) = 500 ns and τ (2) = 92 ns.  The slow lifetime is concluded to be free wire in solution, and the short 
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 4.8uM ReC8argNO2  + 2.4uM iNOS
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Figure 2.11.  Transient luminescence trace of ReC8argNO2 titration into buffer (dotted lines) and 2.4 μM 
iNOSoxy sample (solid lines).  The overlap in luminescence intensity of 3:1 wire to protein sample with 1 
equivalent of wire in buffer sample indicates a 2:1 binding mode of wire to iNOSoxy (arrow).  (λex = 355 




Transient Absorbance.  Single wavelength transient absorption traces were 
measured by 355 nm excitation wavelength and probed every 10 nm from 380 – 450 nm.  
From transient absorption data, Re(I)* has an absorption decay of ~ 580 ns, close to the 
luminescence decay trace of Re(I)* (Figure 2.12).  The absorption curve of Re(I)* can be 
generated by plotting the transient absorption intensity against the probed wavelength at 
various time scales (Figure 2.13).  Re(I)* is shown to have a broad absorption band with 
a λmax at 430 nm that completely decays after two microseconds, shown as a relatively 
flat line.   
Single wavelength transient absorption spectra were also taken of 10 μM iNOSoxy 
in the presence and absence of 80 μM ReC8argNO2.  iNOSoxy was shown to have no 
detectable absorption at any wavelength when excited at 355 nm.  There is a visible spike 
at a short timescale that is due to laser light scattering off of the protein surface (Figure 
2.14, dotted trace).  A transient absorption trace of a sample of 8:1 ratio of wire to protein 
shows a rise in absorption signal that aligns well with the Re(I)* absorption signal of six 
equivalents of wire in buffer; however, after one microsecond, there is another longer-
lived absorption signal that appears as an increase in baseline.  The baseline increase is 
not due to Re(I)* absorption signal.  Since the 8:1 wire to protein sample aligns well with 
the 6 equivalents of wire trace, this again suggests that two equivalents of wire are bound 
to the protein, creating a longer lived species upon 355 nm excitation.  From steady-state 
fluorescence data of concentration greater than 4:1 ReC8argNO2 to protein, it was 
concluded that a second binding site exists.  However, at a nanosecond timescale of 























tau = 580 ns
 
 
Figure 2.12.  Transient absorption trace of 60 μM ReC8argNO2, absorption of Re(I)* (solid line), 
monoexponential fit (dashed line), and residual (dotted line).  An absorbance lifetime decay of τ = 580 ns is 
calculated.  (λex = 355 nm, λobs = 430 nm).  
 
 
























Figure 2.13.  Re(I)* absorption curve generated from transient absorption traces by plotting the transient 
absorbance intensity at various timescales (star, 0.3 μs; diamonds, 0.5 μs; triangles, 1 μs; and rectangles, 2 
μs) against the probed wavelength.  Re(I)* decays after t = 2 μs, indicative of the flat line. 
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A long-lived species generated after Re(I)* decays is proposed to be the transient 
Fe(II) absorption signal produced by direct electron transfer from the Re(I)* state.  The 
immediate appearance of the Fe(II) species indicates that Fe(II) is being created in less 
than 10 ns (the instrument response limit), which is orders of magnitude faster than the 
naturally-generated Fe(II) species produced under biological conditions (kET = 1 s-1).6,21  
 Single wavelength transient absorption traces of various concentrations of 
ReC8argNO2 to protein are shown in Figure 2.15.  A sample of iNOSoxy in buffer exhibits 
a spike from laser scattering off the protein surface.  As wire concentration increases, the 
Re(I)* signal increases with a decay of ~ 500 ns.  A longer-lived species is also shown to 
increase in intensity as wire concentration increases; however, the Fe(II) signal starts to 
level off at 4:1 wire to protein concentration, suggesting that this is the optimal wire to 
protein ratio for maximum binding and Fe(II) production.   
A difference spectrum of the transient species can be obtained by plotting the 
intensity of transient absorption traces against the probed wavelength for every 10 nm 
(Figure 2.16).  The difference spectra show a decrease in intensity within the 390 – 425 
nm region, an isobestic point at 438 nm, and an increase in absorption intensity at around 
445 nm.  The bleach at ~ 423 nm is most likely due to the disappearance of the resting 
state Fe(III).  The Fe(III) is proposed to get reduced by the photo-excited state of the 
Re(I) ground state, creating a transient Fe(II) signal assigned to have an absorbance at 
λmax = 445 nm.  However, 5-coordinate Fe(II) heme species general absorbs with a λmax 
in the mid 400 nm region.22,23  If the signal is indeed Fe(II), then the signal has a huge 















 80uM wire + 10uM iNOS
 
Figure 2.14.  Transient absorption decay traces for 10 μM iNOSoxy (dotted line), 60 μM ReC8argNO2 (open 
circles) and 8:1 ReC8argNO2 to iNOSoxy (solid line).  The Re(I)* absorbance from 80 μM ReC8argNO2 in 
10 μM iNOSoxy sample overlaps with the Re(I)* absorbance of 60 μM ReC8argNO2, indicating that 20 μM 
ReC8argNO2 is quenched by protein (2:1 binding mode), generating a long-lived species (baseline increase 
after 1 μs). (λex = 355 nm, λobs = 443 nm). 
 
 
Figure 2.15.  Transient absorption spectra of titrations of ReC8argNO2 into 9.6 μM iNOSoxy.  The transient 
absorbance of the long-lived species levels off after 4:1 ReC8argNO2 to protein, indicating an optimal 













 9.6uM Re-C8-arg-NO2 + 9.6uM iNOS
 19.2uM Re-C8-arg-NO2 + 9.6uM iNOS
 28.8uM Re-C8-arg-NO2 + 9.6uM iNOS
 38.4uM Re-C8-arg-NO2 + 9.6uM iNOS
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The long-lived species was then proposed to be a six-coordinate Fe(II) product, 
instead of the expected five-coordinate Fe(II) species.  A six-coordinate Fe(II) species 
was previously characterized to absorb around 450 nm for ligands such as CO, NO, and 
O2.24,25  Since this long-lived Fe(II) species lives for hours, it was possible to further 
characterize it by steady-state optical spectroscopy after photo-excitation. 
Figure 2.17 shows a UV-Vis trace of iNOSoxy (solid line, λmax = 423 nm), 
ReC8argNO2- bound iNOSoxy before photo-excitation (dotted line, λmax = 390 nm), and 
ReC8argNO2-bound iNOSoxy after photo-excitation (open circle, λmax = 445 nm).  A 
difference spectrum is shown as the inset.  After laser excitation, there is a decrease in the 
390 - 420 nm region and a slight increase around 445 nm, indicative of a disappearance 
and appearance of a 5-coordinate Fe(III) species and a 6-coordinate Fe(II) species, 
respectively.  After a couple of hours, the six-coordinate Fe(II) species is returned to its 
Fe(III) ground state.  This Fe(II) signal at 445 nm is confirmed by UV-Vis and transient 
absorbance spectroscopy; however, neither method gives a definitive nature of the Fe 
heme coordination or spin state.  Resonance Raman was utilized to help fully characterize 































Figure 2.16.  Difference spectra generated from transient absorption data by plotting the absorbance 
intensities at various timescales (circle, 1.5 μs; triangle, 1.5 μs; diamond, 3.5 μs) against the probed 
wavelength for every 10 nm.  There is an Fe(III) bleach at 423 nm and an increase at 445 nm assigned as 

















 24uM ReC8argNO2 + 12uM iNOS










Figure 2.17.  UV-Vis spectra of iNOSoxy (solid line), ReC8argNO2 bound iNOSoxy before photo-excitation 
(dashed line) and after photo-excitation (open circles).  The difference of before and after photo-excitation 
traces shown as the inset, indicating a λmax = 423 nm disappearance and a λmax = 445 nm disappearance. 
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Resonance Raman.  Resonance Raman scattering is a highly sensitive technique 
used to characterize heme environments, specifically the Fe heme spin, oxidation, and 
ligation states.  The resonance Raman spectra of cytochrome P450 enzymes have been 
extensively studied, which provided many insights on Fe porphyrin structural changes 
brought on by substrate binding.26,27   
Further characterization of the produced long-lived, 6-coordinate Fe(II) species 
from ReC8argNO2 photo-excitation was done using resonance Raman spectroscopy.  
Resonance Raman spectroscopy was conducted by Soret excitation at 441.6 nm with a 
continuous wave He/Cd laser beam.  Resonance Raman spectroscopy was used to study 
the structural and functional relationship of the ReC8argNO2-bound iNOS Fe heme 
before and after 355 nm photo-excitation from the Nd:YAG pulse laser.  The high 
frequency region is sensitive to oxidation and coordination states of the Fe heme.22  The 
ν4 vibrational Fe  heme mode in the 1340 - 1380 cm-1 region is sensitive to the electron 
density of the heme macrocycle, which makes it a good indicator of the oxidation state of 
the Fe heme.  The ν3 vibrational Fe heme mode in the 1475 - 1520 cm-1 region is 
sensitive to both coordination state and oxidation state of the Fe heme.  The ν2 vibrational 
heme mode in the 1560 - 1590 cm-1 region is sensitive to the coordination state only.  The 
low frequency region (200 - 800 cm-1) can be used to identify the sixth ligand vibrational 
stretches or bending modes to the Fe heme; however, the low frequency region was not 
examined in this study because of difficulty in getting good signal to noise ratios.     
The high frequency resonance Raman spectra of substrate-free, low spin, 6-
coordinate Fe(III) iNOSoxy is shown in Figure 2.18a.  A typical spectrum of high-spin 5-
coordinate Fe(III) was obtained with addition of arginine (Figure 2.18b).  The difference 
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between arginine-free and arginine-bound iNOSoxy is shown in Figure 2.18d.  Comparing 
arginine-free iNOSoxy against arginine-bound iNOSoxy, there are four visible peak shifts  
at 1625, 1561, 1487, and 1370 cm-1, indicative of changes in the resonance Raman 
marker lines from six-coordinate low spin Fe(III) to five-coordinate high spin Fe(III).  
Peak summary from this study compared to literature values are shown in Table 2.1.   
 
Table 2.1:  Resonance Raman Marker Lines (cm-1) for High-/Low-Spin Ferric/Ferrous iNOS 
 ν4 ν3 ν2 ν10 Ref. 
Low spin 6-coordinate Fe(III) 1372 1500 1571 1625,1637 28 
High-spin 5-coordinate Fe(III) 1370 1487 1535,1561 1625 28 
iNOSoxy 1372.8 1490,1504 1575 1628,1640 This work 
iNOSoxy + arginine 1367 1488.5 1562.3 1628.7 This work 
Fe(II) nNOSoxy (-arg) 1349,1359    29 
Fe(II)-NO nNOSoxy       (-arg), (+arg) 1376 1508  1646 30 
iNOSoxy + ReC8argNO2 1355.3 1444.2,1375 1582  This work 
Fe(II) after ReC8argNO2 photolysis 1375 1502.1 1580 1639.9 This work 
 
A similar study was done with ReC8argNO2-free and ReC8argNO2-bound 
iNOSoxy, Figure 2.18c.  A similar spectral shift was expected with arginine; however, the 
difference trace of wire-free and wire-bound iNOSoxy is more complicated (Figure 2.18e).  
The difference trace does not exhibit any clear differences between high-spin and low-
spin Fe(III).  There seems to be a mixture of both 1372 and 1370 cm-1 vibrational modes, 
shown as a broad peak in that region.  Other vibrational modes were also very broad, 
which did not allow for clear spectral shift distinctions between wire-free and wire-bound 
iNOSoxy. 
A sample wire bound to iNOSoxy photo-excited at 355 nm by an Nd:YAG pulse 
laser was also probed by resonance Raman spectroscopy for characterization of photo-

























Figure 2.18.  Resonance Raman traces of arginine and ReC8argNO2 bound to iNOSoxy. (a) iNOSoxy; (b) 
iNOSoxy + arginine; (c) iNOSoxy + ReC8argNO2; (d) difference of trace of a minus b; and (e) difference of 























Figure 2.19.  Resonance Raman traces of ReC8argNO2 bound to iNOSoxy before and after photo-excitation.  
(a) iNOSoxy; (b) ReC8argNO2 + iNOSoxy after 355 nm laser excitation; and (c) difference of a minus b. 
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The wire-bound iNOSoxy sample was excited at 355 nm wavelength with an Nd:YAG 
pulse laser and then probed by resonance Raman spectroscopy at 441.6 nm with a 
continuous wave He/Cd laser.  The resonance Raman trace of photo-excited wire-bound 
iNOSoxy exhibits a shift in the ν4 marker line from 1372 cm-1 to 1376 cm-1 (Figure 2.19b), 
which is higher energy than what is expected for a 5-coordinate Fe(II) species.  The 
difference trace of wire-bound iNOSoxy before 355 nm photo-excitation minus wire-
bound iNOSoxy after 355 nm photo-excitation exhibits negative features in the 1625, 
1561, and 1487 cm-1 marker lines.  These are vibrational modes for 5-coordinate Fe heme 
species (Figure 2.19c).28  Positive features were also observed in the 1637, 1571, and 
1500 cm-1 marker lines, which are vibrational modes for 6-coordinate Fe heme species.28  
This suggests that the Fe species that is produced after 355 nm photo-excitation of the 
wire is a six-coordinate Fe species.  However, the oxidation state of the Fe species and 
the source of the sixth ligand is still not clear. 
The high energy shift in the ν4 marker line at 1376 cm-1 has been reported in the 
literature for an iNOSoxy Fe(II)-NO species,29 (Table 2.1).  Although there should not be 
any NO in this system, there is a terminal nitro group of the wire that is electronically 
similar to NO and could potentially coordinate with the Fe heme once the heme is 
reduced to the Fe(II) oxidation state.  It is concluded and fully supported by spectroscopy 
that the transient Fe species produced after photo-excitation of  ReC8argNO2-bound 
iNOSoxy is indeed a six-coordinate Fe(II) species with a possible nitro group as the sixth 




2.4  DISCUSSIONS 
 
Model of ReC8argNO2 in Active Site.  Using the DS Viewer Pro Protein 
Modeling program, ReC8argNO2 was modeled into the active site of nNOSoxy (PDB code 
1MMV), which has similar structures to iNOSoxy, but with available highly resolved 
crystal structures (Figure 2.20).  The arginine end of the wire (mauve) lays parallel to the 
Fe heme in a similar fashion as arginine.  The necessary hydrogen bonding interactions 
are retained between the guanidinium group of the wire and the Gly365, Trp366, and Glu371 
amino acid residues.  The rhenium end of the wire is modeled at the opening of the active 
site channel, closely interacting with two tryptophan residues (Trp490 and Trp84, shown in 
orange).  These two tryptophans are proposed to aid in electron transfer from the wire 
excited state to the Fe heme.  Trp490 and Trp84 are estimated to be 2.98 Å and 4.96 Å 
away from the phenanthroline ligand, respectively, both of which are within Förster 
energy transfer distances.  The active site channel is about 20 Å between the opening of 
the channel to the Fe heme.  From transient absorption measurements, the Fe(II) species 
was shown to be  created in less than 10 ns after photo-excitation of the rhenium center.  
This suggests that electrons would have to travel the distance of 20 Å in order to reach 
the heme for photo-reduction of Fe(III) to Fe(II) to occur.  According to the ET tunneling 
time table (Figure 2.21), electron transfer in protein systems at a distance of 20 Å have 
only been shown to travel as fast as kET = 10-7.31  In this system, in order for electron 
transfer to occur in less 10 ns, there must be another mechanism involved other than 












Wire is parallel 
to the heme plane 
 
Figure 2.20.  Model of ReC8argNO2 in iNOSoxy active site. 
 
 
Figure 2.21.  Tunneling timetable for intraprotein ET in ruthenium-modified azurin (blue circles), cyt c 
(red circles), myoglobin (yellow triangles), cyt b562 (green squares), HiPIP (orange diamonds), and for 
interprotein ET, Fe : Zn - cyt c crystals (fushia triangles).  Solid lines illustrate the tunneling pathway 
predictions for coupling along β - strands (β = 1.0 Å-1) and α-helices (β = 1.3 Å-1); dashed lines illustrate a 
1.1 Å-1 distance decay.  Distance decay for electron tunneling through water is shown as cyan wedge.  
Estimated distance dependence for tunneling through vacuum is shown as black wedge.31 
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Proposed ET Mechanism.  From UV-Vis spectroscopy, there is a spectral shift 
(423 nm to 390 nm) upon binding of ReC8argNO2 to iNOSoxy.  This indicates that a water 
ligated to a low spin, six-coordinate Fe(III) species shifted to a high spin, five-coordinate 
Fe(III) species (Scheme 2.4, step 1).  Upon 355 nm wavelength photo-excitation, Re(I) is 
promoted to its excited state, Re(I)*, Scheme 2.4, step 2.   
Re(I)* does not have a high enough potential to efficiently reduce (kET < 10 ns) 
the Fe heme at such a long distance (20 Å).   
Table 2.2.  Reduction Potentials 




Low spin iNOSoxy (FeIII/II) -0.3534 
Low-spin P450cam (FeIII/II) ~-0.335,36 
 
Electron transfer would be predicted to occur much slower if a direct ET mechanism is 
the case for this system.  From modeling studies, it is possible that a nearby tryptophan 
would quench the Re(I)*, reducing the Re(I)* to Re(0).  The tryptophan would then be 
oxidized, Scheme 2.4, step 3.  Re(0) definitely has a high enough potential for efficient 
long-range electron transfer and to reduce the Fe(III) to Fe(II).  From transient absorption 
and resonance Raman data, the Fe(II) species is shown to have a sixth ligand that is 
similar to NO.  The wire has a nitro terminated arginine substrate that is electronically 
similar to NO and interacts closely with the Fe heme.  Upon photo-reduction of the Fe 
heme, it is proposed that the nitro group itself ligates the Fe(II) heme, creating a low spin, 
six-coordinate Fe(II) species that is detectable by transient absorption and resonance 
Raman spectroscopy (Scheme 2.5).  This mechanism may explain why most guanidinium 
terminated inhibitors do not generate NO via a substrate ligation mechanism, preventing 
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the mechanism from going to completion.  Then, after two hours, the oxidized tryptophan 
is proposed to undergo a series of electron transfer processes with other tryptophan and 
tyrosine residues before oxidizing the Fe(II) back to its Fe(III) resting state (Scheme 2.4, 
step 5).  The N-nitro group ligation could also be the same mechanism for an N-oxy 
ligation of N-hydroxyarginine during the second turnover of the catalytic cycle (Scheme 
2.6).  It was proposed that the Fe-O bond is the initiation of the second turnover, reducing 
Fe(III) to Fe(II) by the N-hydroxyarginine.37  The Fe is then five-coordinate again in 
order to bind oxygen and completes the mechanism.  This mechanism can be better 


































Scheme 2.4.  Proposed electron transfer mechanism.  Upon binding of ReC8argNO2 to iNOSoxy, the Fe 
heme shifts from low spin Fe(III) to high spin Fe(III) (step 1).  Upon 355 nm photo-excitation, the Re(I) is 
promoted to its excited state, Re(I)* (step 2).  A nearby Trp quenches the Re(I)* to generate an (+) Trp and 
Re(0) (step 3).  The produced Re(0) injects an electron into the Fe(III) heme to produce a low spin, six-
coordinate Fe(II) species (step 4).  The (+)Trp recombines with the Fe(II) species, and the electron transfer 
cycle is complete.  A direct electron transfer from the Re(I)* state was concluded unlikely owing to a small 

















































Scheme 2.5.  Two proposed N-nitro group ligation mechanisms.  (A) The produced Fe(II) species could 
attack the nitrogen of the nitro protecting group and cleave it from the arginine wire, generating a Fe(II)-
NO2 species.  This proposal is electronically similar to the Fe(II)-NO species (shown inside the box), 
characterized by resonance Raman.  (B) A second possible mechanism is proposed where the Fe(II) species 
ligates the oxygen of the nitro protecting group, similar to N-hydroxyarginine ligation of the Fe(II) heme 
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Scheme 2.6.37  Proposed N-oxy ligation of N-hydroxyarginine to the Fe(II) heme during the second 







2.5  CONCLUDING REMARKS 
 
The catalytic mechanism of iNOSoxy was investigated by ReC8argNO2 wire to 
characterize intermediates produced by laser-induced electron transfer to the active site of 
the enzyme.  ReC8argNO2 was shown to displace water from the active site upon binding.  
Spectral absorbance of the wire-bound iNOSoxy sample exhibited an optical spectral shift 
at 423 nm to 390 nm,  indicative of a resting state, low spin, six-coordinate Fe(III) heme 
shifting to a high spin, five-coordinate Fe(III) heme, respectively.  ReC8argNO2 
competitively binds with imidazole and L-arginine from competitive binding studies.  
The Kd for ReC8argNO2 was determined to be 3 ± 1 μM, which is a smaller binding 
constant than both L-arginine (Kd = 16 μM) and imidazole (Kd = 12 μM).  Transient 
absorption measurements show that Fe(III) is reduced to Fe(II) in less than 10 ns, orders 
of magnitude faster than reduction by the reductase domain (kET = 0.9 – 1.5 s-1).6,21  Upon 
photo-production of five-coordinate Fe(II), the nitro group moiety of the ReC8argNO2 
wire ligates the Fe(II) heme.  This may further support a mechanism of N-
hydroxyarginine ligation with the Fe heme during the second turnover of the catalytic 
cycle.  ReC8argNO2 has proven to be a novel fluorescent inhibitor, giving insights into 
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PHOTOREDUCTION OF INDUCIBLE NITRIC OXIDE SYNTHASE  




















Two sensitizer-linked substrates (wires), ReC3arg and ReC3argNO2, were 
synthesized to probe the catalytic cycle of iNOSoxy.  The wires were based on the 
structure and composition of ReC8argNO2 from Chapter II.  Although similar in length 
and structure, the two wires have different binding modes and affinities for inducible 
nitric oxide synthase (iNOS).  Upon binding of ReC3arg, a type II perturbation was 
observed with a Kd of 2 μM ± 500 nM.  In contrast, ReC3argNO2 exhibited a type I 
perturbation with a Kd of 7 μM ± 1 μM.  ReC3arg and ReC3argNO2 have an excited state 
lifetime decay of 577 ns and 473 ns, respectively.  The Re(I)* excited states of both wires 
were reductively quenched by ascorbate and para-methoxy-N,N’-dimethylaniline 
(pMDA).  The Re(0) was generated after reductive quenching and subsequently reduced 
Fe(III) to Fe(II) in less than 10 ns.  The first two steps of the catalytic cycle were 











3.1  INTRODUCTION 
 
 The first arginine-based wire, ReC8argNO2, was designed and synthesized for the 
oxygenase domain of inducible nitric oxide synthase (iNOSoxy) (Figure 3.1), as described 
in Chapter II.  This wire had a small rhenium metal center, an eight carbon chain length, 
and a nitro group-protected arginine substrate at the terminus.  ReC8argNO2 exhibits a 
type I perturbation upon binding of iNOSoxy with high affinity (Kd = 3 ± 1 μM).  After 
355 nm photo-excitation, Re(I) was promoted into its excited state, where direct energy 
transfer was established with a nearby tryptophan.  The wire was reduced from Re(I)* to 
Re(0).  Upon production of Re(0), electron transfer occurred between the wire and the 
iron (Fe) heme, reducing the resting state Fe(III) to the transient Fe(II) species.  The nitro 
group at the wire terminus ligates the generated Fe(II) species, creating a six-coordinate 
Fe(II) complex that was long-lived enough to be characterized by transient absorbance, 
UV-Vis, and resonance Raman spectroscopy.  The ligation of the wire to the Fe heme 
upon production of Fe(II) gave insights on the mode of binding and inhibition of 
substrates at protein active sites during catalytic turnovers.   
 Two shorter wires were then designed to further probe the iNOSoxy catalytic cycle 
with hopes to produce a five-coordinate Fe(II) to further characterize short-lived 
intermediates further down the catalytic cycle.  The wires were designed to be only three 
carbons-long in linker length.  One wire was synthesized with a nitro protecting group at 
the terminus, ReC3argNO2, and the other with the arginine substrate fully deprotected, 



































































B: ReC3argNO2  
 




These shorter wires were proposed to not have the length or mobility to fully extend 
down the active site channel to ligate the Fe heme.  The photo-reduced Fe(II) would then 
remain five-coordinate, keeping the sixth ligand site open for dioxygen.  These wires are 




3.2  EXPERIMENTALS 
 
General.  Expression and purification of iNOSoxy is described in Appendix B.  
All materials used during wire synthesis were purchased from Aldrich unless otherwise 
stated.  Wire and protein sample preparations were similar to what was described in 
Chapter II.  Dissociation constants were determined by two techniques: double reciprocal 
plots of UV-Vis competitive-binding studies and Scatchard analysis of steady-state 
fluorescence and transient luminescence experiments.  The detailed methods are 
described in Chapter II under “Experimentals.”  Transient absorbance and transient 
luminescence experiments were conducted and analyzed as previously described in 
Chapter II.  UV-visible absorption spectra were taken on an Agilent 8453 UV-Vis 
spectrometer.  Steady-state emission measurements were made in buffer using a Flurolog 
Model FL3-11 fluorometer equipped with a Hamamatsu R928 PMT.  All laser 
experiments were carried out in atmosphere-controlled 1 cm or 0.5 cm path length 
cuvettes equipped with Kontes valve for pump purge cycles.   
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Synthesis.  Rhenium complex was synthesized as previously described in Chapter 
II.  In summary, rhenium pentacarbonyl chloride was stirred in toluene with dimethyl 
phenanthroline at 50oC (Scheme 3.1).  A yellow precipitate was formed and collected by 
pressure filtration through celite.  The precipitate was dissolved from celite with 
dichloromethane, the filtrate was collected, and carried on without further purification.  
The product was stirred with silvertetrafluoroborate in anhydrous THF at room 
temperature overnight.  The product as a BF4 salt was formed, collected, and purified by 

































Scheme 3.1.  Synthesis of rhenium metal complex. 
 
ReC3arg Synthesis.  Propyl-imidazolyl-arginine ligand was synthesized in two steps: an 
EDC coupling reaction and a dual deprotection step.  A final metalation step was 
conducted to complete the wire synthesis (Scheme 3.2).  Amino-propyl-imidazole 
substrate was coupled with bis-carboxybenzoyl-protected arginine by an EDC coupling 
reaction.  EDC activates the carboxylic acid group, leaving the amines untouched.  The 
primary amine of the amino-propyl-imidazole attacks the activated carboxylic acid group, 
creating an amide bond.  The ligand is then deprotected by a dehydrogenation reaction 
using a Pd/C catalyst.  The final step of the synthesis is the metalation reaction of the 
























































Scheme 3.2.  Synthesis of ReC3arg wire. 
 
 
Propyl-imidazolyl-bisCBz-arginine (imidC3CBzarg).  800 mg (1.8 mmol) 
Biscarboxybenzolylarginine and 520 mg (2.7 mmol) 1-ethyl-3-[3-demethyl-aminopropyl] 
carbodiimide hydrochloride (EDC) were stirred in a flask containing 15 mL (0.09 M) 
THF.  260 μL (2.2 mmol) aminopropylimidazole was added, heated to 50oC, and stirred 
overnight.  The reaction mixture turned from clear to a brown orange solution.  The 
solution was concentrated by rotary evaporation and purified by flash column 
chromatography (10:1 CH2Cl2:MeOH) to collect a yellow oil product (920 mg, 92% 
yield).  1H NMR (300 MHz, CD2Cl2):  δ (ppm) 1.2-1.8 (m, 12H); 4.0 (t, 2H), 5.1 (broad 
s, 4H); 6.9 (s, 1H), 7.1 (s, 1H), 7.4 (broad m, 10H), 7.6 (s, 1H).  
Propyl-imidazolyl-arginine (imidC3arg).  920 mg (1.6 mmol) imidC3CBzarg and 178 
mg (1.6 mmol) Pd/C (5% wt) were added to a round bottom flask which was pumped and 
purged with argon.  8 mL anhydrous MeOH was added, pumped, and purged with argon.  
A balloon filled with H2 gas was attached to the flask with a needle, and the reaction was 
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stirred at 40oC overnight.  Pd/C was filtered off, and the filtrate was collected and 
concentrated by rotary evaporation to a yellow oil.  The product was carried on to the 
next step without purification (203 mg, 43% yield).  1H NMR (300 MHz, CD2Cl2):  δ 
(ppm) 1.2-1.8 (m, 12H); 4.0 (t, 2H); 6.9 (s, 1H), 7.1 (s, 1H), 7.6 (s, 1H).  ESI/MS (m/z)+ 
282.15 (calc 281.36). 
[Re(CO)3(dmp)(imidC3arg)][BF4] (ReC3arg).  410 mg (0.64 mmol) (1) and 200 mg 
(0.71 mmol) imidC3arg were added to 20 mL (1:1) CH2Cl2:THF mixture.  The reaction 
was stirred at 50oC for 2 days.  The reaction mixture was concentrated by rotary 
evaporation and purified by flash column chromatography (CH2Cl2 was used as the first 
eluent, and the final eluent was 50:3 CH2Cl2:MeOH).  The product was collected as a 
yellow solid (43 mg, 8% yield).  The product was unstable on silica gel.  Another 
purification method was not explored.  Enough material was collected for experiments.  
1H NMR (300 MHz, CD2Cl2):  δ (ppm) 1.2-1.8 (m, 12H); 3.0 (s, 6H); 4.0 (t, 2H); 6.4 (s, 
1H), 6.9 (s, 1H), 7.5 (s, 1H); 7.8 (d, 2H); 8.2 (s, 2H); 9.3 (d, 2H).  19F NMR (300 MHz, 
CD2Cl2): δ (ppm) -151 (4F).  ESI/MS (m/z)+ 760.19 [M]+ (calc 759.8). 
 
ReC3argNO2 Synthesis.  ReC3argNO2 was synthesized in three steps: an EDC coupling 
reaction, a deprotection step, and a final metalation step to complete the wire synthesis 
(Scheme 3.3).  Amino-propyl-imidazole was coupled with Nα-carboxybenzoyl-Nω-
nitroarginine by an EDC coupling reaction.  EDC activates the carboxylic acid group, 
leaving the amines untouched.  The primary amine of the amino-propyl-imidazole attacks 
the activated carboxylic acid group creating an amide bond.  The ligand is then 
deprotected by TFA, leaving the nitro group unprotected.  The final step of the synthesis 
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is the metalation reaction of the rhenium complex with the nitroprotected ligand.  



























































Scheme 3.3.  Synthesis of ReC3argNO2. 
 
 
Propyl-imidazolyl-Nα-CBz-Nω-nitroarginine (imidC3BOCargNO2).  500 mg (1.5 
mmol) Na-BOC-Nω-nitroarginine and 480 mg (2.5 mmol) EDC was added to a flask 
containing 15 mL THF.  300 μL (2.5 mmol) aminopropylimidazole was added, and the 
reaction mixture was stirred at 50oC for 1 day.  The reaction turned from a cloudy white 
precipitate to a clear yellow solution.  The solution was concentrated by rotary 
evaporation and purified by flash column chromatography (10:1 CH2Cl2:MeOH).  The 
product was collected as a yellow oil (580 mg, 87.2% yield).  1H NMR (300 MHz, 
CD3OD):  δ (ppm) 1.1 (t, 2H); 1.2 (t, 2H); 1.4 (s, 9H); 1.8 (t, 2H); 2.0 (t, 2H); 3.1 (t, 2H); 
4.0 (t, 2H); 6.9 (s, 1H); 7.1 (s, 1H); 7.7 (s, 1H).  ESI/MS (m/z)+ 427.2 (calc 426.48). 
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Propyl-imidazolyl-Nω-nitroarginine (imidC3argNO2).  580 mg (1.3 mmol) 
imidC3BOCargNO2 was chilled in 15 mL CH2Cl2 at 0oC.  2.1 mL (27 mmol) TFA was 
added drop-wise.  White precipitate formed immediately; the solution then turned clear 
yellow as the reaction warmed to room temperature.  The reaction mixture was 
neutralized by an aqueous bicarbonate workup flowed by washing with brine.  Product 
was extracted with CH2Cl2 and dried over MgSO4.  The MgSO4 was removed by gravity 
filtration, and the organic layer was concentrated by rotary evaporation.  The product was 
purified by flash column chromatography (1:1 ACN:H2O) and collected as a yellow oil 
(440 mg, 100% yield).  1H NMR (300 MHz, CD3OD):  δ (ppm) 1.5-2.0 (m, 9H); 3.1 (t, 
2H); 4.0 (t, 2H); 6.9 (s, 1H); 7.1 (s, 1H); 7.7 (s, 1H).  ESI/MS (m/z)+ 327.2 (calc 326.36).  
 [Re(CO)3(dmp)(imidC3argNO2)][BF4] (ReC3argNO2).  272 mg (0.43 mmol) (1) and 
200 mg (0.61 mmol) imidC3argNO2 were added to 6 mL (1:1) THF:CH2Cl2 and stirred at 
50oC for 5 days.  A yellow precipitate formed.  The reaction mixture was concentrated by 
rotary evaporation and purified by flash column chromatography.  CH2Cl2 was used as 
the first eluent, and 50:3 CH2Cl2:MeOH was the final eluent.  The product was collected 
and concentrated by rotary evaporation to a yellow solid (14 mg, 35% yield).  1H NMR 
(300 MHz, CD3OD):  δ (ppm) 1.5-2.0 (m, 9H); 3.1 (t, 2H); 4.0 (t, 2H); 6.5 (s, 1H); 6.8 (s, 
1H); 7.7 (s, 1H); 7.8 (d, 2H); 8.3 (s, 2H); 9.3 (d, 2H).  19F NMR (300 MHz, CD2Cl2): δ 






3.3  BINDING RESULTS FOR REC3ARG 
 
UV-Vis Spectroscopy of ReC3arg.   
NOS heme Soret exhibits optical spectral shifts upon substrate binding.  The 
nature of the spectral shift, which can be defined as a type I or a type II perturbation, will 
indicate the binding mode and affinity of the substrate to the protein.  A “type I” ligand is 
characterized by the appearance of an absorbance peak at 380 - 390 nm, and a “type II” 
ligand is characterized by an absorbance peak at 425 - 430 nm.1  Upon titration of 
ReC3arg wire (0 - 80 μM) to iNOSoxy (2 μM) sample, a spectral shift of the Fe heme 
resting state (λmax = 423 nm) to low spin Fe heme (λmax = 427 nm) was observed, 
indicative of a type II perturbation.  This spectral shift is a result of a substrate ligation to 
the Fe heme acting as its sixth ligand (Figure 3.3).  A difference spectrum shows a clear 
423 nm bleach and a 436 nm spectral growth when ReC3arg is titrated into iNOSoxy 
sample (Figure 3.4).  This type II spectral change was not expected for an arginine-based 
wire.  A ligation to the Fe heme is normally observed for imidazole-type substrates, 
which have a lone pair electron that can coordinate with the Fe heme.2  Upon binding of 
imidazole to iNOSoxy, a characteristic spectral shift from 423 nm to 427 nm is observed.  
ReC3arg wire was titrated into the imidazole-bound iNOSoxy sample, and the Fe heme 
Soret shifted to an even lower spin complex (λmax = 436nm).  This indicates that the 
ReC3arg wire is a stronger ligand than imidazole, competes imidazole out of the active 
site, and interacts closely with the Fe heme immediately upon mixing.  The guanidium 
group of the arginine moiety is concluded to be within close proximity to the Fe sixth 
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Competitive Binding Studies of ReC3arg.   
 
A competitive binding study was conducted using arginine as the substrate and 
the ReC3arg wire as the inhibitor.  ReC3arg (0 - 100 μM) was titrated into a phosphate 
buffer solution containing iNOSoxy (2 μM) and various concentrations of arginine (10, 20, 
50, and 100 μM) (Figure 3.5).  A type II perturbation was observed even in the presence 
of 100 μM arginine.  A spectral shift from 423 nm to 436 nm was observed from the 
difference spectra, suggesting that ReC3arg wire has a higher affinity to iNOSoxy than that 
of arginine.  In fact, ReC3arg displaces arginine from the active site as more ReC3arg is 
titrated.  A dissociation constant can be calculated by plotting the inverse of the 
absorbance difference (427 - 423 nm) against the inverse of the concentration of the 
ReC3arg wire (Figure 3.6), generating a double reciprocal plot as described in Chapter II.  
By taking the average of the inverse slopes of the lines, an average Kd of 2 μM ± 500 nM 
was obtained.  The binding constant of ReC3arg wire for iNOSoxy is much smaller than 
the binding constant for arginine (16 μM) or imidazole (12 μM).  This implies that 
ReC3arg wire is a very good inhibitor in comparison. 
 A similar competitive binding study was done by titrating ReC3arg (0 – 100 μM) 
into samples of (1, 5, 10, 50, 80, and 100 μM) imidazole-bound iNOSoxy (2 μM).  
Imidazole-bound iNOSoxy exhibits an Fe heme Soret λmax at 427 nm.  A spectral change 
is observed from 427 nm to 436 nm with titrations of ReC3arg (Figure 3.7).  The 
observed red spectral shift suggests that ReC3arg wire is a competitive binder of 
imidazole.  ReC3arg displaces imidazole from the active site even at 100 μM of 




Figure 3.5.  ReC3arg wire (0 – 80 μM) titrated into a solution of arginine (5 μM) bound iNOSoxy (2 μM).  
A spectral shift from λmax = 423nm to λmax = 436 nm, a type II perturbation is observed. 
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Figure 3.6.  Double reciprocal plots of the inverse absorbance difference (Abs427 – Abs423) of ReC3arg (0 – 
100 μM) titrated into samples of arginine (10, 20, 50, and 100 μM) bound iNOSoxy (2 μM).  A Kd =  2 μM 
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Figure 3.7.  Titration of ReC3arg into imidazole bound iNOSoxy. 
 
A double reciprocal plot was analyzed, and a Kd was determined to be 1 μM ± 300 nM, 




Steady-State Fluorescence of ReC3arg.   
 
Steady-state fluorescence of ReC3arg wire titrated into buffer and into buffer 
containing iNOSoxy samples (2.7 μM) were measured.  An increase in Re(I)* 
fluorescence intensity was observed in both buffer and protein samples with each 
ReC3arg titration.  The data obtained from both experiments are overlaid in Figure 3.8.  
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Re(I)* fluorescence in the absence of protein.  This decrease in fluorescence intensity is 
indicative of quenching of the Re(I)* excited state by a chromophore of the protein, most 
likely the Fe heme or aromatic amino acid residues.  By comparing the fluorescence 
intensities of the same wire concentration in the presence and absence of protein, a ratio 
of bound wire and free wire can be calculated.  At an equivalent of 3:1 wire to protein 
concentration (third solid line from the bottom of Figure 3.8), the fluorescence intensity 
of Re(I)* overlaps with the Re(I)* intensity of two equivalents of wire in buffer (second 
dotted line from the bottom of Figure 3.8).  Assuming that bound wire has no 
fluorescence, it is concluded that at 3:1 wire to protein concentration, two equivalents of 
wire are free in solution, while one equivalent of wire is bound to protein.  This indicates 
a 1:1 binding mode of wire to protein.  However, as wire concentration is increased, the 
fluorescence intensities of Re(I)* in the presence of protein continue to decrease 
compared to the fluorescence intensities in the absence of protein.  At 6:1 wire to protein 
concentration (sixth solid line from the bottom of Figure 3.8), the fluorescence intensity 
of Re(I)* overlaps with the Re(I)* fluorescence intensity of four equivalents of wire in 
buffer (fourth dotted line from the bottom of Figure 3.8), suggesting that four equivalents 
of wire are free in solution, while two equivalents of wire are bound to protein.  This 
indicates a 2:1 binding mode of wire to protein.  The location of the second binding site 
cannot be concluded with steady-state fluorescence data. 
 A dissociation constant of both binding sites can be calculated by a Scatchard 
analysis of the fluorescence data as described in Chapter II.  The area under the 
fluorescence curve can be calculated using data analysis programs, such as Igor or 
Origin, and a ratio of bound wire to free wire can be determined.  When plotting the ratio 
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of bound wire over free wire against the initial concentration of wire added, a curved line 
appears.  The curved line can be fit to two different linear equations with two distinct 
slopes (Figure 3.9).  The negative inverse of the slope of the lines gives a Kd value of 4.7 
μM and 104.2 μM for the first and second line, respectively.  This indicates that at 
sample concentration less than 4:1 wire to protein, ReC3arg wire binds at the first binding 
site of iNOSoxy with a Kd = 4.7 μM.  At ratios greater than 4:1 wire to protein, a second 
binding site dominates with a Kd of 104.2 μM.  The first binding site is believed to be the 
channel binding site of the protein.  Considering the weak binding constant for the second 
binding site, it is believed that the surface of the protein can act as a second binding site 
where hydrophobic patches exist between domain interfaces.   
 
 
Figure 3.8.  Steady-state fluorescence traces of ReC3arg titrations into buffer (dotted line) and iNOSoxy 
samples (2.7 μM, solid lines).  Up to 3:1 wire to protein ratio, a 1:1 wire to protein binding mode is 
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Scatchard Plot of ReC3arg
y = -0.2095x + 0.8035



















Figure 3.9.  Scatchard plot of ReC3arg-bound iNOSoxy from fluorescence data.  The curve was fitted to two 




Transient Luminescence of ReC3arg.   
 
Transient luminescence data was also obtained to serve as a comparison to the 
steady-state fluorescence data mentioned previously.  Luminescence decay for ReC3arg 
in buffer was measured.  Data analysis was completed according to procedures described 
in Chapter II.  The luminescence decay trace has a monoexponential fit.  ReC3arg wire 
has an excited state lifetime of 577 ns (Figure 3.10).  If ReC3arg wire binds to protein, 
then the lifetime of Re(I)* should be shorter for bound wire than for free wire.  This is a 
result of either energy or electron transfer pathways.  The transient luminescence lifetime 
decay was measured for 3:1 wire to protein sample (Figure 3.11).  The decay curve has a 
biexponential fit containing a fast (τ = 95 ns) and a slow (τ = 560 ns) lifetime component.  
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The slow lifetime corresponds to the lifetime of unbound wire, and the fast lifetime is the 
lifetime decay of bound wire.  The luminescence lifetime decay traces of wire in the 
presence of protein at different ratios were compared to the lifetime decay of wire in 
solution, as shown in Figure 3.12.  There is significant quenching of the Re(I)* excited 
state when wire is bound to protein compared to when wire is in buffer.  At 3:1 wire to 
protein concentration (third line from the bottom of Figure 3.12), the luminescence 
intensity corresponds to two equivalents of wire in buffer (second dotted line from the 
bottom, Figure 3.12).  This suggested that a little more than one equivalent of wire is 
bound to protein, which is consistent with steady-state fluorescence.  This also confirms 
that a second binding site exists.  Transient absorbance and electron transfer kinetics were 
measured and discussed under the section labeled “Electron Transfer Kinetics (Part I).”  





























Figure 3.10.  Transient luminescence decay trace of 42.3 μM ReC3arg in buffer (solid line), 



































tau2 =  95ns
 
Figure 3.11.  Transient luminescence decay trace of 3:1 ReC3arg to iNOSoxy sample (solid line), 
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Figure 3.12.  Transient luminescence decay traces of ReC3arg titration into 14.1 μM iNOSoxy sample (solid 
lines) and in buffer (dotted lines).  (λex = 355 nm, λobs = 600 nm).  A 2:1 binding mode of wire to protein is 
observed. 
Binds more than 1:1 
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3.4  BINDING RESULTS FOR REC3ARGNO2 
 
UV-Vis of ReC3argNO2 Wire.   
 
Binding studies of ReC3argNO2 were conducted by UV-Vis spectroscopy.  These 
studies served as comparisons to data observed with ReC3arg wire.  The two wires are 
structurally similar in length and in composition, except for ReC3argNO2 which has a 
nitro group protecting the guanidinium moiety at the terminus.  Upon titration of 
ReC3argNO2 into substrate free iNOSoxy sample, no immediate spectral changes were 
observed (Figure 3.13).  There was a decrease in absorbance intensity at 423 nm and a 
slight blue shift in the Fe heme Soret.  A difference spectrum was conducted, and the 
changes were more obvious (Figure 3.13, inset).    A negative 423 nm peak and a positive 
390 nm peak were observed.  This spectral shift indicates that ReC3argNO2 exhibits a 
type I perturbation, shifting the resting state Fe heme Soret from 423 nm to 390 nm, 
creating a high spin Fe (III) heme.  This binding mechanism is similar to arginine binding 
to iNOSoxy, which is expected for arginine-based wires.  This observation, however, is 
different from what was observed for ReC3arg wire, where a type II perturbation was 
observed instead.  A more detailed speculation is explained at the end of the chapter 
under the “Discussions” section for the difference in binding modes between the two 
wires.  In general, it is believed that the nitro group does not allow for close interactions 







Figure 3.13.  UV-Vis spectroscopy of titrations of ReC3argNO2 into iNOSoxy sample; difference spectra is 








































Competitive Binding Studies with ReC3argNO2.   
 
Owing to the type I perturbation, imidazole was chosen as the competitive 
substrate.  A competitive binding study of ReC3argNO2 as the inhibitor was conducted.  
Samples of imidazole-bound iNOSoxy at imidazole concentrations of 1, 5, 20, and 60 μM 
were used for titrations of ReC3argNO2 wire (0 - 100 μM).  A small spectral shift was 
observed (Figure 3.14).  A difference spectrum was obtained, showing a clear negative 
427 nm peak and a positive 390 nm peak.  This suggests that ReC3argNO2 displaces 
imidazole from the active site and shifts the Fe heme Soret to high spin.  A double 
reciprocal plot was analyzed (Figure 3.15).  A dissociation constant for ReC3argNO2 was 
determined to be 7 ± 1 μM.  This suggests that ReC3argNO2 (Kd = 7 ± 1 μM) does not 
bind to iNOSoxy as well as the ReC3arg wire (Kd = 2 μM ± 500 nM).  This was evident 
with small spectral changes observed for titrations of ReC3argNO2 into iNOSoxy samples.  
However, ReC3argNO2 still has a smaller binding constant than imidazole and arginine, 




Figure 3.14.  UV-Vis spectroscopy of titrations of ReC3argNO2 (0 – 100 μM) into imidazole (50 μM) 
bound iNOSoxy (2 μM).  A spectral shift from λmax = 427 nm to λmax = 390 nm is observed, 
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Figure 3.15.  Double reciprocal plots of ReC3argNO2 titrations into imidazole-bound (1, 5, 20, 60μM)  
iNOSoxy (2μM).  An absorbance difference is (Abs390 – Abs430) plotted against 1 / [wire].  A Kd of  7 ± 1 
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Steady State Fluorescence of ReC3argNO2.   
 
Steady-state fluorescence was measured for ReC3argNO2 in buffer and 
ReC3argNO2 bound to iNOSoxy.  Figure 3.16 shows a rough 1:1 binding mode of wire to 
protein.  At 2:1 wire to protein sample, the fluorescence intensity of Re(I)* overlaps with 
the fluorescence intensity of Re(I)* of one equivalent of wire in buffer.  Assuming that 
bound wire has no fluorescence, this result suggests that one equivalent of wire is bound 
to protein, and another equivalent is free in solution.  As wire concentration is increased, 
one equivalent of wire is consistently bound to protein, while the rest of the wire 
concentration is free in solution.  This implies that there is only one dominant binding 
site. 
 A Scatchard analysis was conducted on the steady-state fluorescence data.  The 
areas under the curves were measured.  A ratio of bound wire to free wire is calculated 
and plotted against the initial wire concentration (Figure 3.17).  A curved line was 
revealed and was fitted to two different linear equations with distinct slopes.  The 
negative inverse of the slopes of the lines gives a Kd value of 2.6 μM and 180 μM for the 
two binding sites.  Because of the huge difference in dissociation constants between the 
two sites, it is believed that the first binding site dominates at lower concentrations, while 
the second site dominates at higher concentration.  The first calculated Kd value closely 
agrees with the binding constant derived from competitive binding studies (~ 7 μM) by 





Figure 3.16.  Steady-state fluorescence traces of ReC3argNO2 titrations into iNOSoxy samples (solid lines) 
and into buffer (dotted lines).  A 1:1 binding mode is observed. 
 
Scatchard Analysis of ReC3argNO2
y = -0.3888x + 1.1968


















Figure 3.17.  Scatchard plot of bound over free ReC3argNO2 against initial wire concentration.  Two 
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Transient Luminescence of ReC3argNO2.   
Transient luminescence measured for 34 μM ReC3argNO2 gives an excited state 
lifetime decay of 473 ns (Figure 3.18), which is shorter than the lifetime decay of 
ReC3arg (τ = 577 ns).  A comparison is made between the excited state lifetimes of wire 
in buffer and wire in the presence of protein.  If the wire is tightly bound to the protein 
within close proximity to a protein chromophore, then significant quenching should be 
observed.  Transient luminescence decay traces were measured of 5:1 ReC3argNO2 (42 
μM) to iNOSoxy (8.5 μM) (Figure 3.19).  This decay curve has a biexponential decay with 
a slow (τ = 480 ns) and a fast (τ = 105 ns) lifetime decay component.  The slow lifetime 
decay corresponds to the lifetime decay of wire in buffer (τ = 473 ns), while the fast 
component is the lifetime decay of wire bound to protein.  Titrations of wire into buffer 
and protein samples were conducted, and the transient lifetimes were measured and 
compared (Figure 3.20).  Transient luminescence data corresponds well with steady-state 
fluorescence data.  ReC3argNO2 exhibits a 1:1 binding ratio with protein at various 
concentrations.  A ratio of bound to free wire can be determined using the amplitudes of 
the two decays from a biexponential fit explained in Chapter II.  A Scatchard analysis 
was conducted by plotting the ratio of bound to free wire against the initial concentration 
of wire (Figure 3.21).  A Kd was determined to be 1.5 μM, which is close to the 
dissociation constant calculated by previous methods.  ReC3arg and ReC3argNO2 exhibit 
different modes of binding and affinities for iNOSoxy.  This phenomenon was not initially 
expected for two structurally similar wires with only one different terminal protecting 
group.  However, both wires bind with a low micro molar binding constant, making them 
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Figure 3.18.  Transient luminescence decay trace of 34 μM ReC3argNO2 (solid line), monoexponential fit 
(dashed line), and residual fit (dotted line).  A lifetime decay of τ = 473 ns was calculated.  (λex = 355 nm, 



















Figure 3.19.  Transient luminescence decay traces of 42.5 μM ReC3argNO2 in the presence of 8.5 μM 
iNOSoxy (solid green line) and biexponential fit (orange line), giving two lifetime decays: τ(1) = 480 ns and 
τ(2) = 105 ns.  (λex = 355 nm, λobs = 600 nm). 
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Figure 3.20.  Transient lifetime decay traces of ReC3argNO2 in buffer (dotted lines) and in the presence of 
iNOSoxy (solid lines).  A 1:1 binding mode is observed.  (λex = 355 nm, λobs = 600 nm). 
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3.5  ELECTRON TRANSFER KINETICS (PART I): RESULTS USING 1 CM 
PATH LENGTH CUVETTE 
 
 
Single Wavelength Transient Absorption Results for ReC3arg and ReC3argNO2 
without Quencher.   
The transient absorbance of Re(I)* can be measured using single wavelength 
pump-probe laser spectroscopy.  Samples were excited at 355 nm laser light and probed 
at various wavelengths (380 - 600 nm) with a Xenon arc lamp.  Transient absorbance was 
measured for 40 μM ReC3argNO2 wire in buffer (Figure 3.22).  Transient Re(I)* 
absorbance has a lifetime decay of 450 ns, which agrees with the transient luminescence 
lifetime decay of Re(I)* (τ = 473 ns) measured previously.  A Re(I)* transient absorption 
curve was generated by plotting the transient absorption intensities against the probed 
wavelengths (Figure 3.23).  Re(I)* has an absorption λmax = 430 nm.   
In Chapter II, ReC8argNO2 was shown to conduct energy transfer directly from 
the Re(I)* excited state with a nearby trytophan, creating Re(0) and oxidized tryptophan.  
Electron transfer subsequently occurred between the generated Re(0) and the Fe heme, 
reducing the Fe (III) to Fe(II).  A similar mechanism is expected for ReC3arg and 
ReC3argNO2 wires because of structural similarities.  The difference in wire length was 
expected to change the rate of electron transfer, but not the mechanism.  A similar 
transient absorption study was conducted for ReC3arg and ReC3argNO2 wires, as 
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Figure 3.22.  Transient absorption of 40 μM ReC3argNO2 (solid blue line), a monoexponential fit (pink 
line), and residual fit (dotted line).  A transient absorbance decay was calculated: τ = 450 ns.  (λex = 355 























A sample of 5:1 ReC3argNO2 to iNOSoxy was excited at 355 nm and probed at 
445 nm (Figure 3.24).  In Figure 3.24, the orange trace is the transient absorption decay 
of wire in buffer (τ = 450 ns).  Therefore, any signal after 1 μs would not be due to 
Re(I)* absorbance.  Transient absorption trace of wire in the presence of protein is shown 
in Figure 3.24 as the blue trace.  A similar decay rate (τ = 450 ns) was observed.  This 
signal was most likely due to Re(I)* absorbance.  No other signal was detected.  There 
was a slight rise in baseline after 1 μs, but there is nothing significant.  Fe(II) formation 
was not observed.  
 A transient absorption trace of ReC3arg wire in buffer was also measured (Figure 
3.25).  The Re(I)* absorbance has a lifetime decay of 570 ns, which corresponds to the 
transient luminescence decay rate of ReC3arg wire shown previously (τ = 577 ns).  A 
transient absorption measurement was completed in the presence of protein as well 
(Figure 3.26).  No other signal beyond Re(I)* absorbance can be detected.  Other 
wavelengths were also probed, but there was no increase in baseline after 1 μs.  It is 
concluded that the difference in length between a C3 and a C8 linker must have displaced 
the rhenium complex away from the tryptophan residues that was predicted to participate 
in electron transfer processes.  The tryptophans are too far away for efficient quenching 
to occur.  Furthermore, Re(I)* (-0.7 V vs. NHE)3 does not have a high enough redox 
potential to efficiently reduce the Fe heme (-0.35 V vs. NHE)4 from 20 Å away.  A more 
detailed explanation is given under the “Discussions” section at the end of this chapter.  
The next step was to utilize the flash quench methodology that was explained in Chapter 




Figure 3.24.  Transient absorption traces of ReC3argNO2 in buffer (orange line) and in the presence of 
iNOSoxy (blue line).  (λex = 355 nm, λobs = 445 nm).  No other transient species is observed other than 
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Figure 3.25.  Transient absorption of ReC3arg (solid red line), a monoexponential fit (blue line), and 
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Figure 3.26.  Transient absorption of ReC3arg in buffer (pink trace) and in the presence of protein (blue 






Transient Absorbance and Luminescence with pMDA.   
 
 
In order to reduce Re(I)* to Re(0) and in turn reduce Fe(III) to Fe(II), reductive 
quenchers were chosen for this system: ascorbate and para-methoxy-N,N’-
dimethylaniline (pMDA).  A transient luminescence was measured for 5:1 ReC3argNO2 
to protein with a 1000 fold excess of pMDA (Figure 3.27).  In the absence of an external 
quencher, a slight quenching of the lifetime decay of the Re(I)* by protein is observed.  
However, in the presence of pMDA, the Re(I)* transient luminescence intensity is 
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creating Re(0) and oxidized quencher.  A transient absorption trace of 1:150 ReC3argNO2 
to pMDA observed at 500 nm is shown in Figure 3.28.  The transient absorption decay 
traces of Re(I)* of the wire in the presence and absence of quencher are shown in orange 
and blue, respectively.  Since the Re(I)* absorbance trace decays completely after 1 μs, 




















 52uM ReC3argNO2 + 8.8uM iNOS
 8mM p-methoxyaniline + 52uM ReC3argNO2 + 8.8uM iNOS
 
 
Figure 3.27.  Transient luminescence of ReC3argNO2 in buffer (dotted line), in the presence of protein 
(dashed line), and in the presence of protein and pMDA (solid line).  Re(I)* is significantly quenched in the 
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TA:  ex 355nm, obs 500nm
 
Figure 3.28.  Transient absorption trace of ReC3argNO2 in buffer (dashed line) and in the presence of 
pMDA (solid line).  A longer-lived species is observed, assigned as Re(0) and (+)pMDA transient 





















Figure 3.29.  Transient absorption curve of ReC3argNO2 in the presence of pMDA plotted at 2 μs (circles) 





There is a significant increase in baseline after 1 μs.  The intensity of the long-
lived transient species was plotted against the probed wavelength, and an absorbance 
curve is generated (Figure 3.29).  There is an absorption peak with a λmax around 450 nm 
and a small shoulder around 560 nm.  The absorbance around 430 nm was assigned as the 
Re(0) signal, and the shoulder at 550nm is the oxidized pMDA signal.   
Transient absorption measurements were conducted with 5:1:1000 of 
ReC3argNO2 to protein to quencher.  The sample was excited at 355 nm and was probed 
at various wavelengths (380 – 600 nm).  Transient absorbance traces of wire in buffer, 
wire in the presence of pMDA, and wire in the presence of pMDA and protein were 
compared (Figure 3.30).  The intensity of the long-lived signal in the presence of protein 
(green dotted trace) is decreased compared to the trace without protein (orange dashed 
trace).  The short-lived Re(I)* intensity in the presence of protein is also decreased 
compared to its intensity in the absence of protein and quencher.  In order to generate an 
absorption curve, the transient absorbance intensity for these samples were plotted 
against the probed wavelength (Figure 3.31).  The transient absorbance curves of Re(0) 
and oxidized pMDA shown previously (Figure 3.31, dashed trace) are compared to the 
transient absorbance curve of wire in the presence of pMDA and protein (Figure 3.31, 
solid traces).  Assuming that quantum yields are the same with or without protein, the 
Re(0) signal intensity has decreased significantly in the presence of protein.  The only 
signal that becomes visible is the oxidized quencher signal showing a full absorbance 
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TA: ex 355, obs 500
 
Figure 3.30.  Transient absorption traces of ReC3argNO2 in buffer (solid blue trace), in the presence of 
pMDA (dashed orange trace), and in the presence of pMDA and iNOSoxy (dotted green trace).  (λex = 355 
nm, λobs = 500 nm). 
 





















Figure 3.31.  Transient absorption curve of ReC3argNO2 in the presence of pMDA (dashed triangle line) 
and in the presence of pMDA and iNOSoxy (solid traces) plotted after 2 μs (stars), 3 μs (rectangles), and 4 
μs (circles) to avoid Re(0) absorbance interferences.  Re(0) absorbance intensity is quenched in the 
presence of protein and pMDA, revealing (+)pMDA absorbance signal at λmax = 550 nm.  A small 





There is a small signal around the 400 nm region; however, nothing definitive can be 
concluded for a small signal.  The oxidized quencher signal was observed to live for 
hours before recombining with reduced species.  An obvious color change had occurred 
for all of the samples containing wire and pMDA in the presence and absence of protein 
after photo-excitation.  UV-Vis traces were measured of the samples before and after 
photo-excitation.  Optical changes in the samples were observed, as shown in Figure 
3.32.  The solid lines in Figure 3.32 are traces of before and after photo-excitation of wire 
and pMDA samples in the presence and absence of protein.  The dotted traces are the 
difference between the before and after traces.  For the sample containing wire, pMDA, 
and protein before photo-excitation (Figure 3.32b), there is a slight blue shift in the Fe 
heme Soret after photo-excitation (Figure 3.32a).  For the wire with pMDA sample, there 
is a broad signal increase in the 550 nm region after photo-excitation (Figure 3.32c).  The 
wire and quencher sample after photo-excitation exhibit a growth in a species that 
absorbs between 430 nm and 600 nm (Figure 3.33f).  This signal is assigned as oxidized 
quencher signal that has a lifetime decay of hours before recombination.  The sample of 
wire and quencher in the presence of protein has the same signal growth in 530 nm region 
(assigned as the oxidized quencher signal) and in the 410 nm region (Figure 3.33e).  
There is a negative feature at 390 nm and a positive feature at 415 nm.  The negative 390 
nm feature is most likely a decrease in the resting state Fe(III) heme signal with the 
bound wire.  The positive feature at 415 nm is indicative of a growth of a five-coordinate 




Figure 3.32.  UV-Vis spectroscopy of (a) ReC3argNO2, pMDA, and protein sample after photo-excitation 
(light green trace) and (b) before photo-excitation (dark green trace); (c) ReC3argNO2 plus pMDA after 
photo-excitation (light blue trace) and (d) before photo-excitation (dark blue trace); (e) is a minus b (dotted 
red trace); and (f) is c minus d (dotted pink trace).   
 
 
Figure 3.33.  UV-Vis spectroscopy of Figure 3.32 from 380 – 630 nm.  (+) pMDA is visible at λmax = 550 
nm for samples in the presence (e) and absence (f) of protein.  For samples containing protein, a positive 
absorbance peak is observed at λmax = 405 nm and a negative peak at λmax = 390 nm, indicating an 
















 8mM p-methanil + 52uM ReC3argNO2 before
 8mM p-methanil + 52uM ReC3argNO2 after
 diff of 8mM p-methanil + 52uM ReC3argNO2 before + after photoexcite
 8mM p-methanil + 52uM ReC3argNO2 + 8.8uM iNOS before
 8mM p-methanil + 52uM ReC3argNO2 + 8.8uM iNOS after














A proposed electron transfer scheme is shown in Scheme 3.4.  When wire is 
bound to the protein before laser excitation, the Fe heme Soret exhibits a λmax = 390 nm.  
After laser excitation and in the presence of pMDA, the Re(I)* is quenched by pMDA.  
The wire is then reduced to Re(0) (λmax = 430 nm) while the quencher is oxidized (λmax = 
550 nm), which lives for hours and is detectable by transient absorbance spectroscopy 
and UV-Vis spectroscopy.  The generated Re(0) quickly undergoes electron transfer (kET 
< 10 ns, measured by transient absorbance spectroscopy) with the Fe heme, which is 
reduced to Fe(II).  The generated Fe(II) species exhibits an absorbance λmax = 415 nm 
and is also long-lived.  After 2 hours, the transient species recombine, and the Fe heme 
resting state is regenerated.      
However, the proposed Fe(II) signal is still very small.  It is barely visible by 
transient absorption traces.  Furthermore, it is swamped by oxidized quencher signal and 
excess Re(0) signal from wire free in solution.  It is concluded that a smaller path length 
cuvette would solve the issue of low protein signal.  The absorbance of protein will be cut 
by half to allow an increase of protein concentration without raising the delta optical 
intensity above 1.0.  The wire to protein ratio was reduced to 3:1 to reduce excess signal 
of wire free in solution.  A second quencher (ascorbate) was chosen to eliminate any 
oxidized quencher signal that interferes with Fe(II) signal.  A repeat of the experiments 














































Scheme 3.4.  Proposed electron transfer mechanism.  Upon binding of ReC3argNO2 to iNOSoxy, the Fe 
heme shifts from low spin Fe(III) to high spin Fe(III) (step 1).  Upon 355 nm photo-excitation, the Re(I) is 
promoted to its excited state, Re(I)* (step 2).  In the presence of quencher, the Re(0) and (+)quencher are 
generated (step 3).  The produced Re(0) injects an electron into the Fe(III) heme to produce a high spin, 
five-coordinate Fe(II) species (step 4).  The (+)quencher recombines with the Fe(II) species, and the 











3.6  ELECTRON TRANSFER KINETICS (PART II):  RESULTS USING 0.5CM 
PATH LENGTH CUVETTE 
 
Transient Absorbance and Luminescence with Ascorbate.   
 
A transient luminescence trace of 6:1 ReC3arg wire to protein with and without 
ascorbate is shown in Figure 3.34.  The Re(I)* excited state is quenched significantly by 
ascorbate. The decrease in luminescence intensity suggests that there is either energy or 
electron transfer between the species.  The transient absorbance of 40 μM ReC3argNO2 
was measured with and without ascorbate (Figure 3.35).  A short-lived species (Re(I)*) 
and a long-lived species are observed (Re(0)).  The intensity of these transient absorbance 
traces were plotted against wavelength.   
 
 
Figure 3.34.  Transient luminescence of ReC3arg with iNOSoxy (dashed trace) and in the presence of 























 86uM Re argwire + 14.3uM iNOS



















 40uM ReC3argNO2 + 10mM ascorbate
 
Figure 3.35.  Transient absorbance traces of ReC3argNO2 in buffer (dotted trace) and in the presence of 
ascorbate (solid trace).  The Re(I)* absorbance is quenched, and a long-lived species is observed.  (λex = 
355 nm, λobs = 420 nm). 
 
 




























ReC3arg t = 2e-6
ReC3arg t = 4e-6
 
Figure 3.36.  Transient absorbance curve of ascorbate in the presence of (a) ReC3argNO2 and (b) ReC3arg.  




An absorbance curve was generated for both ReC3argNO2 (Figure 3.36A) and 
ReC3arg (Figure 3.36B) in the presence of ascorbate.  ReC3argNO2 (Figure 3.36A) and 
ReC3arg (Figure 3.36B) wires exhibit similar absorbance traces for Re(0) signal produced 
by ascorbate.  Oxidized ascorbate absorbs in the low 300 nm region;5,6 therefore, it does 
not interfere with any transient Re(0), Fe(III), or Fe(II) signals.  Re(0) is shown to have a 
λmax at 430 nm. 
 The transient absorbance of 3:1 wire to protein was also measured in the presence 
of excess ascorbate.  Both disappearance (negative feature) and appearance (positive 
features) of long-lived transient species were observed (Figure 3.37).  There is an 
increase in baseline when probed at 390 nm wavelength.  At 450 nm, there is a significant 
decrease in baseline.   
The intensities from these traces were plotted versus wavelength, and a full 
absorbance curve was generated (Figure 3.38).  In order to prevent Re(I)* signal from 
interfering with protein signal, the intensities of the long-lived signals were taken after 2 
μs.  The transient absorbance curve of wire sample in the presence of protein (Figure 
3.38, closed shapes) is overlaid with the transient absorbance curve of wire in the 
presence of ascorbate (Figure 3.38, open circles).  There is a significant bleach at 440 nm 
and a growth at 410 nm.  The bleach at 440 nm is likely the disappearance of Re(0) 
signal.  When Re(0) disappears, it can either recombine with oxidized quencher or 













50uM ReC3argNO2 + 20uM iNOS + 10mM asc  TA
 @ 390nm (Fe(II) growth)
 @ 425nm (Fe(III) bleach)
 @ 450nm (Fe(III) and Re(0) bleach)
 @ 470nm no signal
 
Figure3.37.  Transient absorbance of ReC3argNO2, iNOSoxy, and ascorbate excited at 355 nm and probed at 
390 nm (green), 425 nm (pink), 450 nm (red), and 470 nm (blue). 
 





















@ t = 2e-6
 
Figure 3.38.  Transient absorbance curve of ReC3argNO2 and ascorbate in the absence of iNOSoxy (open 
circles) and in the presence of iNOSoxy (closed shapes) after 2 μs (diamonds), 3 μs (stars), and 4 μs 
(circles).  An appearance of Fe(II) species (λmax = 405 nm) and a disappearance of Fe(III) heme (λmax = 430 
nm) are observed. 
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If there was a recombination of the Re(0) with the oxidized ascorbate, then a signal 
would appear in the low 300 nm region.  However, none was detected.  On the other 
hand, if Re(0) undergoes electron transfer with the Fe heme, then an Fe(II) signal should 
appear.  The 410 nm absorbance signal is Fe(II) signal.  It is concluded that Fe(II) is 
generated through an electron transfer mechanism with the Re(0). 
A similar experiment was conducted with ReC3arg wire with protein and 
ascorbate.  Similar positive and negative features were observed (Figure 3.39).  The 
intensities were plotted versus wavelength to generate an absorbance curve (Figure 3.40).  
The transient signal of wire in the presence of ascorbate is overlaid for comparison 
(Figure 3.40, open circles.)  Again, there is a positive signal at 410 nm and a negative 
signal around 440 nm.  It is concluded that the negative signal at 440 nm is due to the 
disappearance of Re(0), as Fe(II) is created at 410 nm.  Since these transient species seem 
to live for hours, UV-Vis measurements were taken after laser photo-excitation (Figure 
3.41).  The trace of the sample before photo-excitation is shown as a solid line with an Fe 
heme Soret at 423 nm.  After photo-excitation, the Fe heme Soret is blue shifted.  A 
difference spectrum is shown as the inset.  There is a bleach at 430 nm and a positive 
signal at 410 nm, which agrees with transient absorbance traces.  This further confirms 












TA of 50uM ReC3arg + 20uM iNOS + 10mM ascorbate
 @ 390 (Fe(II) growth)
 @ 460 no signal
 @ 440 (Fe(III) and Re(0) bleach)
 
Figure 3.39.  Transient absorbance traces for ReC3arg in the presence of iNOSoxy and ascorbate excited at 
355 nm and probed at 390 nm (blue), 460 nm (green), and 440 nm (orange). 
 
 



















ReC3arg + asc @ t = 2e-6
 
Figure 3.40.  Transient absorbance curve for ReC3arg and ascorbate in the absence of iNOSoxy (open 
circles) and in the presence of iNOSoxy (closed shapes) after 2 μs (diamonds), 3 μs (stars), and 4 μs 
(circles).  An appearance of Fe(II) species (λmax = 405 nm) and a disappearance of Fe(III) heme (λmax = 430 




Figure 3.41.  UV-Vis spectroscopy of ReC3arg with ascorbate and protein before (solid line) and after 
(dotted line) laser photo-excitation.  Difference of before and after photo-excitation is the inset, revealing a 































50uM ReC3arg + 10mM ascorbate + 20uM iNOS
 before laser shots
 after laser shots
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Transient Absorbance and Luminescence with pMDA.   
 
pMDA was used as a quencher as a comparison to ascorbate.  Experiments were 
conducted as described above with a 0.5 cm path length cuvette.  A sample of wire mixed 
with pMDA was excited at 355 nm and probed at various wavelengths (380 – 600 nm).  
The intensity of the transient absorbance signal was plotted versus the probed wavelength 
to generate an absorbance curve.  A Re(0) absorbance curve created by pMDA is shown 
in Figure 3.42.  Re(0), in this case, has a λmax at 470 nm, which is red shifted from Re(0) 
absorbance when created by ascorbate.  This is due to the overlap of oxidized pMDA 
signal at 530 nm. 
 





















Figure 3.42.  Transient absorbance curve of ReC3arg in the presence of pMDA.  Re(0) has an absorbance 
λmax = 460 nm, and (+) pMDA has an absorbance λmax = 530 nm. 
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 A transient absorbance curve is also generated for samples of wire and pMDA in 
the presence of protein (Figure 3.43).  Transient absorbance traces of wire and pMDA in 
the presence of protein after 2 μs are shown (Figure 3.43, closed shapes).  Re(0) and (+) 
pMDA signal is overlaid for comparison (Figure 3.43, open circles).  Oxidized pMDA 
signal has an absorbance curve from 430 nm to 600 nm.  In the presence of protein, (+) 
pMDA signal is enhanced when the Re(0) signal exhibits a negative feature at 430 nm.  
An increase in signal at 410 nm suggests that Fe(II) is produced as Re(0) signal decays.  
This is consistent with data generated by ascorbate.     
 Owing to long-lived transient species and a slow back reaction, UV-Vis spectra 
were taken for samples before and after laser photo-excitation (Figure 3.44).  There is a 
blue shift in the Fe heme Soret after photo-excitation.  The difference spectrum is shown 
as the inset.  There is a positive peak at 390 nm (Fe(II) signal), a negative peak at 440 nm 
(Fe(III) bleach), and a broad positive peak centered at 600 nm ((+) pMDA).  These are all 
consistent with transient absorbance data.  
 The same experiment was completed with pMDA and ReC3argNO2.  The 
transient absorbance curve is shown in Figure 3.45.  The transient absorbance traces of 
ReC3argNO2 and pMDA are shown as open circles, while the transient absorbance trace 
of wire in the presence of protein is shown as closed shapes.  The same positive peak at 
410 nm (Fe(II) signal), a negative peak at 430 nm (Fe(III) bleach), and a broad positive 
peak centered at 500 nm ((+) pMDA) were observed.  These are all consistent with 



























Figure 3.43.  Transient absorbance curve for ReC3argNO2 and pMDA in the absence of iNOSoxy (open 
circles) and in the presence of iNOSoxy (closed shapes) after 2 μs (circles), 3 μs (diamonds), and 4 μs 
(stars).  An appearance of Fe(II) species (λmax = 405 nm) and a disappearance of Fe(III) heme (λmax = 430 
nm) are observed.  (+) pMDA has an absorbance λmax = 530 nm. 
 
 
Figure 3.44.  UV-Vis spectroscopy of ReC3rg, pMDA and protein before (solid line) and after (dotted line) 
laser photo-excitation.  The difference of before and after photo-excitation is the inset, revealing a positive 
absorbance at 405 nm (Fe(II) species) and a negative absorbance at 430 nm (Fe(III) bleach).  (+) pMDA 













40uM ReC3arg + 10mM ap-methoxy + 20uM iNOS
 before laser shots














UV-Vis spectra were taken before and after photo-excitation of ReC3argNO2 
samples (Figure 3.46).  This data agrees well with UV-Vis data from ReC3arg 
experiments.  The Fe heme Soret exhibits a blue shift after photo-excitation, indicative of 
the creation of an Fe(II) species.  The difference spectrum shows the same positive peak 
at 390 nm (Fe(II) signal), a negative peak at 430 nm (Fe(III) bleach), and a broad positive 
peak centered at 500 nm ((+) pMDA).   
 From transient absorbance experiments with both ReC3arg and ReC3argNO2 wires 
in the presence of protein with both ascorbate and pMDA quenchers, it is concluded that 
Re(I)* is quenched by both quenchers to create Re(0) (λmax = 430 nm), which in turn 
reduces the Fe(III) heme (λmax = 423 nm) to Fe(II) heme (λmax = 410 nm).  The oxidized 
quencher and the Fe(II) signal live for hours because of slow back reactions, which 




























Figure 3.45.  Transient absorbance curve of ReC3argNO2 and pMDA in the absence of iNOSoxy (open 
circles) and in the presence of iNOSoxy (closed shapes) after 2 μs (circles), 3 μs (diamonds), and 4 μs 
(stars).  An appearance of Fe(II) species (λmax = 405 nm) and a disappearance of Fe(III) heme (λmax = 430 
nm) are observed.  (+) pMDA has an absorbance λmax = 530 nm. 
 
 
Figure 3.46.  UV-Vis spectroscopy of ReC3argNO2, pMDA and protein before (solid line) and after (dotted 
line) laser photo-excitation.  Difference of before and after photo-excitation is the inset, revealing a positive 
absorbance at 405 nm (Fe(II) species) and a negative absorbance at 430 nm (Fe(III) bleach).  (+) pMDA 













40uM ReC3argNO2 + 10mM p-methoxy + 20uM iNOS
 before laser shots








3.7  DISCUSSIONS 
 
Binding Properties.   
 
The binding properties of iNOSoxy with various substrates are depicted in Scheme 
3.5.  When substrates are bound to iNOSoxy, a type I (high spin) or a type II (low spin) 
perturbation can be monitored by UV-Vis spectroscopy.7  Although similar in length and 
structure, ReC3arg and ReC3argNO2 do not exhibit similar binding properties to iNOSoxy.  
It is expected that both wires will bind to the channel of the protein in a relatively similar 
manner, except for the interference of the extra nitro protection group on the terminal end 
of ReC3argNO2 wire.  The addition of the nitro group stabilizes the guanidium group 
from tautomerization and allows for some distance between the wire and the Fe heme, 
therefore preventing direct ligation.  A spectral shift from a Fe(III) resting state (λmax = 
423 nm) to five-coordinate Fe(III) (λmax = 390 nm) was observed.  ReC3arg wire does not 
have a protecting group; therefore, the guanidinium group tautomerizes between the 
amines, creating an electron density the will weakly coordinate with the Fe heme.  The 
wire interacts closely with the heme to shift the Fe heme Soret to an even lower spin 


























































Electron Transfer Mechanism without Quencher.   
 
As presented in Chapter II, ReC8argNO2 was designed and synthesized for 
iNOSoxy.  ReC8argNO2 was found to bind to iNOSoxy with high affinity.  Electron transfer 
kinetics were also observed without the presence of quencher.  An electron transfer 
mechanism was proposed and reproduced in Scheme 3.6.  Trytophan residues near the 
opening of the channel were proposed to quench the Re(I)* generated after laser photo-
excitation.  Re(I)* is subsequently reduced to Re(0), and the tryptophan is oxidized; 
thereby, electron transfer occurred between the wire and the Fe heme.  However, upon 
photo-reduction of Fe(III) to Fe(II), the nitro group of the wire was proposed to ligate the 
Fe(II) heme, whereby six-coordinate Fe(II) signal was observed and characterized.  The 
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oxidized tryptophan recombines with the Fe(II), allowing the Fe heme to return to its 
resting state.  ReC3arg and ReC3argNO2 were then designed and synthesized for 
comparison.  Despite high affinity for iNOSoxy, no visible transient Fe (II) species was 
detected for either of the two shorter wires in the absence of quencher.  There was a slight 
increase in baseline in the transient absorbance traces, but it was not significant enough 
for full characterization.   
A difference in electron transfer kinetics is proposed between the C8 and C3 
wires.  Mainly because of the difference in length, the two shorter wires do not exhibit 
the same quenching mechanism by tryptophan residues as seen for the longer 
ReC8argNO2 wire.  A model of the C8 and C3 wires in the active is shown in Figure 3.47.  
ReC3argNO2 is proposed to be pulled further into the channel in order to interact closely 
with the Fe heme upon binding.  ReC8argNO2 is modeled to extend down the channel 
within close proximity to the Fe heme.  ReC8argNO2 is also long enough to extend 
further out of the opening and close to the tryptophan residues.  ReC8argNO2 is shown to 
be 2.8 Å and 4.2 Å away from the two tryptophan residues.  On the other hand, 
ReC3argNO2 wire is shown to be 6.4 Å and 5.04 Å away from the same two trytophan 
residues, where inefficient energy transfer is expected.  Because of the increase in 
distance, Re(I)* was not efficiently reduced to Re(0) by trytophan residues, where most 




































Scheme 3.6.  Proposed electron transfer mechanism.  Upon binding of ReC8argNO2 to iNOSoxy, the Fe 
heme shifts from low spin Fe(III) to high spin Fe(III) (step 1).  Upon 355 nm photo-excitation, the Re(I) is 
promoted to its excited state, Re(I)* (step 2).  A nearby Trp quenches the Re(I)* to generate an (+) Trp and 
Re(0) (step 3).  The produced Re(0) injects an electron into the Fe(III) heme to produce a low spin, six-
coordinate Fe(II) species (step 4).  The (+)Trp recombines with the Fe(II) species, and the electron transfer 
cycle is complete.  A direct electron transfer from the Re(I)* state was concluded, unlikely owing to a small 
difference in redox potential between substrate and product (step 6). 
 
 
Figure 3.47.  Model of (a) ReC8argNO2 and (b) ReC3argNO2 in iNOSoxy active site. 
 
2.8Å 




Electron Transfer Mechanism with Quencher.   
 
Subsequent experiments employed ascorbate and pMDA as quenchers to facilitate 
efficient reduction of Re(I)* to Re(0).  Transient Re(0) species were observed and 
characterized.  Photo-production of Fe(II) was also observed and characterized.  The 
proposed electron transfer mechanism is shown in Scheme 3.8.  Upon binding of 
ReC3argNO2, the Fe(III) loses the water ligand and becomes a five-coordinate, high spin 
Fe(III) heme.  After 355 nm photo-excitation, Re(I)* is quenched by either ascorbate or 
pMDA and becomes Re(0), while the quencher itself gets oxidized.  Electron transfer 
then occurs between Re(0) and the Fe(III), producing a five-coordinate Fe(II) species, 
characterized by transient absorbance and UV-Vis spectroscopy.  The back reaction is 
much slower than expected, resulting in a very long-lived oxidized quencher and Fe(II) 
species.  After hours, the species recombine, and the protein is observed to return to its 
resting state.   
 The resulting five-coordinate Fe(II) species (λ = 410 nm) was not observed with 
the longer ReC8argNO2 wire.  Upon photo-reduction of Fe(II), the nitro group of 
ReC8argNO2 was characterized to ligate the Fe (II) heme (λ = 445 nm).  The difference in 
the generated Fe(II) species could be explained by the length difference between the two 
wires.  From Figure 3.48, ReC8argNO2 is shown to extend the full length of the 20 Å 
channel, whereas ReC3argNO2 wire is depicted to sit somewhere in between the opening 
of the active site and the Fe heme.  Owing to the length of the wire, ReC3argNO2 (~ 17 
Å) and ReC3arg (~ 15 Å) are proposed to extend down the channel away from the 
tryptophan residues at the opening of the channel.  Owing to less mobility, ReC3argNO2 
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is proposed to sit far enough from the Fe heme for inefficient ligation upon photo-
production of Fe(II).  ReC3arg was shown to ligate the Fe heme upon binding.  However, 
a five-coordinate Fe(II) species was produced after photo-excitation.  ReC3arg is 
expected to dissociate from the Fe (II) species in order for O2 to bind.  On the contrary, 
ReC8argNO2 (~22 Å) can extend the entire channel and has the mobility to closely 









































Scheme 3.8.  Proposed electron transfer mechanism.  Upon binding of ReC3argNO2 to iNOSoxy, the Fe 
heme shifts from low spin Fe(III) to high spin Fe(III) (step 1).  Upon 355 nm photo-excitation, the Re(I) is 
promoted to its excited state, Re(I)* (step 2).  In the presence of quencher, the Re(0) and (+)quencher are 
generated (step 3).  The produced Re(0) injects an electron into the Fe(III) heme to produce a high spin, 
five-coordinate Fe(II) species (step 4).  The (+)quencher recombines with the Fe(II) species, and the 





3.8 CONCLUDING REMARKS 
 
 Two wires were designed and synthesized to probe the catalytic cycle of iNOSoxy, 
ReC3arg and ReC3argNO2.  Although similar in length and structure, the two wires have 
different binding modes and affinities for the protein.  ReC3arg binds with a Kd of 2 μM 
± 500 nM, demonstrating a type II perturbation.  ReC3argNO2 binds with a Kd of 7 μM ± 
1 μM.  A type I perturbation was observed.  ReC3arg and ReC3argNO2 have excited state 
lifetime decays of 577 ns and 473 ns, respectively.  The excited states of both wires were 
quenched by ascorbate and pMDA.  Re(0) was generated and produced Fe(II) in less than 
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SURFACE BINDING WIRE  

























Surface-binding sensitizer-linked substrates (wires) were designed and 
synthesized to characterize short-lived intermediates produced by laser-induced electron 
transfer to the active site of the oxygenase domain of inducible nitric oxide synthase 
(iNOSoxy).  [Ru(dmbpy)(aminophenanthroline-C10F9)][PF6]2 (RuphenF9bp) binds on the 
surface of the protein with a Kd of 500 ± 60 nM, presumably at the back face of the 
channel where the FMN domain was suggested to occupy the full length enzyme 
complex during electron transfer processes.  After laser excitation, transient absorption 
measurements and UV-Vis spectroscopy show that Fe(III) is reduced to Fe(II) in less 
than 10 ns.  The electron is proposed to travel along a similar pathway as the natural 














4.1  INTRODUCTION 
 
 
Three ruthenium wires were previously synthesized for binding and inhibition 
studies with Δ65 and Δ114 iNOSoxy, the first 65 and 114 amino acid residues cleaved, 
respectively (Figure 4.1).1  All of the ruthenium wires share a ruthenium bipyridine (bpy) 
center with different degrees of bulky substituents off the bpy rings.  Fluorinated 
biphenyl rings (Fnbp, where n is equal to the number of fluorines off the rings) serve as 
the hydrophobic moiety that facilitate binding with the protein.  All three wires vary in 
size at the substrate end, playing an important role in binding.  Spectroscopic evidence 
showed that two of the three ruthenium wires do not displace L-arginine from the active 
site of NOS, suggesting that these wires do not bind in the active site but on the surface 
of the protein instead.  Ru-F8bp-Im is the only ruthenium wire that binds in the active site 
channel, displaces L-arginine from the active site, and ligates the Fe heme similarly to 
how imidazole binds to NOS.   
Modeling of ruthenium wires with Δ65 and Δ114 iNOSoxy helps explain the 
phenomenon of active site versus surface binding of ruthenium wires to monomeric and 
dimeric forms of iNOSoxy.  The sizes of the metal head groups and the substrate end of 
the ruthenium wires have been shown to affect binding to Δ65 and Δ114 iNOSoxy by 





















































A:  Ru-F9bp B:  Ru-F8bp-IM C:  Ru-F8bp-Ad
 
 





Figure 4.2  (A) Model of Ru-F8bp-Im to the exposed heme of Δ114 NOS.  (B) Model of Ru(bpy)3 docked 






A fourth ruthenium wire was designed and synthesized for binding and inhibition 
studies with the full length oxygenase domain of iNOS (iNOSoxy) to serve as a 
comparison to the three existing ruthenium wires (Figure 4.3, RuphenF9bp) that were 
studied with Δ65 and Δ114 iNOSoxy.  The fourth ruthenium wire introduces an 
aminophenanthroline ligand for synthetic ease.  The synthetic step, of the primary amine 
nucleophilic attack at the para-carbon sites, allows for a better and cleaner coupling 
reaction than what was used for precedent wires.  The bulky ruthenium center and the 
electrostatic characteristics of the decafluorophenanthroline ligand are retained to 
promote surface binding effects.  Surface binding ruthenium wires may provide an 
effective means of NOS inhibition by preventing electron transfer between the reductase 
and oxygenase domains.  Inhibitors that disrupt protein to protein interactions are of great 
value owing to the biologically relevant protein intermediates during the catalytic 

























4.2  EXPERIMENTALS 
 
General.  Expression and purifications of iNOSoxy is described in Appendix A.  
Preparations of protein and wire samples were described in Chapter II.  All chemicals 
used during synthesis were purchased from Aldrich, unless otherwise stated.  The binding 
constant was determined from steady-state fluorescence data by Scatchard analysis as 
was described in Chapter II. The binding constant was also determined by using the 










 ,   (eq 4.1) 
where values were calculated from transient luminescence data as described in Chapter 
II.  Molecular modeling was done using the DS ViewerPro Peptide Modeling Program.  
UV-visible absorption spectra were taken on an Agilent 8453 UV-Vis spectrometer.  
Steady-state emission measurements were made in buffer using a Flurolog Model FL3-11 
fluorometer equipped with a Hamamatsu R928 PMT.  All laser experiments were carried 
out in atmosphere-controlled 0.5 cm path length cuvettes equipped with Kontes valves 
for pump purge cycles, unless otherwise stated.   
 
Synthesis.  The ruthenium surface binding wire can easily be synthesized by a 
three step process.  Nitrophenanthroline is commercially available.  Reduction of the 
nitro group can be done using Pd/C and N2H4 in anhydrous methanol (Scheme 4.1).  A 
nucleophilic attack of the amine at the para carbons of the decafluorobiphenyl is induced 
by the NaH deprotonation step.  The ligand synthesis is completed in two steps.  Two 
equivalents of 4,4’-dimethyl-2,2’-bipyridine are complexed with a ruthenium metal by 
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refluxing ruthenium trichloride trihydrate alone for 2 hours in ethanol and water (Scheme 
4.2).  Two equivalents of ligand and HCl were added and refluxed for another hour.  
Product was collected as a purple solid.  The final step is to metalate the wire in H2O and 
EtOH (Scheme 4.2).  The final wire is precipitated out with hexafluorophosphate salt, and 




























































































Scheme 4.2.  (Top) Synthesis of Ru(dmbpy)Cl2. (Bottom) Metalation of phenF9bp with the ruthenium 
complex. 
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Aminophenanthroline (NH2phen).  1 g (4.4 mmol) 5-nitrophenanthroline and 283 mg 
(2.6 mmol) Pd/C (10% wt) was added to a round bottom flask, pumped and purged with 
argon.  Anhydrous methanol (85 mL) was added slowly under a stream of argon.  The 
mixture was carefully pumped and purged with argon (over 5 cycles) while stirring until 
oxygen was removed from the solvent.  Then, 1 mL (22 mmol) hydrazine monohydrate 
was added drop wise into the reaction mixture and heated to 65oC.  The reaction was 
stopped after 4 hours.  Pd/C solid was filtered off through a filter frit containing celite.  
The filtrate was concentrated by rotary evaporation and carried onto the next step without 
further purification.  A yellow brown solid was obtained (800 mg, 92% yield).  1H NMR 
(300 MHz, CD3OD): δ (ppm) 3.3 (s, 1H); 7.5 (m, 1H); 7.7 (m, 1H); 8.1 (d, 1H); 8.6 (d, 
1H); 8.7 (d, 1H); 9.0 (d, 1H).   
5-aminophenanthroline nonafluorobiphenyl (NH2phenF9bp).  100 mg (0.51 mmol) 
NH2phen and anhydrous THF (1.5 mL) was added to a round bottom flask and stirred.  
Solid NaH (15 mg, 0.61 mmol) was added into the flask with a stream of argon.  The 
reaction mixture was stirred for 2 hours at room temperature.  Then, 205 mg (0.61 mmol) 
decafluorobiphenyl was added and stirred at 40oC overnight (12 hours).  The reaction 
mixture turned red the next morning.  There was a small amount of precipitate in 
solution, presumably the starting material, which was separated by vacuum filtration.  
The filtrate was collected and concentrated by rotary evaporation.  A red oil resulted, 
which was purified by flash column chromatography (50:3 CH2Cl2:MeOH).  An orange 
solid was collected.  (150 mg, 59% yield).   
Ru(4,4’-dimethyl-2,2’-bipyridine)Cl2 (Ru(dmbpy)Cl2).  370 mg (1.7 mmol) RuCl3 x 3 
H2O was added to 12 mL (3:2) EtOH:H2O into a round bottom flask and stirred at 78oC 
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for 3 hours.  The reaction turned from red to blue to green over the reaction time.  Then, 
7.5 mg (4.1 mmol)  4,4’-dimethyl-2,2’-bipyridine was dissolved in 15 mL (6:1) 
EtOH:HCl solution and added to the reaction mixture.  The solution continued to reflux 
at 78oC for 1 hour until the reaction mixture turned purple.  The volume was reduced and 
the precipitate was collected by a filter frit by vacuum filtration.  The solid was washed 
with water and ether.  The product was collected as a purple solid.  (487 mg, 50% yield).   
1H NMR (300 MHz, CD3OD): δ (ppm) 2.4 (d, 6H); 2.7 (d, 6H); 6.9 (d, 1H); 7.0 (d, 1H); 
7.3 (d, 1H); 7.5 (d, 1H); 7.7 (m, 2H); 8.2 (s, 1H); 8.3 (s, 1H); 8.4 (s, 1H); 8.5 (s, 1H); 9.0 
(d, 1H); 9.8 (d, 1H).  
[Ru(4,4’-dimethyl-2,2’-bipyridine)(5-aminophenanthroline-nonafluorobiphenyl)] 
[PF6]2 (RuphenF9bp).  40 mg (0.091 mmol) Ru(dmbpy)Cl2 and 41 mg (0.10 mmol) 
NH2phenF9bp were stirred in 5 mL (6:3:1) EtOH:CHCl3:H2O mixture.  The reaction 
mixture was heated to 80oC and stirred for 24 hours.  The reaction turned from purple to 
red over the reaction time.  The reaction solution was concentrated to a red oil and 
purified by flash column chromatography.  The first eluent was 1:2 H2O:ACN to wash 
off unreacted starting materials.  Once the column ran clean, a mixture of 2.5 : 20 : 80 
KNO3 : H2O : ACN was used to collect product as an orange band.  The fractions 
containing product were concentrated by rotary evaporation.  The product was 
redissolved in 10 mL H2O.  A saturated amount of ammonium hexafluorophosphate was 
dissolved in a small beaker containing 10 mL water, and then added to the 10 mL of 
product and water solution.  A precipitate immediately formed, which was collected by a 
filter frit by vacuum filtration.  Product as a red solid was collected.  (75 mg, 65% yield).  
1H NMR (300 MHz, CD3OD): δ (ppm) 2.5 (d, 6H); 2.7 (d, 6H); 7.1 (d, 1H); 7.3 (m, 3H); 
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7.4 (t, 1H); 7.5 (d, 1H); 7.6 (m, 2H); 7.7 (t, 1H); 7.9 (d, 1H); 8.1 (d, 1H); 8.5 (s, 1H); 8.55 
(s, 1H); 8.65 (s, 1H); 8.7 (s, 1H); 8.5-8.8 (m, 2H); 9.6 (d, 1H).  19F NMR (300 MHz, 




4.3  RESULTS 
 
UV-Vis Absorbance Spectroscopy.  Perturbation of the Fe heme upon binding of 
RuphenF9bp is visible by UV-Vis spectroscopy.  The resting state of the Fe heme Soret at 
λmax = 423 nm is optically red shifted to λmax = 430 nm upon mixing of RuphenF9bp 
(Figure 4.4).  This is indicative of a close interaction between the inhibitor and the Fe 
heme perturbing the Fe coordination state.2  A type II perturbation suggests a replacement 
of the water ligand with the inhibitor in the sixth Fe coordination site, causing the Fe 
heme become low spin.  The inhibitor is closely associating with the Fe heme within 
bonding distance in order to create such a spectral change.  However, because 
RuphenF9bp is terminated with fluorines, a direct ligation of the Fe heme is not viewed 
possible.  Generally, when water is displaced from the active site by a substrate like 
arginine, the Fe heme Soret is blue shifted to around 390 nm, making the Fe heme five-
coordinate and high spin.3  The opposite occurred in this case; therefore, the wire is 
concluded to interact close enough to the Fe heme to displace water without Fe heme 
ligation.   
 A competitive binding study of RuphenF9bp with arginine was conducted.  A 
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sample of RuphenF9bp bound iNOSoxy was titrated with arginine.  A spectral shift by UV-
Vis spectroscopy was observed from λmax = 430 nm to λmax = 390 nm.  This indicates that 
arginine is bound to the active site.  This could mean that either arginine displaced 
RuphenF9bp from the active site, or that RuphenF9bp is in a completely different binding 
site that is not detectable by UV-Vis spectroscopy.  A similar experiment is conducted, 





Figure 4.4.  UV-Vis spectroscopy of titrations of RuphenF9bp into 2 μM iNOSoxy.  A spectral shift is 
























 2uM iNOS + 1uM Ru wire
 2uM iNOS + 2uM Ru wire












Steady-State Fluorescence.  As arginine was titrated into a sample of 
RuphenF9bp bound to iNOSoxy, the fluorescence of Ru(II)* did not change.  If arginine 
was indeed displacing RuphenF9bp from the active site, then an increase in fluorescence 
was expected as RuphenF9bp was displaced further away from the Fe heme.  However, 
the fluorescence intensity did not change.  This implied that RuphenF9bp remained bound 
to iNOSoxy at a biding site different from the active site.   
Steady-state fluorescence experiments were also conducted of RuphenF9bp 
titration into iNOSoxy buffer samples to monitor the fluorescence change of Ru(II)* as the 
wire binds to the protein.  If RuphenF9bp is at a different binding site than the active site 
and is situated close enough to the Fe heme for spectral changes to occur, then the 
intensity of Ru(II)* should decrease when energy or electron transfer occurs between the 
Ru metal center and the Fe heme.  A 0.5:1 wire (1 μM) to protein (2 μM) emission 
spectra is shown in Figure 4.5, open circle.  An emission spectrum of wire in buffer is 
shown as a solid line in Figure 4.5.  The emission λmax is centered at 640 nm.  When wire 
is titrated into iNOSoxy sample, the emission intensity of the ruthenium (II) excited state 
(Ru(II)*) is blue shifted to 620 nm and increased in intensity (Figure 4.5, open circles).  
An increase in intensity was not expected and has never been shown before for previous 
wires.  After 10 minutes, the emission intensity drops a little below the emission of the 
same concentration of wire in buffer (Figure 4.5, dashed line).   
 Another sample of higher concentration 1:1 wire (2 μM) to iNOSoxy (2 μM) was 
prepared, and the same fluorescence experiment was conducted (Figure 4.6).  The same 























 1uM RuF9bp + 2uM iNOSoxy
 1uM RuF9bp + 2uM iNOSoxy after 10 mins
 
Figure 4.5.  Steady-state fluorescence spectra of 1 μM RuphenF9bp in buffer (solid blue trace) and in 2 μM 
iNOSoxy (open circles) immediately after mixing and after 10 minutes (dashed line).  An initial increase in 










 2uM Ru F9bp
 2uM Ru F9bp + 2uM iNOSoxy
 2uM Ru F9bp + 2uM iNOSoxy after 50mins
 1uM RuF9bp
 
Figure 4.6.  Steady-state fluorescence spectra of 2 μM RuphenF9bp in buffer (solid trace), and in 2 μM 
iNOSoxy (open circles) immediately after mixing, and after 50 minutes of equilibration (dashed line).  
Emission spectrum of 1 μM RuphenF9bp in buffer is shown as closed circles for comparison. 
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Immediately after mixing, the emission intensity of wire in complex with the protein 
(Figure 4.6, open circles) is higher than the emission intensity of the same concentration 
of wire in buffer (Figure 4.6, solid line).  The emission intensity of wire in the presence 
of protein slowly decreased below the intensity of wire in the absence of protein over a 
50 minute time period (Figure 4.6, dashed lines).  This intensity of wire in the presence of 
protein after 50 minutes of equilibration overlaps closely with the emission intensity of 1 
μM of wire in the absence of protein.  Assuming that bound wire has no fluorescence, it 
is inferred that when wire is in complex with iNOSoxy, there is roughly 1.5 μM of wire 
free in solution and 0.5 μM of wire bound to 2 μM protein.  At this concentration, only 
0.25:1 binding mode of wire to protein is observed. 
 The fluorescence of 2:1 wire (4 μM) to protein (2 μM) sample was measured 
(Figure 4.7).  Initially, the emission intensity of wire in complex with protein was 
increased compared to the emission of wire in buffer.  After 5 minutes, the emission 
intensity is less than the emission of the same concentration of wire in buffer.  After 50 
minutes of equilibration, the emission of wire in complex with protein is less than the 
emission intensity of 3 μM wire in buffer.  Equilibration at a longer timescale did not 
increase binding.  It is inferred that at 2:1 wire to protein concentration, about 3 μM of 
wire is free in solution, and only 1 μM of wire is bound to protein.  It is concluded that 
only 0.5:1 binding mode of wire to protein is observed in this system.   
 The fluorescence traces of the titration of wire (dotted lines) into buffer and 
iNOSoxy (solid lines) after equilibration are shown in Figure 4.8.  Comparing the emission 
intensity of free wire to bound wire, it is inferred that only about half equivalent of wire 


















 4uM RuF9bp 
 4uM RuF9bp + 2uM iNOS
 4uM RuF9bp + 2uM iNOS after 5 mins
 4uM RuF9bp + 2uM iNOS after 50 mins
 3uM RuF9bp 
 
Figure 4.7.  Steady-state fluorescence spectra of 4 μM RuphenF9bp in buffer (solid trace) and in 2 μM 
iNOSoxy (open circles) immediately after mixing, after 5 minutes (dashed line), and after 50 minutes of 
























 1uM RuF9bp 
 2uM RuF9bp
 3uM RuF9bp 
 4uM RuF9bp 
 1uM RuF9bp + 2uM iNOSoxy
 2uM RuF9bp + 2uM iNOSoxy
 3uM RuF9bp + 2uM iNOSoxy
 4uM RuF9bp + 2uM iNOSoxy
 
Figure 4.8.  Steady-state fluorescence traces of RuphenF9bp titrations into buffer (dotted lines) and  
iNOSoxy samples (solid lines).  A 0.5:1 binding mode is observed. 
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At 4:1 wire to protein concentration (Figure 4.8, fourth solid line from the bottom), the 
emission intensity overlaps the emission intensity of 3 μM of wire alone (third dotted line 
from the bottom of Figure 4.8).  Assuming that bound wire has no fluorescence, it is 
inferred that 3 μM of wire is free in solution, and 1 μM of wire is bound to 2 μM of 
iNOSoxy, exhibiting a 0.5:1 binding mode of wire to protein.   
A dissociation constant was determined by Scatchard analysis of the fluorescence 
data.  The areas under the curves were calculated to find the ratio of bound wire to free 
wire as described in Chapter II.  A Scatchard plot was generated by plotting [bound wire] 
/ [free wire] against [wire] (Figure 4.9).   
Scatchard Plot of RuF9bp


















Figure 4.9.  Scatchard analysis of fluorescence data, resulting in a Kd of 500 ± 60 nM. 
 
The negative inverse of the slope of the line gave a dissociation constant of 500 ± 60 nM.  
This binding constant is much lower than the binding constant for both arginine (16 μM) 
and imidazole (12 μM); however, steady-state fluorescence data suggested that only half 
equivalent of wire concentration is bound to protein even after 50 minutes of 
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equilibration.  It is concluded that RuphenF9bp could possibly be binding to an area of the 
protein that is not easily accessible, such as the surface, where protein conformational 
changes need to occur to allow for equilibration for complete binding of wire to protein.  
This explains the time dependence for binding and quenching.  However, once the wire is 
bound to the surface of the protein, it interacts closely to the heme with high affinity (Kd 
= 500 ± 60 nm).  Detailed explanation of surface binding versus substrate channel 
binding can be found in the ‘Discussions’ section. 
 
Transient Luminescence.  Transient luminescence of wire in buffer was 
measured by exciting at 480 nm with an Nd:YAG pulse laser, and luminescence traces 
were observed at 630 nm.  The traces exhibit a monoexponential decay with a decay rate 
of 475 ns (Figure 4.10).  A luminescence decay rate of 475 ns is typical for what is 
normally observed for a ruthenium metal to bipyridine ligand charge transfer type 
system.4  Transient luminescence is measured on the wire in the presence of protein, and 
the lifetime decay trace of Ru(II)* is shown to be slightly quenched by the protein 
(Figure 4.11).  Figure 4.11 shows a slight quenching of the Ru(II)* excited state while in 
the presence of protein.  This indicates that a chromophore moiety of the protein, either 
an aromatic amino acid residue or the Fe heme, is facilitating either energy or electron 
transfer from the wire excited state.  Transient luminescence was measured for different 
wire to protein concentrations (Figure 4.12).  For each wire to protein ratio, only a slight 
decrease in luminescence intensity is observed.  Each individual wire to protein 
































excite 480 nm, obs 630 nm 
tau = 475 ns
 
Figure 4.10.  Transient luminescence of 10 μM RuphenF9bp in buffer, exhibiting a monoexponential 












 10uM RuF9bp + 10uM iNOSoxy
 
Figure 4.11.  Transient luminescence of 10 μM of RuphenF9bp in buffer (blue trace) and in the presence of 
10 μM of iNOSoxy.  A slight quenching of Ru(II)* is observed in the presence of protein.  (λex = 480 nm, 
λobs = 630 nm). 
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A sample of 3:1 RuphenF9bp (30 μM) to 10 μM of iNOSoxy was analyzed, and 
two lifetime decays were observed (τ(1) = 661 ns and τ(2) = 114 ns) (Figure 4.13).  The 
longer lifetime decay is 661 ns, which should be the lifetime of free wire in solution; 
however, it is actually longer than the lifetime of wire in buffer (τ = 475 ns).  The longer 
lifetime is assigned to wire bound to the hydrophobic surface patch of the protein.  The 
hydrophobic patch is thought to protect the excited state ligand radical from quickly 
decaying back to its ground state, thus increasing the lifetime decay time from 475 ns to 
661 ns.  This phenomenon is similar to what was observed by steady-state fluorescence 
experiments, where emission intensity increased upon mixing of wire to protein and then 
decreased after equilibrium.  The shorter lifetime is assigned to the wire bound tightly to 
the surface of the protein, where it is in close contact with the Fe heme for energy or 
electron transfer to occur.  These two lifetimes are consistent over various wire to protein 
ratios (Figure 4.14).  The long lifetime decay is consistently around 600 ns and is longer 
than the lifetime decay of wire in buffer.  The shorter lifetime decay is also consistently 
around 90 ns.   
 A binding constant was determined by the derived Michealis-Menten equation (eq 
4.1).  The ratio of bound to free wire is determined by the amplitudes of the two lifetime 
decays.  The concentration of wire and protein is plugged into the equation, and a 
dissociation constant of 400 ± 80 nM was determined.  This value is consistent with 
Scatchard analysis of the binding studies by steady-state fluorescence spectroscopy (500 



























 10uM RuphenF9bp + 10uM iNOS
 20uM RuphenF9bp + 10uM iNOS
 40uM RuphenF9bp + 10uM iNOS
 
Figure 4.12.  Transient luminescence traces of RuphenF9bp titrations into buffer (solid blue traces) and into 





























30uM Ru wire + 10uM iNOS
tau (1) = 661ns
tau (2) = 114ns
 
Figure 4.13.  Transient luminescence trace of 30 μM RuphenF9bp in 10 μM iNOSoxy (solid lines), 
biexponential fit (dotted line), and residual (green line above). τ(1) = 661 ns and τ(2) = 114 ns.  (λex = 480 































































Figure 4.14.  Transient luminescence of 1:1 wire to protein (A, solid line) and 4:1 wire to protein (B, solid 
line).  The biexponential fits are shown as dotted lines, and the residual is shown above each trace.  At 1:1 
wire to protein sample, τ(1) = 645 ns and τ(2) = 90 ns.  At 4:1 wire to protein sample, τ(1) = 612 ns and 





Transient Absorbance.  Transient absorbance was measured for wire in buffer 
(Figure 4.15).  The sample was excited at 480 nm laser light and probed at various 
wavelengths.  The transient absorbance of wire in buffer sample fits a monoexponential 
decay, and the lifetime decay of Ru(II)* absorbance was measured to be 260 ns.  This 
lifetime decay is much smaller than the transient luminescence lifetime decay of Ru(II)*.  
The two numbers should correspond; however, the transient absorbance of Ru(II)* is half 
the luminescence decay.  This phenomenon cannot be explained.  There must be another 
decay pathway, possibly through the decafluorobiphenyl rings which may absorb at 
different wavelengths.   
 Transient absorbance of wire in buffer was measured at various wavelengths 
(Figure 4.16).  The transient absorbance intensity was plotted against the probed 
wavelength, and an absorbance curve is generated for Ru(II)* (Figure 4.17).  Ru(II)* has 
an absorbance λmax at 370 nm.  Ru(II) ground state absorbance has an absorbance λmax at 
450 nm, which decays as Ru(II)* is generated.  Transient absorbance decay traces were 
measured for RuphenF9bp in the presence of iNOSoxy; however, there was no signal 
beyond the Ru(II)* signal, or beyond 500 ns.  This was expected because Ru(II)* does 
not have a high enough potential to reduce the Fe heme at such long distances.   
 
Table 4.1.  Reduction Potentials 






Low spin iNOSoxy (FeIII/II) -0.357 






















ex 480  obs 370
tau = 260ns
 
Figure 4.15.  Transient absorbance decay trace of 50 μM RuphenF9bp (solid blue line), monoexponential 

















Figure 4.16.  Transient absorbance of 50 μM RuphenF9bp probed at 370 nm (solid trace) and 450 nm 

























Figure 4.17.  Transient absorbance curve of RuphenF9bp, exhibiting a Ru(II)* absorbance at λmax = 360 nm 
and a Ru(II) ground state decay at λmax = 450 nm. 
 
 
If the wire is bound on the surface of the protein, then there is not any aromatic amino 
acid residues (evident from modeling studies) close enough to the Ru metal center for 
energy transfer or electron transfer to occur with the Fe heme.  A flash quench 
methodology would have to be employed for this system to generate Ru(I) and in turn 






Transient Luminescence and Absorbance with Ascorbate.  Ascorbate was the 
first quencher employed for this system.  Transient luminescence data was measured of 
samples containing RuphenF9bp, iNOSoxy, and ascorbate; however, there was very little 
quenching observed, even with 1000 fold excess of ascorbate (Figure 4.18).  With the 
addition of tetramethylbenzene-para-diamine (TMPD), the Ru(II)* excited state was 
quenched significantly.  Presumably, the TMPD keeps the ascorbate from auto-oxidation, 
to allow the ascorbate to donate an electron to the Ru(II)*.   
 Transient absorbance of RuphenF9bp in the presence of ascorbate and TMPD was 
measured at various wavelengths (380 – 600 nm) (Figure 4.19).  Both formation (positive 
traces) and disappearance (negative traces) of transient species were observed.  Transient 
absorbance of wire in the presence and absence of quencher were overlaid for a 
comparison (Figure 4.19, dotted trace).  The Ru(II)* decays in 260 ns; therefore, any 
signal after 1 μs would not be due to Ru(II)* signal.  The transient absorbance intensity 
was plotted against the probed wavelength to generate a full transient absorbance curve 
(Figure 4.20).  There is a large absorbance peak with λmax = 360 nm (π - π* bpy-, ε = 
14,000 M-1cm-1) and another peak at λmax = 500 nm (π* - π* bpy-, ε = 11,000 M-1cm-1).10  
These were assigned as Ru(I) absorbance features.  There is also a shoulder at λmax = 610 
nm, which was assigned as the oxidized TMPD signal (λmax = 610 nm, ε = 12,000 M-1cm-
1).11,12  Oxidized ascorbate (λmax = 260 nm)13,14 and oxidized TMPD (λmax = 610 nm) 
have absorbance features that do not interfere with Ru(II) (λmax = 450 nm), Ru(II)* (λmax 























 32.8uM RuF9bp + 16.4uM iNOS
 32.8uM RuF9bp + 16.4uM iNOS + 10mM ascorbate
 32.8uM RuF9bp + 16.4uM iNOS + 10mM ascorbate + 10mM tmpd
 
Figure 4.18.  Transient luminescence traces of 32.8 μM RuphenF9bp in 16.4 μM iNOSoxy in buffer (blue 
trace), plus 10 mM ascorbate (green trace), and plus 10 mM TMPD (orange trace).  Ru(II)* is quenched the 










 50uM RuF9bp (Ru(II)*)





Figure 4.19.  Transient absorbance traces of RuphenF9bp in buffer (dotted trace) and RuphenF9bp in the 





















Figure 4.20.  Transient absorbance curve of Ru(I) generated by ascorbate and TMPD, generating Re(I) 
transient absorbance signal with a λmax = 360 nm and a small shoulder at λmax = 510 nm.  Another small 
shoulder at λmax = 610 nm is owing to (+)TMPD.  Transient absorbance at 410 - 490 nm was not measured. 
 
Transient absorbance was measured for the wire in the presence of ascorbate, 
TMPD, and iNOSoxy (Figure 4.21).  The transient absorbance intensity was plotted 
against the probed wavelength to generate an absorbance curve (Figure 4.22).  The 
transient absorbance curve was plotted after 2 μs to limit any interference from Ru(II)* 
signal.  Figure 4.22 shows a positive absorbance curve at 390 nm, a negative curve at 430 
nm, and another positive feature at 550 nm for samples that contained RuphenF9bp, 
ascorbate, TMPD, and iNOSoxy.  It was shown previously that Ru(I) has absorbance 
peaks at 360 nm and 500 nm (Figure 4.22, open circles).  Assuming that quantum yields 
are the same for the generation of Ru(I) by ascorbate in the presence and absence of 
protein, the Ru(I) absorbance intensity should be equal if neither energy or electron 














80uM RuF9bp + arg + 20uM iNOSoxy




Figure 4.21.  Transient absorbance traces of RuphenF9bp in the presence of ascorbate, TMPD, and iNOSoxy 
probed at 420 nm (dashed line) and 360 nm (solid line).  (λex = 480 nm). 
 
 
50uM RuF9bp + 10mM tmpd + 10mM asc + 1mM arg 




















50uM RuphenF9bp + asc
+ TMPD = Ru(I)
 
Figure 4.22.  Transient absorbance curve of RuphenF9bp in the presence of ascorbate and TMPD (open 
circle) plus iNOSoxy (closed shapes).  In the presence of protein, the Ru(I) transient absorbance (λmax = 360 
nm) is quenched, revealing an Fe(II) species with a λmax = 390 nm and (+)TMPD signal with at λmax = 610 
nm.  A disappearance of Fe(III) (λmax = 423 nm) is also observed. 
Ru(I) is quenched 
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However, for samples containing protein, the Ru(I) transient absorbance signal is 
observed to be quenched when compared to Ru(I) transient absorbance intensity in the 
absence of protein (Figure 4.22).  A clear signal with a λmax = 390 nm is evident instead.  
This transient species with λmax = 390 nm is assigned as the transient Fe(II) species 
generated by electron transfer from Ru(I) oxidation state of the wire.  The large signal 















50uM RuF9bp + 1mM arg + 10mM TMPD + 10mM ascorbate + 20uM iNOS
 before laser shot
 after laser shot
 
Figure 4.23.  UV-Vis spectroscopy of the RuphenF9bp, ascorbate, TMPD, and iNOSoxy sample before 
(green trace) and after (orange trace) laser photolysis. 
 
 
 The generated Fe(II) signal lives long enough for steady-state UV-Vis analysis.  
UV-Vis spectroscopy was measured of samples before and after laser photolysis (Figure 
4.23).  There is a slight blue shift in the Fe heme Soret region, which is expected to occur 
if Fe(II) is produced.  If Ru(I) was still in the sample, then the generated Ru(I) signal (ε = 
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14,000 M-1cm-1) would not interfere with the Fe signal (ε = 75,000 M-1cm-1).  The (+) 
TMPD signal (ε = 11,000 M-1cm-1) should also be small in comparison.  It is concluded 
that the shift in steady-state UV-Vis is owing to the photo-generated Fe(II) signal. 
 
 
 Transient Luminescence and Absorbance with pMDA.  A second quencher 
was chosen for comparison to transient data from ascorbate and TMPD samples.  
Transient luminescence lifetime decays were measured for wire in the presence of protein 
and para-methoxy-N,N’-dimethylaniline (pMDA) (Figure 4.24).  The excited state 
lifetime of Ru(II)* is slightly quenched in the presence of pMDA.  Transient absorbance 
was measured with 480 nm excitation and probed at various wavelengths (Figure 4.25).  
The transient absorbance lifetime decay of Ru(II)* is significantly quenched to 80 ns.  
There is a longer-lived species that appears after 1 μs and was shown to live for hours.  
When probed at different wavelengths, a clear disappearance (negative features) and 
appearance (positive features) of transient species become evident (Figure 4.26).  The 
transient absorbance intensities of these species were plotted against the probed 
wavelength to generate an absorbance curve (Figure 4.27).  There is a positive signal with 
a λmax = 390 nm, a negative feature with a λmax = 430 nm, and a huge positive absorbance 
with a λmax = 550 nm.  The large absorbance at 550 nm is assigned as oxidized pMDA 
signal, which was previously shown in Chapter III.  The feature at 390 nm is assigned as 
the photo-produced Fe(II) absorbance, similar to what was observed for Fe(II) signal 
generated by ascorbate and TMPD.  The negative feature at 430 nm is indicative of 






















 80uM RuF9bp + arg + 20uM iNOS
 10mM pMDA + 80uM RuF9bp + arg + 20uM iNOS 
 
Figure 4.24.  Transient luminescence traces for 80 μM RuphenF9bp in the presence of 20 μM iNOSoxy 
(solid trace) and in 10 mM pMDA (dotted trace).  The Ru(II)* is only slightly quenched by protein.  (λex = 




















 RuF9bp + pMDA + arg + iNOS
ex 480 obs 380
tau = 80ns
 
Figure 4.25.  Transient absorbance trace of RuphenF9bp in the presence of iNOSoxy and pMDA (solid blue 














50uM RuF9bp + 10mM pMDA





Figure 4.26.  Transient absorbance traces of 50 μM RuphenF9bp in the presence of 20 μM iNOSoxy and 10 
mM pMDA probed at 380 nm (blue trace), 440 nm (green trace), and 600 nm (pink trace).  (λex = 480 nm). 
 
 



















Figure 4.27.  Transient absorbance curve of RuphenF9bp in the presence pMDA (open circles) and iNOSoxy 
(closed shapes).  (+)pMDA has a λmax = 550 nm; Re(I), λmax = 360 nm; Fe(II), λmax = 390 nm; and Fe(III), 
λmax = 423 nm.  A slight quenching of Re(I) is observed with small appearance of Fe(II) species.   
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Ru(I) absorbance was observed to be quenched from electron transfer to the Fe heme 
producing a transient Fe(II) species.  This is indicative of the disappearance of Ru(I) 
signal and the appearance of Fe(II) signal. 
 A UV-Vis spectra before and after laser photolysis were measured (Figure 4.28).  
There is a slight blue shift in the Fe heme Soret.  A difference between absorbance traces 
before and after laser photolysis is generated (Figure 4.28, inset).  A positive feature at 
390 nm and a negative feature at 430 nm become clear.  This is a good indication that 














50uM RuF9bp + 1mM arg + 20uM iNOS + 10mM pMDA
 before laser shots
 after laser shots
 
Figure 4.28.  UV-Vis spectroscopy of RuphenF9bp in the presence of pMDA and iNOSoxy before (green 
trace) and after (orange trace) laser photolysis.  The difference between the two traces is shown as the inset. 
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4.4  DISCUSSIONS 
 
Surface Binding Phenomenon.   
 
It has been proposed from previous work that the ruthenium head group is too big 
to fit inside the active site channel, therefore the ruthenium wires are proposed to bind to 
the surface of the protein instead where hydrophobic patches exist.1  The RuphenF9bp 
wire is modeled inside the substrate channel of neuronal NOSoxy (PDB code 1MMV) 
which has similar structures and conformations as iNOSoxy (Figure 4.29) and crystals 
structures of nNOS are readily available.  Figure 4.29A shows the substrate channel 
unoccupied by substrate.  The two oxygenase monomers (green and tan) dimerizes as 
substrate binds in the active site channel.  During the dimerization process, the substrate 
channel closes up and becomes more restricted for substrate access.  RuphenF9bp has a 
huge ruthenium center that is shown by modeling to not fit well into the substrate channel 
(Figure 4.29B). 
The heme is also accessible from the back face of the active site channel (Figure 
4.30A).  The back face of the channel has a hydrophobic patch, where the FMN domain 
was proposed to interact with the oxygenase domain during electron transfer reactions.15    
The back face of the channel is not restricted during the dimerization process and remains 
open for the FMN domain or substrates to bind.  Figure 4.30B shows RuphenF9bp fitting 







Figure 4.29.  (A) Space filling model of the crystal structure of nNOSoxy (PDB code 1MMV) showing the 
substrate channel unoccupied.  The substrate channel is formed by monomer-a (tan) and monomer-b, 





Figure 4.30. (A) Space filling model of the crystal structure of nNOSoxy (PDB code 1MMV) showing the 
unoccupied back face of nNOSoxy channel at a 180o horizontal turn of Figure 4.29A.  (B) Model of 








A close up of two RuphenF9bp wires binding in the substrate channel and the 
back face of the protein are constructed in Figure 4.31.  Because of the huge head group 
of the ruthenium center, the wire can only be modeled in the substrate channel as close as 
8.76 Å away from the Fe heme (Figure 4.31, red RuphenF9bp).  However, the back face 
of the channel is more open for the wire to bind closer to the Fe heme at 4.91 Å away 
(Figure 4.31, orange RuphenF9bp).  The back face binding site is most likely the 
preferred binding site for RuphenF9bp, owing to the easy access and close proximity to 
the Fe heme. 
 An electrostatic potential surface of the oxygenase domain is constructed in 
Figure 4.32A.  The back face of the channel has a positive surface potential, while the 
substrate channel has a negative surface potential.  Considering the negative electrostatic 
potential of the wire ligand (Figure 4.32B), it is most likely that the wire would prefer the 














Figure 4.31.  Model of RuphenF9bp with the crystal structure of nNOSoxy (PDB code 1MMV).  A zoom in 
model of two RuphenF9bp wires in the substrate channel (red) and the back face (orange) of nNOSoxy with 
8.76 Å and 4.91 Å from the heme, respectively.  Arginine is also shown in a ball and stick fashion.  The 
RuphenF9bp is able to interact closer with the Fe heme from the back face than from the substrate access 





Figure 4.32.  (A) Electrostatic potential surfaces of nNOS, where positive and negative charges are shown 
in blue and red, respectively.  The back face (BF) and substrate channel (SC) are circled.  (B) Electrostatic 
potential surfaces of RuphenF9bp.  The negatively charged fluorinated biphenyl rings will prefer to bind to 







Electron Transfer Kinetics.  
 
A proposed electron transfer pathway is depicted in Scheme 4.3.  Upon binding of 
RuF9bp, the Fe heme Soret red shifts from 423 nm to 436 nm.  This is indicative of the 
wire binding closely to the Fe heme.  Upon 480 nm photo-excitation, the ruthenium is 
promoted to its excited state.  In the presence of quencher, the Ru(II)* is reduced to Ru(I) 
(λmax = 360 nm), and the quencher is oxidized (+TMPD with a λmax = 610 nm and pMDA 
with a λmax = 550 nm).  Upon formation of Ru(I), electrons transfer from the ruthenium to 
the Fe heme, reducing Fe(III) to Fe(II).  Fe(II) production was characterized by transient 
absorbance spectroscopy, where a negative 430 nm peak and a positive 390 nm peak 
were observed.  The 390 nm peak is assigned as the appearance of Fe(II) heme signal, 
and the 430 nm peak is assigned as the disappearance of the resting state Fe(III) heme.   
The first electron transfer step is fully characterized by photo-excitation of a 
surface binding wire.  The electron transfer pathway from the RuphenF9bp on the surface 
of the protein to the Fe heme is proposed to be similar to the electron transfer pathway 
from the reductase domain to the Fe heme.16,17  Lys423 and Trp409 have been shown to 
participate in ET pathways from the reductase domain to the Fe heme.16  A model of the 
surface binding wire with the protein shows close interactions of the RuphenF9bp wire 
with Lys423 and Trp409.  It is possible that upon photo-excitation of Ru(II) in the presence 
of quencher, the generated Ru(I) donates an electron that hops from the ruthenium center 
to the decafluorobiphenyl rings and onto Lys423 (distance = 9.6 Å).  From the Lys423 the 
electron is proposed to travel to the Trp409 (distance = 10.6 Å), to the Cys415 (distance = 
4.4 Å), and finally to the Fe(III) heme to produce Fe(II) heme.  That total distance would 
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be about 25 Å.  Another possible ET pathway would be a single step tunneling from the 
ruthenium center to the Fe heme (distance = 17 Å).  From transient absorbance 
experiments, the ET rate is estimated to be < 10 ns, the instrument response limit.  
According to the ET timetable18 (Chapter I), a direct single step electron transfer rate of < 
10 ns over 17 Å is pretty fast.  A hopping mechanism could be the case for this system, 
either through the amino acid residues or through the fluorinated biphenyl rings into the 






































Scheme 4.3.  Proposed electron transfer pathway for RuphenF9bp.  Upon binding of RuphenF9bp to 
iNOSoxy, a type II perturbation is observed (step 1).  RuphenF9bp is promoted to its excited state upon 
photo-excitation (step 2).  In the presence of quencher, Re(I) is produced (step 3).  Ru(I) then injects an 
electron into the Fe heme, reducing Fe(III) to Fe(II) (step 4).  The oxidized quencher recombines with 





Figure 4.33.  Proposed ET pathways from the RuphenF9bp to the Fe heme.  A direct ET pathway would be 
from the ruthenium center to the F(III), 16.9 Å.  A hopping mechanism may dominate from the ruthenium 
center to Lsy423,Trp409, and then to the Fe heme, a total distance of 24.6 Å, which is the proposed ET 












10.6 Å 4.4 Å 
 174
4.5  CONCLUDING REMARKS 
 
 A surface binding wire (RuphenF9bp) was designed and synthesized for iNOSoxy.  
RuphenF9bp binds with high affinity (Kd = 500 ± 60 nM) at the back face of the protein 
where electrostatic and hydrophobic interactions are proposed to be the driving force for 
binding on the surface of the protein.  The substrate channel is too conformationally 
restricted and electrostatically unfavorable for RuF9bp to bind.  Upon 480 nm photo-
excitation, the excited state ruthenium is reductively quenched by either ascorbate + 
TMPD or pMDA.  The Ru(II)* is reduced to Ru(I), while the quencher is oxidized.  Ru(I) 
has a high enough potential to reduce the Fe(III) heme to Fe(II) to return back to its 
Ru(II) ground state.  The recombination of oxidized quencher and reduced Fe is slow 
enough for characterization of the transient species by UV-Vis spectroscopy.  A 390 nm 
absorbance growth and a 430 nm absorbance bleach were observed.  The 390 nm peak 
was assigned as Fe(II) signal.  The surface binding wire was modeled in the back face of 
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ASSAYS FOR NITRIC OXIDE PRODUCTION FROM PHOTOEXCITATION  
OF SENSITIZER-LINKED SUBSTRATES:   
 


















Both 4-amino-5-methylamino-2’,7’-difluorescein (DAF-FM) and oxyhemoglobin 
(oxyHb) assays were utilized to probe for nitric oxide (NO) production by inducible nitric 
oxide synthase (iNOS) via photo-excitation of channel and surface binding wires.  It was 
concluded that these wires are strong inhibitors of iNOS, preventing the turnover of 
arginine by more than 50%.  There are possibilities and implications that these wires may 
serve as iNOS substrates as well as produce NO during enzyme catalysis; however, only 
a very small amount of NO is detected.  NO production may be inefficient, owing to the 
required five electrons to complete two turnovers of the catalytic cycle.  Two methods of 














5.1  INTRODUCTION 
 
 
 The “wires project” has a long standing goal of designing and synthesizing 
substrate based inhibitors (wires) for mechanistic study of cytochrome P450-like 
enzymes.  These inhibitors are designed to serve one of three purposes:  (1) inhibit and 
inactivate enzyme activity with high affinity, (2) inhibit, serve as the reductase substitute 
(or an electron donor), and activate enzyme activity for catalytic mechanistic study, or (3) 
serve as a substrate substitute to enhance enzyme activity.  The two methods of 
determining which of the three roles a wire serve for a specific enzyme is to (1) 
characterize short-lived intermediates of the protein catalytic cycle produced by photo-
excitation of the wire or (2) assay for enzyme activity in the presence of wires with or 
without the natural substrate.  Transient luminescence and absorbance spectroscopy were 
described in previous chapters on how to characterize laser-induced, short-lived 
intermediates.  Many wires described in this thesis served as mechanistic inhibitors.  
However, this chapter will focus on characterizing these wires as substrate substitutes of 
inducible nitric oxide synthase (iNOS) by assaying for enzyme activity.  
NOS catalytic cycle has two turnovers1 that are based on the cytochrome P450 
mechanism (Chapter I).  With the aid of many cofactors, such as iron protoporphyrin IX 
(Fe heme), tetrahydrobiopterin (BH4), L-arginine substrate,2 flavin adenine dinucleotide 
(FAD), flavin mononucleotide (FMN), nicotinamide adenine dinucleotide phosphate 
(NADPH), and calmodulin (CAM).  NOS catalyzes L-arginine and O2 by five electron 
transfer processes to produce L-citrulline and nitric oxide (NO).  Nitric oxide is a 
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secondary signaling molecule that diffuses readily through cell membranes to induce a 
variety of biological processes, such as vasodilatation, neurotransmission, inflammation, 
and apoptosis.3  Overproduction or underproduction of NO results in many diseases and 
disorders, such as Alzheimer’s, Parkinson’s, septic shock, schizophrenia, and long term 
depression.  Research in regulating NO production is critical for the cure of these 
diseases.  Owing to the transient and volatile nature of NO, direct detection methods of 
NO is difficult.  However, NO exists primarily as nitrite (NO2) and nitrate (NO3) in 
biological systems4 (eq 5.1-3), which can be quantified as a measurement of NOS 
activity.   
++−− +⎯→⎯→+
+
HNOONOONO H 322                        (eq 5.1) 
−− +⎯→⎯→+ 32422 22 NONOONONO
OH
             (eq 5.2) 
−⎯→⎯→+ 2322 22 NOONNONO
OH
                         (eq 5.3) 
Characterization of NOS activity can be carried out by three common methods:5 (1) 
quantification of radiolabeled citrulline from the introduction of radiolabeled arginine, (2) 
exploitation of the reactivity of NO with various reagents characterize by spectroscopy, 
or (3) measurements of the concentration of NO2 and NO3 in solution.     
 Two NO indicators were used in this research, which employs the direct reaction 
of NO with an organic reagent or a heme enzyme.  The first NO detection method 
utilized was a fluorescence assay with 4-amino-5-methylamino-2’,7’-difluorescein (DAF-
FM) as the NO indicator.6,7  DAF-FM is a reagent that can quantify low concentrations of 
NO in solution.8  Initially, DAF-FM is weakly fluorescent until it reacts directly with NO 
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Figure 5.1.  Channel binding wires, ReC3arg, ReC3argNO2, and ReC8argNO2, and surface binding wire. 
RuphenF9bp were used for NOS catalytic turnover studies. 
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DAF-FM quantum yield is ~0.005 and increases 160 fold (~ 0.81) after reaction 
with NO.   The fluorescence changes can be measured by 495 nm excitation wavelength 
and emission maximum monitored at 515 nm.  DAF-FM has many advantages over other 
NO indicators in that it is photo-stable, even at neutral to high pH levels, and is very 
sensitive to NO concentration (detection limit of ~ 3 nM).     
 A second NO detection method described in this chapter is the oxyhemoglobin 
(oxyHb) assay measured by UV-Vis spectroscopy.9,10  The assay is based on the direct 
reaction of NO with the oxygenated, ferrous form of hemoglobin, which produces the 
ferric form, methemoglobin (metHb), and nitrate (Scheme 5.2).  The oxidation of oxyHb 
by NO is stoichiometric and occurs faster than the reaction between NO and O2.  A 
change in absorbance (A401 - A415) with an isobestic point at 411 nm can be followed by 
UV-Vis spectroscopy.  There are advantages of detecting NO by this method over others 
in that all reagents are readily available, and sample collection and detection is simple.  
However, there are some potential problems with this assay that needs to be addressed 
and can be avoided if handled carefully.  Both oxyHb and metHb have considerable 
absorbance at 401 nm, causing irreproducible extinction coefficient values.  A Δε401 of 
60,000 M-1cm-1 [A401(metHb) – A401(oxyHb)] was deemed to be the best approximation 
in literature.  A second problem is the interference caused by reduced BH4, peroxide, 
superoxides, and uncoupled NADPH oxidation.  Concentrations of reduced BH4 can be 
limited by introducing DTT into the sample.  Uncoupled NADPH had been demonstrated 
a problem only at saturated amounts of arginine, BH4, or other inhibitors.  
Morpholinosydnonimine (SIN-1) can be added into the sample, which simultaneously 
produce NO and O2-, to prevent reaction between NO and O2-, which can lead to loss of 
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NO during the assay.  Superoxide dismutase (SOD) can also be added to the reaction to 
limit any other reactions with O2-, including a direct oxidation of oxyHb or metHb.  
However, neither SIN-1 nor SOD were explored in this research.  Sample preparations 
were prepared at optimal concentrations of substrate and inhibitors.   
Wires described in previous chapters were included in iNOS activity assays to 
probe whether these wires serve as substrates or inhibitors (Figure 5.1).  Assay for iNOS 
activity was conducted under different experimental conditions using either of the two 
methods described above to answer these four questions: (1) Can these wires photo-
chemically produce NO only in the presence of iNOSoxy; in other words, will these wires 
serve as both the substrate and the reductase? (2) Are these wires substrates of iNOS, 
meaning, will full length iNOS with the reductase domain intact (iNOSFL) turnover these 
wires and produce NO under biological conditions? (3) Are these wires inhibitors of 
arginine turnover by iNOSFL? (4) can the surface binding wire photo-chemically turnover 
arginine bound to iNOSoxy?    
 
 
5.2  EXPERIMENTALS 
 
General.  Full length iNOS was a gift from the Michael Marletta lab from the 
University of Berkeley.  Expression and purification of iNOSoxy is described in Appendix 
B.  All chemicals were bought from Aldrich unless otherwise stated.  UV-visible 
absorption spectra were taken on an Agilent 8453 UV-Vis spectrometer.  Steady-state 
emission measurements were made in buffer using a Flurolog Model FL3-11 fluorometer 
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equipped with a Hamamatsu R928 PMT.  Wires were excited with a Xenon arc lamp.  
Filters were used when appropriate. 
 Synthesis.  The synthesis of ReC8argNO2 is described in Chapter II, ReC3arg and 
ReC3argNO2 in Chapter III, and RuphenF9bp in Chapter IV of this thesis.   
Sample Preparation for DAF-FM Experiments.  DAF-FM was purchased from 
Invitrogen.  The entire vile (1 mg) was diluted with 0.35 mL of anhydrous DMSO, 
creating a ~ 7 mM stock solution.  Stock solution was aliquoted out to three 100 μL and 
one 50 μL stock solutions to minimize freeze thaw cycles.  The recommended starting 
concentration is 1 – 10 μL.  Samples were thawed when ready to use and added directly 
to protein sample.  Samples were excited at 480 nm, and emission intensity was observed 
at 515 nm by fluorescence spectroscopy.  Absorbance changes were observed at 490 nm 
for DAF-FM (ε =  84,000 M-1cm-1) and 500 nm for DAF-FMT (ε = 73,000 M-1cm-1) with 
a UV-Vis spectrometer.  
Preparation of Oxyhemoglobin.  Oxyhemaglobin stock solution was prepared 
fresh everyday of 6 mg of hemoglobin (Aldrich) added to 500 μL 50/50 mM KPi / KCl 
buffer (pH = 7.4).  Hemoglobin was dissolved by stirring slowly to prevent bubbles.  A 
few grains of dithionite were added, and a light stream of oxygen was blown on the 
surface of the solution.  The color of the solution changed twice, from dark brown 
(Fe(III) metHb) to dark purple (deoxyferrohemoglobin, Fe(II)), and then to a bright red 
solution (oxyHb, Fe(II)-O2).  The solution is then desalted through a Sephadex G-25 
PD10 column (BioRad).  The main oxyHb band was collected letting the leading and tail 
ends run through.  The concentration of the oxyHb stock was checked by a UV-Vis 
spectrometer.  The concentrations of possible species in the stock solution were 
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determined by using the following equations: 
 
[oxyHb] (μM) = (1.055A576 – 0.4275A630 – 0.7630A560) x 100,            (eq 5.4) 
[deoxyHb] (μM) = (1.444A560 – 0.7853A576 – 0.7847A630) x 100, and        (eq 5.5) 
[metHb] (μM) = (3.090A630 + 0.2026A576 – 0.4191A560) x 100.            (eq 5.6) 
 
Any excess oxyHb solution was stored at – 80oC. 
Preparation of BH4.  BH4 was prepared fresh everyday.  1 mg BH4 is dissolved 
in 100 μL of buffer.  Samples were kept from oxygen and light until ready to use.   
Sample Preparation for Oxyhemoglobin Assay.  A typical oxyHb assay with 
iNOSFL contains the following: 100 μM – 1 mM L-arginine (when needed), 20 – 50 µM 
wire (when needed), 60 – 100 µM NADPH, 2 – 5 µM oxyHb, 5 – 10 µM H4B, 0 – 20 µM 
DTT, oxygenated 50/50 mM KPi / KCl buffer (pH = 7.4), and 4 – 6 nM iNOSFL (500 µL 
total assay volume).  The sample is generally prepared and incubated on ice for 30 
minutes without NADPH or oxyHb present.  When the reaction is ready to be initiated, 
the sample solution is incubated at 37oC.  NADPH and BH4 were then added.  
Absorbance measurements were taken immediately after initiation and every minute 
during the reaction time for the first 20 minutes.  Data collection time was increased as 






5.3  RESULTS FOR DAF-FM INDICTATOR 
 
 DAF-FM reactivity with NO was employed to probe the turnover of ReC8argNO2 
by iNOSoxy.  In this experiment, ReC8argNO2 is replacing the roles of arginine and the 
reductase domain.  A control experiment of DAF-FM in buffer was photo-excited with a 
Xenon arc lamp.  The emission spectra were measured using the fluorometer with a 480 
nm excitation wavelength at various time periods after photo-excitation (Figure 5.2).  
There is a slight increase in emission intensity after 300 minutes of photo-excitation, but 
nothing significant enough to conclude that DAF-FMT is being formed.  DAF-FM is 
most likely photo-degrading to a slightly fluorescent by-product. 
 A sample of 1 μM iNOSoxy in the presence of 1 μM DAF-FM was prepared, 
photo-excited by the arc lamp, and the emission intensity was measured after various 
time periods (Figure 5.3).  Again, the emission intensity increased only slightly.  No 
formation of DAF-FMT was detected.  The absorbance of the sample was also measured 
after various photo-excitation time periods using the UV-Vis spectrometer (Figure 5.4).  
The Fe heme Soret has a λmax at 423 nm and an epsilon value of 75,000 M-1cm-1.  DAF-
FM has an absorbance λmax at 490 nm and an epsilon value of 84,000 M-1cm-1.  DAF-
FMT has an absorbance λmax at 500 nm and an epsilon value of 73,000 M-1cm-1.  Figure 
5.4 does not show a shift in the DAF-FM absorbance, indicating that DAF-FMT was not 




















































































Sample of 1 μM iNOSoxy in the presence of 1 μM DAF-FM and 1 μM 
ReC8argNO2 were prepared and excited with an arc lamp equipped with a 320 – 380 nm 
band pass filter (BPF) in between the sample and the arc lamp to photo-excite only the 
rhenium wire, preventing any photo-excitation of the heme or DAF-FM.  A quencher was 
not needed in this system because ReC8argNO2 was shown to reduce Fe(III) to Fe(II), the 
first electron transfer step in the catalytic cycle, without a reductant present as described 
in Chapter II.  The changes in fluorescence of the sample at various photo-excitation time 
periods were measured on the fluorometer at 480 nm excitation wavelength (Figure 5.5).  
DAF-FM and DAF-FMT both have an emission λmax at 515 nm; however, DAF-FMT has 
higher emission intensity than DAF-FM.  As the sample is excited up to 300 minutes, the 
fluorescence at 515 nm is significantly increased.  This indicates that NO is present in the 
sample, in order to react with DAF-FM and in turn produce DAF-FMT.  This suggests 
that ReC8argNO2 is acting as both a substrate and the reductase domain in order to inject 
five electrons into the system and turnover itself to produce NO as a product, detected by 
the formation of DAF-FMT.  
 The absorbance of the samples at various time periods were also measured for 
further characterization (Figure 5.6).  Figure 5.6 indicates a red shift in the DAF-FM 
absorbance at 490 nm to 500 nm after 20 minutes, as well as a decrease in the optical 
density.  This data also suggest the formation of DAF-FMT, which was not seen before in 
the absence of wire.  This suggests that iNOSoxy could possibly be catalyzing the wire by 
direct electron injection from the rhenium into the Fe heme after photo-excitation, 
resulting in NO as a product.  The formation of DAF-FMT was confirmed by 
fluorescence and UV-Vis spectroscopy.    
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Figure 5.4.  UV-Vis spectra of 1 μM iNOSoxy in the presence of 1 μM DAF-FM after various photo-
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Figure 5.5.  Fluorescence spectra of 1 μM iNOSoxy in the presence of 1 μM DAF-FM and 1 μM 
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Figure 5.6.  UV-Vis spectra of 1.3 μM iNOSoxy in the presence of 1.3 μM DAF-FM and 4 μM 
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Figure 5.7.  Fluorescence spectra of 1 μM iNOSoxy in the presence of 1 μM DAF-FM and 1 μM 




Another control was conducted to verify the formation of DAF-FMT by preparing 
a sample containing 1 μM DAF-FM, 1 μM iNOSoxy, and 1 μM of the rhenium complex 
without the C8argNO2 ligand attached to the wire.  The sample was photo-excited with an 
arc lamp, and the emission was measured at various photo-excitation times (Figure 5.7).  
Figure 5.7 indicates a significant increase in the emission intensity at 515 nm.  This was 
not expected for a system without an arginine analogue as a substrate.  Some other 
mechanism must be occurring, other than DAF-FMT formation by NO production. 
Sample of 1 μM DAF-FM and 1 μM ReC8argNO2 were prepared in the absence 
of protein, and the samples were photo-excited with an arc lamp.  The emission was 
measured at various time periods (Figure 5.8).  The emission intensity of the sample still 
increased even in the absence of protein.  This suggested that DAF-FM must be photo-
reacting with the rhenium, creating a species similar to DAF-FMT, which has huge 
fluorescence intensity.  It is possible that the nitro group moiety of wire would be 
cleaved, act as an NO replacement, react with DAF-FM to make DAF-FMT, and lose 
oxygen as a by-product.  The absorbance of the sample was measured by a UV-Vis 
spectrometer at various photo-excitation times (Figure 5.9).  There is no visible shift in 
the DAF-FM absorbance, even after 300 minutes of photo-excitation with the arc lamp.  
This indicated that DAF-FMT was not created; however, this did not explain the 
observed increase in fluorescence intensity.   
 It was concluded that DAF-FM was not a good NO indicator for this system.  An 
unknown photochemical reaction is occurring between the wire and DAF-FM that is 
causing an increase in the emission intensity at 515 nm.  By UV-Vis spectroscopy, all of 
the prepared samples did not seem to create DAF-FMT, except for the sample containing 
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wire, DAF-FM, and iNOSoxy present, where an absorbance shift from 490 nm to 500 nm 
was observed.  This was suggestive of NO production, but not conclusive owing to 









































Figure 5.8.  Fluorescence data of 1 μM DAF-FM in the presence of 1 μM ReC8argNO2 without protein. 
 
 
Figure 5.9.  UV-Vis spectra of 1 μM DAF-FM and 1 μM ReC8argNO2.  There is no shift in DAF-FM 
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5.4  RESULTS FOR OXYHEMOGLOBIN ASSAY 
 
Is it a substrate? 
The following experiments employed full length iNOS (iNOSFL) to probe for the 
turnover of arginine followed by spectroscopic changes in oxyhemoglobin (oxyHb) 
absorbance.  A sample containing 1 mM L-arginine, 10 µM BH4, 50/50 mM KPi / KCl 
buffer (pH 7.4), and 4 nM of iNOSFL was prepared and incubated on ice.  Time was 
allowed for arginine and BH4 to equilibrate (about 30 minutes).  When ready for 
initiation, the reaction sample was incubated at 37oC, while another sample of 100 µM 
NADPH and 6 µM oxyHb were prepared.  The NADPH and the oxyHb mixture was 
added to the reaction sample, giving a total volume of 500 µL.  Absorbance 
measurements were taken immediately at various time periods throughout the reaction 
(Figure 5.10).  The absorbance λmax for iNOSFL is centered at 390 nm in the presence of 
arginine and BH4; however, at such small concentration compared to oxyHb, iNOSFL 
absorbance is negligible.  NADPH has an absorbance λmax at 340 nm, which is visible at 
100 µM.  OxyHb has an absorbance λmax at 415 nm.  As oxyHb reacts with NO, loses O2, 
and is oxidized to metHb, the absorbance exhibits a shift from 415 nm to an absorbance 
λmax at 405 nm.  NADPH absorbance intensity is also decreased, indicative of its 
consumption during the reaction. 
 The amount of NO production can be quantified by calculating the concentration 
of oxyHb, metHb, and deoxyHb initially and throughout the reaction process.  The 
concentration of these species can be calculated using the equations 5.4-5.6 described 





Figure 5.10.  UV-Vis spectra of oxyHb assay probing the turnover of arginine by iNOSFL; inset, difference 
spectra.  An absorbance shift from λmax = 415 nm to λmax = 405 nm is indicative of NO production. 
 
 





























Figure 5.11.  Plots of oxyHb (rectangles), deoxyHb (circles), and metHb (diamonds) concentrations during 





































An excel graph is plotted for the decay of oxyHb concentration, equilibrium of deoxyHb, 
and growth of metHb concentration against the reaction time (Figure 5.11).  Under these 
conditions, about 2 μM of NO was produced.   
Another sample containing the same ingredients (except 1 mM arginine, which 
was replaced with 1 mM nitroarginine) was prepared.  Sample absorbance was measured 
for various time periods (Figure 5.12).  Only a bleach in the oxyHb Soret and NADPH 
absorbance was observed.  Concentrations of oxyHb, deoxyHb, and metHb were 
calculated and plotted against the reaction time (Figure 5.13).  Instead of a sigmoidal 
curvature in the depletion and growth of species usually seen during a reaction, a linear 
line was observed instead, due to the bleach in the oxyHb Soret.  It is concluded that NO 
was not produced in this sample, which is expected for nitroarginine, an inhibitor of 
iNOSFL.   
 The same experiments were conducted including the synthesized wires as 
substrates for iNOSFL.  Samples were prepared similarly as above, with ReC3arg 
replacing arginine.  ReC3arg is the only wire with that has the potential of being a 
substrate.  Absorbance spectra were measured during the reaction time (Figure 5.14).  
There is an initial bleach in the oxyHb Soret, but the Soret levels off at 405 nm, which 
suggests the appearance of metHb.  However, only a bleach of the oxyHb Soret was 
observed throughout the entire reaction cycle of the nitroarginine experiment, with no 
visible growth at 405 nm.  The inset of Figure 5.14 shows a small growth at 405 nm for 







Figure 5.12.  UV-Vis spectra of oxyHb assay probing the turnover of nitroarginine by iNOSFL; inset, 
difference spectra.  An Fe heme bleach is observed with no indication of NO formation. 
 
 



























Figure 5.13.  Plots of oxyHb (rectangles), deoxyHb (triangles), and metHb (diamonds) during the 














































Figure 5.14.  UV-Vis spectra of oxyHb assay containg ReC3arg as the substrate.  The first 2 minutes of the 
reaction demonstrated a slight growth at λmax = 405 nm, followed by a bleach; inset, difference spectra.  
The inset indicates a small appearance of NO formation. 
 
 
































































The concentration of the species in the reaction was plotted against the reaction time 
(Figure 5.15).  The plots form a linear line rather than a sigmoidal curve.  It is concluded 
that no significant amount of NO is produced in this sample either.   
 A sample containing ReC3argNO2 was prepared, and the same experiment was 
conducted.  UV-Vis spectra of the reaction are shown in Figure 5.16.  An initial bleach in 
the oxyHb Soret was observed.  There was a slight increase at 405 nm before the entire 
oxyHb Soret is bleached out over a two hour period.  The concentration of the species in 
the sample was plotted against the reaction time (Figure 5.17).  Again, the graph reveals 
linear lines that do not represent a reaction proceeding from substrate to product.  Only a 
linear depletion of oxyHb is concluded here. 
 Another analysis of the UV-Vis absorbance data is conducted by plotting the 
difference in absorbance intensity at 401 nm (growth of metHb) minus 421 nm 
(disappearance of oxyHb) against the reaction time for each sample (Figure 5.18).  For 
the sample containing arginine, there is an immediate change within 10 minutes of the 
reaction.  The reaction is complete and levels off.  For the sample containing 
nitroarginine and the other wires, there is a slow increase; then, the reaction levels off 
after 20 minutes.  Since nitroarginine is a know inhibitor of iNOSFL, meaning the protein 
cannot turnover nitroarginine and produce NO, it is concluded that both ReC3arg and 







Figure 5.16.  UV-Vis spectra of oxyHb assay containg ReC3argNO2 as the substrate; inset, difference 
spectra.  An Fe heme bleach is observed. 
 
 


























Figure 5.17.  Plots of oxyHb (rectangles), deoxyHb (triangles), and metHb (diamonds) during the 





























































Figure 5.18.  Plots of the difference in absorbance (Abs401 - Abs421) against the reaction time for oxyHb 
assays containing arginine (diamonds), nitroarginine (rectangles), ReC3arg (circles), and ReC3argNO2 
(stars).  An immediate change in absorbance for the reaction containing arginine indicates NO formation.  












Is it an inhibitor? 
 
 In order to test whether these wires are inhibitors of iNOSFL, samples containing 1 
mM L-arginine, 10 µM BH4, 50/50 mM KPi / KCl buffer (pH = 7.4), 4nM of  iNOSFL, 
and either nitroarginine, ReC3arg, ReC3rgNO2, or RuphenF9bp were prepared.  Time was 
allowed for arginine, BH4, and the wire to equilibrate.  Then, 100 µM NADPH and 6 µM 
oxyHb were added to the sample, keeping the total volume at 500 µL.  Absorbance 
measurements were taken immediately at various time periods.  Figure 5.19 shows the 
difference spectra of the sample containing RuphenF9bp as the inhibitor measured at 
various time periods.  The difference spectra has a positive peak at 405 nm and a negative 
peak at 415 nm, which is similar to the difference spectra for the turnover of arginine by 
iNOSFL (Figure 5.10, inset) without inhibitors.  The concentrations of the species in the 
sample were plotted against the reaction time (Figure 5.20).  Figure 5.20 shows a 
decrease in oxyHb concentration and an increase in metHb concentration, indicative of 
NO production.  The absorbance traces of the samples containing the other wires as 
inhibitors of arginine turnover were also measured by UV-Vis spectroscopy.  Two of the 
concentration plots for those samples are shown in Figure 5.21 for simplicity.  Those 
samples also exhibit the same appearance and disappearance of metHb and oxyHb, 
respectively.  The rate at which oxyHb and metHb disappears and appears is compared 
for each sample by plotting the difference in absorbance (Abs401 – Abs421) against the 





Figure 5.19.  The difference spectra of the absorbance changes during arginine turnover by iNOSFL in the 
presence of RuphenF9bp as the inhibitor.  NO formation is observed. 
 
 
























Figure 5.20.  Plots oxyHb (starts), deoxyHb (rectangles), and metHb (circles) during the arginine turnover 



























































Figure 5.21.  Plots of oxyHb (circles), deoxyHb (rectangles), and metHb (triangles) during the arginine 
turnover process in the presence of (a) ReC3argNO2 and (b) nitroarginine as inhibitors. 
 




























Figure 5.22.  Plots of the difference in absorbance (Abs401 – Abs421) against reaction time for oxyHb assays 
containing arginine (circles), RuphenF9bp (stars), nitroarginine (rectangles), ReC3argNO2 (triangles), 






It can be concluded from Figure 5.22 that RuphenF9bp exhibits about a 20% inhibition of 
arginine turnover, whereas nitroarg, ReC3arg, and ReC3argNO2 exhibit a 50% inhibition 
and ReC8argNO2 exhibit a 75% inhibition.  Most of these wires have proven to be great 
inhibitors of the turnover of arginine by iNOSFL.   
  At this point, only three of the four questions proposed in the beginning of this 
chapter were answered.  (1) Can these wires photo-chemically produce NO only in the 
presence of iNOSoxy; in other words, will these wires serve as both the substrate and the 
reductase?  There were strong suggestions that these wires can potentially serve as both a 
substrate and the electron donor based on the data from DAF-FM experiments with 
ReC8argNO2.  Again, the data is not conclusive.  Another NO indicator that does not 
photo-degrade during the reaction time is needed.   
(2) Are these wires substrates of iNOS, meaning, will iNOSFL turnover these 
wires and produce NO under biological conditions?  From oxyHb assays, there was only 
a small increase at 405nm that was visible.  It can only be concluded that if these wires 
do serve as substrates of iNOSFL and if NO is being produced as a result, then there is 
only a small amount of NO that is detected.  Nitroarginine also seems to exhibit similar 
results.  OxyHb assays may also not be ideal for these kinds of experiments.   
(3) Are these wires inhibitors of arginine turnover by iNOSFL?  The answer to this 
question is a definite YES.  These wires were shown to be good inhibitors of arginine 
turnover by iNOSFL, with more than 50% inhibition.   
Then the final question: (4) Can the surface binding wire photo-chemically 
turnover arginine bound to iNOSoxy?  At this point, some preliminary studies were done 
to probe for arginine turnover by photo-excitation of the surface binding wire.  However, 
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it was concluded that a five electron process was not possible, simply by photo-excitation 
of wire alone.  Quenchers were introduced into the system, serving as another electron 
source; however, the NOS catalytic cycle was not initiated.  No significant amount of NO 
was detected.  Further experimentations lead to the conclusion that only one turnover of 
the catalytic cycle could be completed by photo-excitation of the wire.  It is probable that 
the wire is only capable of injecting one or two electrons into the system.  In order to 
complete two turnovers and produce NO, another 2 or 3 electron sources are needed for 
the system.  
 
 
5.5  FUTURE DIRECTIONS:  Do these wires do at least one turnover? 
  
 A closer inspection of the iNOS catalytic cycle (Scheme 5.3) led us to believe that 
the synthesized wires could only complete one turnover of the catalytic cycle, a two 
electron process, instead of two complete turnovers, a 5 electron process.  Upon photo-
excitation of the wires, an electron is injected into the resting state Fe heme, reducing 
Fe(III) to Fe(II).  A second electron injection can be made possible in the presence of 
quencher, as long as the Fe(II)-O2 species is long-lived enough to allow the quencher to 
re-reduce the metal center, a process that is diffusion-limited.  It has been demonstrated 
that electron transfer into the Fe(III) by photo-excitation of the wire is very fast, faster 
than the naturally occurring electron transfer rate.  Therefore, it is believed that a second 
electron transfer step is possible by this method.  However, owing to lifetimes of these 
short-lived high-valent Fe intermediates, it is improbable that photo-excitation of the 
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wires will supply all five electrons to complete two turnovers.   
Organic species that supply one (dithionite) or two electrons (H2O2) are usually 
employed to specifically study one turnover of arginine by NOS.11-14  This method can be 
useful for these wire systems where a full turnover of the enzyme has proven difficult.  
Furthermore, NOS oxygenase domains can fold, dimerize, and function properly without 
the reductase domain intact.  Single turnover studies can be conducted without the 
complication or interferences of the flavins by introducing external electron donors, such 
as dithionite, H2O2, or wires.  Dithionite and H2O2 together will still not complete two 
turnovers of the arginine to produce NO.  Together they only supply three electrons.  
However, in the presence of wires with photo-excitation supplying two electrons, these 
small molecules can complete both turnovers of the NOS catalytic cycle with only the 
oxygenase domain.    
 However, a third NO detection method must be employed given that H2O2 will 
react with oxyHb.  The third common NO detector, the Greiss reagents based on 
detecting the break down of NO to NO2- and NO3-, can be utilized for this system.  
Spectrophotometric quantitation of nitrite using the Greiss reagents is straight forward, 
simple, and sensitive.  In the presence of Nitrate Reductase, all nitrate that is formed will 
be converted to nitrite, which diazotizes the sulfanilamide into a diazonium salt (Scheme 
5.4).  The diazonium salt then reacts with naphthylethylenediamine to produce an azo 
chromophore with an absorbance at 540 nm.  The possible drawback of this assay is the 
photo-stability of the final product.  Generally, azo compounds will cis-trans isomerize at 
specific wavelengths.  This isomerization may not interfere with the spectral growth at 
































Azo compound:  520-550nm
 










































































The functional groups, such as amines and sulfoxides, may also photo-react with the 
wires upon photo-excitation.  NADPH is essential to initiate NOSFL activity; 
unfortunately, it interferes with the Greiss reagents.  To limit unwanted reactions with 
excess NADPH, the concentration of NADPH can be lowered and optimized.  Another 
solution is to introduce lactase dehydrogenase into the system, which will also destroy the 
excess NADPH in solution.  However, the use of iNOSoxy for these studies will eliminate 
complications that may arise with the flavins.  With these limitations in mind, the Greiss 
reagent is a possibility for NO detection for these systems.   
 Two other methods of characterizing a single turnover of the NOS catalytic cycle 
is to (1) probe for N-hydroxyarginine product by organic extraction of N-
hydroxyarginine from the reaction sample and analyzed by a mass spectrometer or (2) 













5.6  CONCLUDING REMARKS 
 
Both DAF-FM and oxyHb assays were utilized to help answer four important 
questions about the effects or contributions of wires on iNOS catalytic cycle:  (1) Can 
these wires serve as both the substrate and the reductase?  (2) Will iNOSFL turnover these 
wires and produce NO under biological conditions?  (3) Are these wires inhibitors of 
arginine turnover by iNOSFL?  (4) Can the surface binding wire photo-chemically 
turnover arginine bound to iNOSoxy?  It was concluded that these wires are definite 
inhibitors of iNOSFL, inhibiting the turnover of arginine by more than 50%.  There are 
possibilities and implications that these wires may serve as iNOSFL substrates and could 
be producing NO, but only at very small amounts that are barely detectable by known NO 
indicators.  NO production may be inefficient, owing to the required five electrons to 
complete two turnovers.  Methods of detecting one turnover of iNOS catalytic cycle and 
methods of introducing other organic electron donors to aid in completing two turnovers 
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 Two wires, ReC3F9bp and ReC3F8bpimid, were designed and synthesized for 
inducible nitric oxide synthase (iNOS).  Binding and inhibition studies were conducted 
for a direct comparison to structurally similar wires synthesized previously, ReF9bp and 
ReF8bpimid.  All four wires bind to Δ65 iNOSoxy with micro molar to low nano molar 
affinity.  The fluorine-terminated wires displace the water ligand from the Fe heme sixth-
coordination site.  The imidazole-terminated wires displace water from the active site and 
ligate the Fe heme upon binding.  The transient luminescence traces of all four wires 
were shown to be quenched by the protein at < 200 ps timescale.  The quenching 
mechanism was proposed to occur between a nearby tryptophan and the rhenium 
complex.  The Fe(II) signal (the ET product) was characterized after photo-excitation of 
the imidazole terminated wires.  No electron transfer product was detected after photo-
excitation of the fluorine terminated wire.  It was concluded that a through bond pathway 
facilitated an electron transfer process between the reduced rhenium center and the Fe 
heme, which occurred at 300 – 700 ps, nine orders of magnitude faster than the naturally 
occurring electron transfer process observed under biological conditions.   
 







6.1  INTRODUCTION 
 
 
There has been a long standing interest in the Gray group to unravel the 
cytochrome P450 mechanism (Chapter I).  Previously, several sensitizer-linked substrates 
(wires) have been synthesized specifically for cytochrome P450 to study binding, 
inhibition, and electron transfer kinetics, as well as to characterize short-lived redox 
intermediates of the Fe heme.1-3  Most of these wires were ruthenium-based complexes 
linked to a cytochrome P450 substrate at the terminus end.  In recent years, our group 
became interested in the mechanism of nitric oxide synthase, specifically inducible nitric 
oxide synthase (iNOS), which has a cytochrome P450-like mechanism (Chapter I). Given 
the mechanistic similarities between cytochrome P450 and iNOS, efforts were made to 
synthesize wires with similar composition and structures to study iNOS.  Two rhenium-
based wires, previously studied with iNOS, are shown in Figure 6.1.4  These rhenium 
based wires were shown to bind to Δ114 iNOSoxy (oxygenase domain of iNOS with the 
first 114 residues cleaved) with low micro molar to nano molar dissociation constants, 
calculated by UV-Vis and fluorescence spectroscopy.4 
 In this study, similar wires at various carbon lengths were designed for iNOSoxy to 
serve as a comparison of binding, inhibition, and electron transfer kinetics to previous 




























































Transient luminescence and transient absorbance measurements were conducted with the 
previous wires, which were previously unstudied,4 to compare to the new longer wires.  
The lengths of the wires were extended and varied in order to probe for the distance 
dependence of electron transfer processes.  These new wires were found to bind to Δ65 
iNOSoxy (the first 65 residues cleaved) with low micro molar dissociation constants.  Δ65 
iNOSoxy is structurally and functionally similar to the full length iNOSoxy.  Two of the 
wires were shown to reduce the Fe heme at rates nine orders of magnitude faster than the 
naturally occurring electron transfer rate.  This unexpected discovery brings us closer to 
characterizing the second electron transfer step of the catalytic mechanism. 
 
 
6.2  EXPERIMENTALS 
 
General.  UV-visible absorption spectra were taken on an Agilent 8453 UV-Vis 
spectrometer.  All chemicals used during synthesis were purchased from Aldrich, unless 
otherwise stated.  Steady-state emission measurements were measured using a Flurolog 
Model FL3-11 fluorometer equipped with a Hamamatsu R928 PMT.  All laser 
experiments were carried out in atmosphere-controlled 1 cm path length cuvette equipped 
with Kontes valve for pump purge cycles.   
Sample Preparation.  Only samples of Δ65 iNOSoxy were used in this study, 
serving as a direct comparison to previous research of similar wires and Δ114 iNOSoxy.4   
Δ65 iNOSoxy samples were prepared as described previously.6  Small aliquots of the 
protein solutions were exchanged into phosphate buffer (50/50 mM KPi / KCl at pH = 
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7.4) using a Sephadex 35 PD10 (BioRad) desalting column immediately before 
spectroscopic measurements.  The absorbance measurement of the Fe heme Soret 
maximum at 423 nm confirmed the presence of low-spin, water-bound heme.  
Monomeric, heme-containing protein concentration was determined using the extinction 
coefficient ε423 = 75,000 M-1cm-1.   
Quantum yields.  Emission quantum yields (φwere determined in deoxygenated 
solutions relative to tris-(2,2’-bipyridine) ruthenium(II) (φ= 0.042 in water) by standard 
methods. 
Förster Energy Transfer.  Förster energy transfer (FET) calculations were 
completed according to the following expression (equation 6.1):  





  ,                                                (eq 6.1) 
where k0 is the intrinsic luminescence decay rate of the donor (the rhenium sensitizer), R 
is the distance between donor and acceptor (the iNOS heme group), and R0, the Förster 
distance, is the distance at which half of the luminescence intensity of the donor is 
quenched by FET.  R0 was calculated (in cm) from equation 6.2:  
                                                )(108.8
42256
0 JnR Dφκ
−−×=  ,                                   (eq 6.2) 
where the overlap integral, ∫= λλλελ dFJ AD 4)()( , κ2 is a measure of the spatial 
orientation of the transition dipoles of the donor and acceptor with respect to each other 
(κ2 = 2/3 in randomly oriented pairs), n is the refractive index of the solvent (n = 1.34 for 
water), and φD is the luminescence quantum yield of the donor.  
Transient Spectroscopy.  Nanosecond transient luminescence lifetime decays 
and transient absorption measurements were taken using a tripled Nd:YAG laser (λ = 355 
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nm) as the excitation source.  The instrument has a response limit of approximately 10 ns.  
Luminescence decay curves for the wires and Δ65:wire complexes were fit in Igor Pro 
using a nonlinear least-squares algorithm according to the following expression (Eq. 6.3):  






 ,             (eq 6.3) 
where n = 1-3 for mono-, bi-, and triexponential decays respectively.  Transient 
absorbance data was converted from intensity to optical density using eq. 6.4:                         












 ,                        (eq 6.4) 
where I was the intensity of sample absorbance after excitation, and I0 was taken as the 
average light intensity over the 200 ns prior to the laser shot.  Decays of the Fe(II) signals 
observed upon photoreduction of the enzyme were fit using equation 6.3.  The yield of 
Fe(II) in each sample was calculated at t = 20 ns using the following expression (Eq. 6.5): 







              ,                              (eq 6.5) 
where Δε445 (6-coordinate Fe(III) – 6-coordinate Fe(II)) was estimated by subtracting the 
absorptivity measured for wire-bound ferric Δ65 iNOSoxy from the absorptivity reported 
for CO-bound ferrous iNOSoxy (105,400 M-1cm-1).7  
For picosecond transient absorption measurements, the samples were excited at 
10 Hz with 70 ps, 355 nm pulses from a regeneratively amplified, mode-locked Nd:YAG 
laser.  In order to eliminate interference from fluorescence either of free wire or protein, 
the sample was placed far from the detector and probed with 441.6 nm light from a 
continuous wave He/Cd laser.  Stray light from the room was filtered with a 442 nm 
notch filter, and light intensity with (I, 10,000 counts) and without (I0, 10,000 counts) 
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excitation of the sample was collected directly by a fiber optic (Fiberguide Industries) 
and a Hamamatsu C5680 streak camera.  The raw image files were converted to xy data 
using an in-house macro for Matlab.  The raw data was then converted to optical density 
using eq 6.4, and the rate of formation of ferrous heme was fit to one exponential using 
eq 6.3.   
This setup presented many challenges.  Because the resting (ferric) heme already 
has appreciable absorbance at 442 nm, the initial probe light intensity, and therefore the 
overall signal strength, was attenuated.  Additionally, the protein would not tolerate more 
than about 20,000 pump/probe shots before it began to visibly deteriorate by precipitating 
from solution.  A compromise between sample concentration, probe laser power, and 
total laser shots was therefore made in order to maximize signal to noise ratio.8 
Dissociation Constants.  For the ReF9bp in the presence of the Δ65 iNOSoxy 
sample, the equilibrium dissociation constant was calculated from the biexponential fit of 
the luminescence decay (eq 6.3, n = 2) as described previously.9   Briefly, kem1 and kem2 
are the luminescence decay constants for the wire-bound and wire-free enzymes, 
respectively, and the dissociation constants were calculated from the ratio of c1 to c2.  
Due to the rapidity of the luminescence decay of bound ReF8bpimid wire toΔ65 iNOSoxy, 
the ReF8bpimid dissociation constant was calculated as described in earlier work from 
steady-state luminescence spectra.4  Because of their low solubility and tendency to 
aggregate in water, dissociation constants for ReC3F9bp and ReC3F8bpimid with Δ65 
iNOSoxy could not be reproducibly determined.  In approximate 1:1 wire to protein 
mixtures at 1 – 10 μM concentrations, however, observation of significant Δ65 iNOSoxy 
Fe heme Soret shifts the visible luminescence quenching of the wires allowed for the 
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estimation of micro molar dissociation constants for both wires.  
Synthesis.  The wire design was inspired by previous Ru-bpy-based wires that 
were made for cytochrome P450cam.9  In this prior work, substituted perfluorobiphenyls 
were not only shown to be synthetically malleable, but also to be very efficient bridges 
for electron transfer.  Further investigation has also suggested their hydrophobicity and 
potential ability to pi-stack facilitate binding to target proteins. 
Rhenium complex synthesis.  Rhenium complex was synthesized, as was 
previously described in Chapter II.  In summary, rhenium pentacarbonyl chloride was 
stirred in toluene with dimethyl phenanthroline at 50oC (Scheme 6.1).  A yellow 
precipitate formed and collected by pressure filtration through celite.  The precipitate was 
dissolved from celite with dichloromethane.  The filtrate was collected and concentrated 
by rotary evaporation.  The product was carried onto the next step without further 
purification.  The product was stirred with silvertetrafluoroborate in anhydrous THF at 
room temperature overnight.  The Re complex as a BF4 salt was formed, collected by 
vacuum filtration, and purified by flash column chromatography (eluent 50:3 CH2Cl2: 
MeOH).  
ReF9bp and ReF8bpimid synthesis.  The synthesis of ReF9bp and ReF8bpimid 
was completed in only two steps (Scheme 6.2).  An imidazole ligand is deprotonated with 
a mild base (K2CO3) in the presence of decafluorobiphenyl, which initiates a nucleophilic 
aromatic substitution of the para fluorine to produce two substituted products (mono- and 
bis-substituted).  The two ligands can easily be separated by flash column 
chromatography.  With the two purified ligands in hand, metalation with the rhenium 
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N-perfluorobiphenylimidazole (Im-F9bp) (2) and N-(1’-N-imidazolyl-
perfluorobiphenyl)imidazole (Im-F8bp-Im) (3).  Potassium carbonate (1.2 g, 9.0 mmol) 
was added to a vacuum-dried 100 mL Schlenk flask under argon flow and dried under 
heat and vacuum for one hour.  The heat was removed, and imidazole (0.61 g, 9.0 mmol) 
was added to the flask under argon flow.  The flask was then returned to vacuum for 30 
minutes.  Approximately 50 mL anhydrous DMSO was vacuum-distilled into the flask.  
Decafluorobiphenyl (2.0 g, 6.0 mmol) was added to the suspension under argon flow.  
The reaction was then sealed under argon and stirred for 12 hours at 30oC.  The reaction 
was removed from heat.  100 mL water was added.  The resulting mixture was extracted 
three times with 100 mL aliquots of dichloromethane.  The combined organic layer was 
washed further with 100 mL of water to remove traces of DMSO.  The organic layer was 
then dried over magnesium sulfate.  The magnesium sulfate was removed by gravity 
filtration.  The filtrate was concentrated by rotary evaporation, resulting in a light yellow 
oil.  The oil was re-dissolved in minimal dichloromethane and purified over silica gel by 
flash column chromatography with a 2:1 mixture of ethyl acetate and hexanes as the 
eluent.  The two products were separated.  Product 2 (0.46 g, 1.2 mmol, 20% yield):   1H 
NMR (300 MHz, CD2Cl2): δ  (ppm) 7.30 (s, 1H); 7.35 (s, 1H); 7.84 (s, 1H).  19F NMR 
(300 MHz, CD2Cl2): δ  (ppm) -161.2 (2F); -150.5 (1F); -148.2 (2F); -138.0 (2F); -137.3 
(2F).  The third fraction contained product 3 as a white solid (1.243 g, 2.9 mmol, 48% 
yield).  1H NMR (300 MHz, CD2Cl2): δ  (ppm) 7.30 (s, 2H); 7.35 (s, 2H); 7.90 (s, 2H).  
19F NMR (300 MHz, CD2Cl2): δ  (ppm)  -148.0 (4F); -136.9 (4F).  ESI/MS (m/z)+: 431.3 
(calc: 431.3).   
 
 221
[(4,7-dmp)Re(CO)3(Im-F9bp)][BF4] (ReF9bp).  2 (0.34 g, 0.88 mmol) was added to a 
50 mL, 3-neck round bottom flask fitted with a stir bar and condenser.  1 was dissolved in 
a mixture of 12 mL dichloromethane and 5 mL THF and added to the flask.  The reaction 
was stirred at 30oC.  Aliquots were tested by ESI/MS at various time points, and the 
reaction was removed from heating when the product peak stopped growing (48 - 120 
hours).  The reaction was then rotary evaporated to an orange oil.  The oil was re-
dissolved in minimal dichloromethane and purified by flash column chromatography over 
silica gel under the following conditions:  3% methanol in dichloromethane was used as 
eluent until the first two bands (one fluorescent orange band containing various rhenium 
species and one colorless band containing free ligand) were collected.  The methanol was 
then gradually increased to 40%.  The fluorescent yellow-green product was collected 
and rotary evaporated to dryness to yield a yellow solid (0.12 g, 0.12 mmol, 14.5% 
yield).  ESI/MS (m/z)+: 860.8 (calc: 861).  1H NMR (300 MHz, CD2Cl2): δ  (ppm)  3.0 
(s, 6H); 6.8 (s, 1H); 7.1 (s, 1H); 7.9 (s, d, 3H); 8.3 (s, 2H); 9.35 (d, 2H).  19F NMR (300 
MHz, CD2Cl2): δ  (ppm)  -161.1 (2F); -150.2 (1F); -148.0 (2F); -137.6 (2F); -136.4 (2F).  
[(4,7-dmp)Re(CO)3(Im-F8bp-Im)][BF4]  (ReF8bpimid).  3 (0.37 g, 0.88 mmol) was 
added to a 100 mL, 3-neck round bottom flask fitted with a stir bar and condenser.  1 
(0.44 mmol by theoretical yield, 0.5 subcess to prevent bis-Re-substituted wire 
formation) was dissolved in a mixture of dichloromethane, and THF was added to the 
flask.  The reaction was stirred at 30oC until ESI/MS showed that the product peak had 
stopped growing (2 - 5 days).  The reaction was removed from heat and stirring, and the 
product was then extracted into dichloromethane and washed with water.  The organic 
solution was dried over magnesium sulfate and rotary evaporated to dryness.  The 
 222
product was re-dissolved in dichloromethane and purified by flash chromatography under 
the same conditions as (ReF9bp).  The clean product was rotary evaporated to dryness to 
obtain a yellow solid (0.08 g, 0.07 mmol, 17.3% yield based on Re concentration).   
ESI/MS (m/z)+: 908.7 (calc: 909).  1H NMR (300 MHz, CD2Cl2): δ  (ppm) 3.0 (s, 6H); 
6.8 (s, 1H); 7.1 (s, 1H); 7.25 (s, 1H); 7.35 (s, 1H); 7.8 (s, 1H); 7.9 (d, 2H); 7.95 (s, 1H); 
8.3 (s, 2H); 9.4 (d, 2H).  19F NMR (300 MHz, CD2Cl2): δ  (ppm) -147.9 (4F); -136.3 
(4F). 
 
ReC3F9bp and ReC3F9bpimid synthesis.  The synthesis of rhenium wires with a 
three carbon linker was completed in two steps for ReC3F9bp or three steps for 
ReC3F8bpimid (Scheme 6.3).  Aminopropylimidazole is commercially available.  A 
similar deprotonation step as described above is utilized here for the nucleophilic attack 
of the decafluorobiphenyl by the primary amine, resulting in the ligand product.  
ReC3F9bp is completed by a typical rhenium metalation reaction.  ReC3F8bpimid was 
synthesized by a nucleophilic attack of a deprotonated imidazole at the fluorine-















































































Nonafluorobiphenylpropylamino imidazole (Im-C3-F9bp) (4).  Decafluorobiphenyl 
(3.0 g, 9.2 mmol) and K2CO3 (2.3 g, 16.7 mmol) were stirred in anhydrous DMF (15 mL) 
while under argon.   Aminopropylimidazole (1 mL, 8.3 mmol) was added via syringe.  
The reaction mixture was stirred overnight (12 hours) at room temperature.  HF salt 
precipitated out of solution and was isolated by vacuum filtration through celite.  Water 
was added to the filtrate.  Product was extracted with dichloromethane (3 x 10mL).  
Organic layers were combined, dried over magnesium sulfate, and concentrated by rotary 
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evaporation.  Product was purified by flash column chromatography on silica gel 
(CH2Cl2:MeOH = 50:1).  (2.2 g, 64% yield) 1H NMR (300 MHz, CDCl3): δ  (ppm) 2.2 
(m, 2H), 3.5 (t, 2H), 4.3 (t, 2H), 4.7 (s, 1H), 7.0 (s, 1H), 7.2 (s, 1H), 8.65 (s, 1H).  19F 
NMR (300 MHz, CDCl3): δ  (ppm) -138.5 (2F); -141.5 (2F); -152.5 (1F); -160.5 (2F); -
162 (2F). 
[(4,7-dmp)Re(CO)3(Im-C3-F9bp)][BF4] (ReC3F9bp).  [Re(CO)3(dmp)(THF)][BF4] (1) 
(1 g, 1.7 mmol) and nonafluorobiphenylpropylamino imidazole (4) (0.75 g, 1.7 mmol) 
were stirred in 2:1 mixture of CH2Cl2:THF (5 mL) at 40oC for 5 days.  Reaction mixture 
was cooled to room temperature, vacuum filtered through celite with a filter frit, and 
washed with CH2Cl2.  The filtrate was concentrated by rotary evaporation.  Product was 
purified using flash column chromatography on silica gel (CH2Cl2:MeOH = 50:3).  (900 
mg, 49% yield)  1H NMR (300 MHz, CD2Cl2): δ  (ppm)1.95 (m, 2H), 3.0 (s, 6H), 3.3 (t, 
2H), 3.9 (t, 2H), 4.6 (s, 1H), 6.5 (s, 1H), 6.8 (s, 1H), 7.25 (s, 1H), 7.9 (d, 2H), 8.3 (s, 2H), 
9.3 (d, 2H).  19F NMR (300 MHz, CD2Cl2): δ (ppm) -139 (2F); -142.5 (2F); -152.5 (4F); -
153.5 (1F); -161 (2F); -163 (2F).  ESI/MS (m/z)+: 917.9 (calc. 918.2). 
[(4,7-dmp)Re(CO)3(Im-C3-F9bp-Im)][BF4] (ReC3F8bpimid).  Imidazole (74 mg, 1.1 
mmol) and K2CO3 (150 mg, 1.1 mmol) were stirred in anhydrous DMF (5 mL).  
ReC3F9bp (1 g, 0.99 mmol) was added and stirred overnight under argon at room 
temperature.  Reaction mixture was cooled to room temperature, vacuum filtered through 
celite with a filter frit, and washed with CH2Cl2.  The filtrate was concentrated by rotary 
evaporation.  Product was purified using flash column chromatography on silica gel 
(CH2Cl2 : MeOH = 50 : 3).  (700 mg, 67% yield)  1H NMR (300 MHz, CD2Cl2): δ  (ppm) 
1.95 (m, 2H), 3.0 (s, 6H), 3.3 (t, 2H), 3.9 (t, 2H), 4.6 (s, 1H), 6.5 (s, 1H), 6.8 (s, 1H), 7.25 
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(s, 1H), 7.3 (s, 1H), 7.35 (s, 1H), 7.8 (s, 1H), 7.9 (d, 2H), 8.3 (s, 2H), 9.3 (d, 2H).  19F 
NMR (300 MHz, CD2Cl2) δ  (ppm): -138 (2F); -142 (2F); -149.5 (2F); -152.5 (4F); -
161.5 (2F).  ESI/MS (m/z)+: 965.1 (calc. 967.8). 
 
ReCnF9bp and ReCnF9bpimid synthesis.  The longer wires (n = 4, 6, and 8) were 
synthesized differently than the wires with a three carbon linker, owing to commercial 
unavailability of starting materials.  The longer fluorine-terminated wires were completed 
in five steps, and the imidazole terminated wires were completed in six steps. 
 A deprotonation of a phthalamide ligand in the presence of dibromoalkane 
resulted in a bromoalkylphthalamide product (Scheme 6.4).  The wire length is 
determined by the length of the dibromoalkane chain.  A deprotonated imidazole was 
then introduced in the reaction mixture for a nucleophilic attack at the bromine end, 
resulting in a phthalylalkylimidazole product. The phthalamide is then deprotected by 
hydrazine, resulting in a primary amine product (Scheme 6.5).  The primary amine is 
deprotonated by NaH for a nucleophilic attack at the para fluorine of the 
decafluorobiphenyl.  A disubstitution product was not observed.  Typical rhenium 
metalation reaction was conducted to obtain ReCnF9bp wires (Scheme 6.6).  Synthesis of 
the imidazole terminated wire is the same as above with a nucleophilic attack of the 
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Bromoalkylphthalamide (BrCnphth).  1.0 g (6.8 mmol) phthalamide was added to a 
flask containing 1 g (7.5 mmol) K2CO3 and 10 mL (0.5 M) DMF.  1.1 mL (7.5 mmol) of 
dibromohexane (Br2C6) was added and stirred overnight at room temperature.  The 
reaction mixture was concentrated and purified by flask column chromatography (6 : 1 
Hex : EtAc).  BrC6phth product was collected as a yellow oil (2 g, 95% yield).  1H NMR 
(300 MHz, CDCl3): δ  (ppm) 1.3 (m, 2H), 1.5 (m, 2H), 1.7 (m, 2H), 1.9 (m, 2H), 3.4 (t, 
2H), 3.7 (t, 2H), 7.7 (dd, 2H), 7.9 (dd, 2H).  BrC4phth and BrC8phth were synthesized 
by the same procedure with similar yields.  BrC4phth:  1H NMR (300 MHz, CDCl3): δ  
(ppm) 1.9 (m, 4H), 3.4 (t, 2H), 3.7 (t, 2H), 7.7 (dd, 2H), 7.9 (dd, 2H).  BrC8phth:  1H 
NMR (300 MHz, CDCl3): δ  (ppm) 1.2-1.4 (m, 8H), 1.6 (m, 2H), 1.9 (m, 2H), 3.4 (t, 2H), 
3.7 (t, 2H), 7.7 (dd, 2H), 7.9 (dd, 2H).   
Phthalylalkylimidazole (phthCnimid) (5).  220 mg (3.2 mmol) imidazole was stirred in 
5 mL (0.6 M) anhydrous DMF.  85 mg (3.5 mmol) of solid NaH was added to the 
reaction and stirred for 2 hours.  1 g (3.2 mmol) BrC6phth was added and stirred 
overnight at 40oC.  The reaction mixture was concentrated by rotary evaporation to 
remove DMF.  50 mL water and 20 mL toluene were added to the oil in a separation 
funnel.  The toluene layer was collected, and product was further extracted from the 
water layer with another 20 mL toluene.  This was repeated three times.  The organic 
layer was dried over MgSO4.  MgSO4 was removed by gravity filtration, and the organic 
layer was concentrated resulting in a pale yellow solid as the product (PhthC6imid) (490 
mg, 51% yield).  1H NMR (300 MHz, CDCl3): δ  (ppm) 1.2-1.4 (m, 4H), 1.7 (m, 2H), 1.8 
(m, 2H), 3.6 (t, 2H), 3.9 (t, 2H), 6.9 (s, 1H), 7.0 (s, 1H), 7.2 (s, 1H), 7.7 (dd, 2H), 7.9 (dd, 
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2H).   PhthC4imid and PhthC8imid were synthesized by the same procedure with similar 
yields.  PhthC4imid:  1H NMR (300 MHz, CDCl3): δ  (ppm) 1.7 (m, 2H), 1.9 (m, 2H), 
3.7 (t, 2H), 4.0 (t, 2H), 6.9 (s, 1H), 7.0 (2, 1H), 7.5 (s, 1H), 7.7 (dd, 2H), 7.9 (dd, 2H).  
PhthC8imid:  1H NMR (300 MHz, CDCl3): δ  (ppm) 1.2-1.4 (m, 8H), 1.6 (m, 2H), 1.8 
(m, 2H), 3.6 (t, 2H), 3.9 (t, 2H), 6.9 (s, 1H), 7.0 (s, 1H), 7.1 (s, 1H), 7.7 (dd, 2H), 7.9 (dd, 
2H).   
Aminoalkylimidazole (NH2Cnimid).  490 mg (1.6 mmol) phthC6imid and 560 μL (11.5 
mmol) N2H2 were stirred in 1 mL (1.6 M) EtOH for 2 hours.  A white precipitate formed 
and was removed by vacuum filtration through a filter frit.  The product was washed with 
more EtOH.  The filtrate was collected and concentrated by rotary evaporation.  Product 
(NH2C6imid) was carried onto the next step without further purification (300 mg, 100% 
yield).  1H NMR (300 MHz, CDCl3): δ  (ppm) 1.2-1.5 (m, 6H), 1.8 (m, 2H), 2.7 (t, 2H), 
3.9 (t, 2H), 6.9 (s, 1H), 7.0 (s, 1H), 7.4 (s, 1H).  NH2C4imid and NH2C8imid were 
synthesized by the same procedure with similar yields.  NH2C4imid:  1H NMR (300 MHz, 
CDCl3): δ  (ppm) 1.7 (m, 2H), 1.9 (m, 2H), 2.6 (t, 2H), 4.0 (t, 2H), 6.9 (s, 1H), 7.0 (2, 
1H), 7.5 (s, 1H).  NH2C8imid:  1H NMR (300 MHz, CDCl3): δ  (ppm) 1.2-1.4 (m, 8H), 
1.6 (m, 2H), 1.8 (m, 2H), 2.6 (t, 2H), 3.9 (t, 2H), 6.9 (s, 1H), 7.0 (s, 1H), 7.1 (s, 1H).   
Imidazolylalkylnonafluorobiphenyl (imidCnF9bp) (6).  300 mg (1.8 mmol) NH2C6imid 
and 500 mg (3.6 mmol) K2CO3 were added to a round bottom flask containing 4 mL (0.6 
M) anhydrous DMF and stirred for 20 minutes under argon.  668 mg (2.0 mmol) 
decafluorobiphenyl was added and stirred at room temperature overnight.  A white 
precipitate was removed by vacuum filtration through a filter frit.  The filtrate was 
collected and concentrated by rotary evaporation.  100 mL water and 50 mL CH2Cl2 were 
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added to the oil.  The product was extracted out of water by 50 mL CH2Cl2 with a 
separation funnel (repeated 3 times).  The organic solvent was dried over MgSO4.  The 
MgSO4 was removed by gravity filtration.  The filtrate was concentrated by rotary 
evaporation and purified by flash column chromatography (CH2Cl2 as the first eluent and 
50:3 CH2Cl2:MeOH as the second eluent).  A brown oil was collected as the product 
imidC6F9bp (230 mg, 34% yield).  1H NMR (300 MHz, CDCl3): δ  (ppm) 1.2-1.4 (m, 
4H), 1.6 (m, 2H), 1.8 (m, 2H), 3.4 (t, 2H), 4.0 (t, 2H), 6.9 (s, 1H), 7.1 (s, 1H), 7.6 (s, 1H).  
19F NMR (300 MHz, CDCl3): δ  (ppm): -138.5 (2F); -142 (2F); -152.5 (1F); -161 (2F); -
162 (2F).  ImidC4F9bp and imidC8F9bp were synthesized by the same procedure with 
similar yields.  ImidC4F9bp:  1H NMR (300 MHz, CDCl3): δ  (ppm) 1.7 (m, 2H), 1.9 (m, 
2H), 3.4 (t, 2H), 4.0 (t, 2H), 6.9 (s, 1H), 7.0 (2, 1H), 7.7 (s, 1H).  19F NMR, CDCl3  
δ (ppm): -138 (2F); -141 (2F); -152 (1F); -160 (2F); -161 (2F).  ImidC8F9bp:  1H NMR 
(300 MHz, CDCl3): δ (ppm) 1.2-1.4 (m, 8H), 1.6 (m, 2H), 1.8 (m, 2H), 3.4 (t, 2H), 3.9 (t, 
2H), 6.9 (s, 1H), 7.0 (s, 1H), 7.4 (s, 1H).  19F NMR (300 MHz, CDCl3): δ  (ppm) -139 
(2F); -142.5 (2F); -152 (1F); -162 (2F); -163 (2F).   
[Re(CO)3(dmp)(imidC6F9bp)][BF4] (ReC6F9bp).  262 mg (0.47 mmol) 
[Re(CO)3(dmp)(THF)][BF4] (1)  and 230 mg (0.47 mmol) imidC6F9bp were added to a 
flask containing 1 mL THF and 2 mL CH2Cl2.  The reaction mixture was stirred at 40oC 
for 5 days.  The reaction mixture was collected and vacuum filtered through a filter frit 
containing celite.  The solid was washed with CH2Cl2.  The filtrate was concentrated by 
rotary evaporation and purified by flash column chromatography (CH2Cl2 was the first 
eluent and 50:3 CH2Cl2:MeOH was the final eluent).  The product was collected as bright 
yellow solid (200 mg, 40% yield).  1H NMR (300 MHz, CDCl3): δ  (ppm) 1.1 (m, 2H), 
 230
1.3 (m, 2H), 1.6 (m, 4H), 3.0 (s, 6H), 3.4 (t, 2H), 3.7 (t, 2H), 6.4 (s, 1H), 6.7 (s, 1H), 7.3 
(s, 1H), 7.9 (d, 2H), 8.3 (s, 2H), 9.3 (d, 2H).  19F NMR, CDCl3: δ  (ppm) -139 (2F); -143 
(2F); -152.5 (4F); -154 (1F); -161.5 (2F); -162.5 (2F).   
[Re(CO)3(dmp)(imidC4F9bp)][BF4] (ReC4F9bp).  ReC4F9bp was synthesized by the 
same procedure as the synthesis for ReC6F9bp.  1H NMR (300 MHz, CD2Cl2): δ  (ppm) 
1.4 (m, 2H), 1.6 (m, 2H), 3.0 (s, 6H), 3.4 (t, 2H), 3.8 (t, 2H), 6.5 (s, 1H), 6.8 (2, 1H), 7.3 
(s, 1H), 7.8 (d, 2H), 8.3 (s, 2H), 9.3 (d, 2H).  19F NMR (300 MHz, CD2Cl2): δ  (ppm) -
139 (2F); -143 (2F); -152.5 (4F); -154 (2F); -161.5 (2F); -162.5 (2F).       
[Re(CO)3(dmp)(imidC8F9bp)][BF4] (ReC8F9bp). ReC8F9bp was synthesized by the 
same procedure as the synthesis for ReC6F9bp.  1H NMR (300 MHz, CDCl3): δ  (ppm) 
1.2-1.8 (m, 12H), 3.0 (s, 6H), 3.4 (t, 2H), 3.8 (t, 2H), 6.3 (s, 1H), 6.7 (s, 1H), 7.3 (s, 1H), 
7.9 (d, 2H), 8.3 (s, 2H), 9.3 (d, 2H).  19F NMR, CDCl3: δ  (ppm) -139 (2F); -143 (2F); -
153 (4F), -154 (1F); -162 (2F); -163 (2F).   
[Re(CO)3(dmp)(imidC6F8bpimid)][BF4] (ReC6F8bpimid).  14 mg (0.21 mmol) 
imidazole and 30 mg (0.21 mmol) K2CO3 were stirred in 1 mL anhydrous DMF.  200 mg 
ReC6F9bp was added to the reaction mixture under argon and stirred at room temperature 
overnight (12 hours).  The reaction turned from dark brown to dark red during the 
reaction time.  The reaction mixture was concentrated by rotary evaporation and purified 
by flash column chromatography (first eluent was CH2Cl2 and the final eluent was 50:3 
CH2Cl2:MeOH).  The product was collected as a bright yellow solid (140 mg, 67% 
yield).  1H NMR (300 MHz, CD3CN): δ  (ppm) 0.9 (2H), 1.2 (m, 2H), 1.4 (m, 2H), 1.6 
(m, 2H), 3.0 (s, 6H), 3.3 (t, 2H), 3.7 (t, 2H), 6.4 (s, 1H), 6.8 (s, 1H), 7.3 (s, 1H), 7.3 (s, 
1H), 7.4 (s, 1H), 7.8 (s, 1H), 7.9 (d, 2H), 8.3 (s, 2H), 9.4 (d, 2H).  19F NMR (300 MHz, 
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CD3CN): δ  (ppm) -140 (2F); -144 (2F); -151 (1F); -152.5 (4F); -162.5 (2F).   
[Re(CO)3(dmp)(imidC4F8bpimid)][BF4] (ReC4F8bpimid).  ReC4F8bpimid was 
synthesized by the same procedure as the synthesis for ReC6F8bpimid.  1H NMR (300 
MHz, CD2Cl2): δ  (ppm) 1.4 (m, 2H), 1.6 (m, 2H), 3.0 (s, 6H), 3.4 (t, 2H), 3.8 (t, 2H), 6.5 
(s, 1H), 6.8 (2, 1H), 7.2 (s, 1H), 7.3 (s, 1H), 7.4 (s, 1H), 7.8 (s, 1H), 7.9 (d, 2H), 8.3 (s, 
2H), 9.3 (d, 2H).  19F NMR (300 MHz, CD2Cl2): δ  (ppm) -139 (2F); -143 (2F); -152.5 
(4F); -154 (2F); -162.5 (2F).       
[Re(CO)3(dmp)(imidC8F8bpimid)][BF4] (ReC8F8bpimid).  ReC8F8bpimid was 
synthesized by the same procedure as the synthesis for ReC6F8bpimid.  1H NMR (300 
MHz, CDCl3): δ (ppm) 1.2-1.8 (m, 12H), 3.0 (s, 6H), 3.3 (t, 2H), 3.8 (t, 2H), 6.3 (s, 1H), 
6.7 (s, 1H), 7.2 (s, 1H), 7.3 (s, 1H), 7.4 (s, 1H), 7.8 (s, 1H), 7.9 (d, 2H), 8.3 (s, 2H), 9.3 
(d, 2H).  19F NMR (300 MHz, CDCl3): δ  (ppm) -139 (2F); -143 (2F); -153 (4F), -154 
(2F); -163 (2F).   
 
 
6.3  RESULTS 
 
Characterization of Wires.  Binding and inhibition studies were investigated for 
the three carbon linker wires, ReC3F9bp and ReC3F9bpimid, for a comparison to the 
shorter wires, ReF9bp and ReF8bpimid.  Typical of Re-diimine wires, all four complexes 
have very similar spectroscopic behavior with MLCT absorption bands centered at 360 
nm, emission maxima at 560 nm, and close to one microsecond luminescence lifetime 
decays (Table 6.1).   
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Table 6.1.5  Re-wire characterization and dissociation constants with Δ65 iNOSoxy.  Except where noted, 
numbers in parenthesis denote standard deviation of at least three separate measurements. 
Compound ε360 (mM-1cm-1) τLT (μs) φ  R0 (Å) Kd with Δ65 
ReF8bpimid 4.1(4) 0.97(3) 0.055(2) 32(8) 0.13(7)μM 
ReC3F8imida 5.0(4) 0.78(1) 0.04(1)b  <10 μM 
ReF9bp 4.1(6) 0.95(4) 0.054(1) 32(8) 1.4(5) μM 
ReC3F9bpa 4.3(4) 0.79(1) 0.042(6)b  <10 μM 
a.  Measured in 50% glycerol.  b.  Average of two measurements. 
 
All four wires have 4 - 5% luminescence quantum yields in water, and Förster distances 
(R0) of 32 ± 8 Å in the presence of Δ65 iNOSoxy were calculated.   
Binding of the wires to Δ65 iNOS.  All four wires, described above, bind in the 
active site channel of Δ65 iNOSoxy, measured by UV-Vis spectroscopy (Figure 6.3).  
Both imidazole terminated wires, ReF8bpimid and ReC3F8bpimid, ligate the Fe heme, 
causing a characteristic red shift, or a type II perturbation, in the Fe heme Soret band at 
427 nm.  The fluorine terminated wires, ReF9bp and ReC3F9bp, displace water from the 
active site, causing a partial blue shift (a type I perturbation) toward high-spin Fe(III). 
A competitive binding study was conducted between the fluorine and the 
imidazole terminated wires.  A sample of Δ65 iNOSoxy was prepared and titrated with 
ReC3F9bp.  A high spin shift was observed (Figure 6.4).  With the same sample, 
ReC3F8bpimid wire was titrated, and an immediate spectral change was observed.  The 
Fe heme Soret was red shifted, indicative of the imidazole ligation to the Fe heme.  This 
suggests that ReC3F8bpimid is a competitive binder of ReC3F9bp, and both wires are 







































Figure 6.3.  UV-visible absorption spectra of Δ65:wire complexes.  (A) Δ65 in buffer (5 μM; black) and 
Δ65 bound to one equivalent of ReF8bpimid (red) and one equivalent of ReF9bp (blue).  (B)  Δ65 in buffer 
(5 μM; black) and Δ65 bound to approximately one equivalent each of ReC3F8bpimid (red) and ReC3F9bp 





Figure 6.4.  (A) A sample of Δ65 iNOSoxy titrated with ReC3F9bp (mono wire).  A high spin shift is 
observed.  (B) A sample of ReC3F9bp (mono wire) bound Δ65 iNOSoxy titrated with ReC3F8bpimid (bis 
wire). ReC3F8bpimid displaces ReC3F9bp out of the active site and the imidazole terminus ligates the Fe 
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Transient Luminescence.   
 
Transient luminescence decay traces were measured for wire free in solution and 
wire bound to protein.  The binding constant was calculated according to procedures 
described in the Experimental Section.  By transient luminescence decay kinetics, 
ReF9bp was determined to have a dissociation constant of 1.4 ± 0.5 μM for Δ65 
iNOSoxy  (Figure 6.5).   In the presence of protein, the quenching of the transient 
luminescence intensity of Re(I)* was observed.  The trace was fit to a biexponential 
decay, and both fast and slow rates were determined: kem1 = 8(1) × 108 s-1 and kem2 = 
1.0(3) × 106 s-1.  The fast component was concluded to be the luminescence lifetime of 
wire bound to protein (~ 80 ns).  This data is similar to that previously described for the 
ReF9bp : Δ114 iNOSoxy complex, suggesting Förster energy transfer quenching of the 
Re excited state by the Fe heme with a distance of ~ 18 Å.   
Transient luminescence decay measurements on a 1:1 mixture of Δ65 iNOSoxy 
and ReF8bpimid (Figure 6.6) show that the bound wire is quenched too rapidly to be 
measured at this timescale.  The transient luminescence of Re(I)* is completely quenched 
in the presence of protein.  There is no apparent free wire in solution (evident by the lack 
of a long-lived species).  A dissociation constant for the complex could not, therefore, be 
calculated from the transient luminescence data.  Instead, the dissociation constant was 
calculated from steady-state luminescence measurements of ReF8bpimid in buffer and in 
complex with Δ65 (Figure 6.7).  A ratio of bound-wire to free-wire is calculated by the 























Figure 6.5.  Transient luminescence decays of ReF9bp in buffer (blue) and a 1:1 mixture with Δ65 (7 μM) 
with ReF9bp (red).  The decay trace in the presence of protein was fit to a bi-exponential fit (kem1 = 8(1) × 
108 s-1, kem2 = 1.0(3) × 106 s-1, yellow).  The fast component of the luminescence decay corresponds to 
























Figure 6.6.  Transient luminescence decays of ReF8bpimid in buffer (blue) and a 1:1 mixture with Δ65 (11 
μM) with ReF8bpimid (red).  The lack of an apparent slow decay indicates that almost all of the wire is 




If bound-wire has no fluorescence, then any fluorescence detected in the presence of 
protein is concluded to be due to free-wire in solution.  The concentration of bound-wire 
was then calculated from the difference of the areas from wire in buffer and free-wire in 
the presence of protein.  A dissociation constant was determined to be 130 ± 70 nM from 
steady-state fluorescence data. 
Due to their low solubility and tendency to aggregate in water, the concentrations 
of the longer wires, ReC3F9bp and ReC3F8bpimid, in buffer could never be precisely 
measured.  As such, micro molar dissociation constants for the longer wires with Δ65 
were estimated from UV-Vis (Figure 6.3) and transient luminescence spectra (Figure 
6.8a,b).  For the transient luminescence data of longer wires in the presence of protein, 
there is evidence of an extremely fast phase (below the instrument response time), which 
is indicative of bound wire.  The slower phase matched well with the lifetime decay of 
wire alone in solution.  Semilog plots of the transient luminescence data were generated 
in order to investigate the multiple phases more closely (Figure 6.9).  The transient 
luminescence traces for wire free in solution exhibit a biexponential decay with rates kem1 
= 1.0(1) × 107 s-1 and kem2 = 1.35(5) × 106 s-1.  The species with the faster decay rate (~ 
100 ns) was concluded to be wire aggregate in solution, while the longer lived species (1 
μs) is wire free in solution.  Wire in the presence of protein exhibited a triexponential 
decay with two rates similar to the wire free phases, while the third phase had a decay 
rate of kem3 = 9.1(6) × 109 s-1.  This third decay was concluded to be the bound wire 
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Figure 6.7.  Steady state fluorescence spectra of ReF8bpimid (blue) and a 1:1 mixture of with Δ65 (2 μM; 




Figure 6.8.  a) ReC3F8bpimid alone (blue) and a 1:1 mixture with Δ65 (5 μM; red).  b) ReC3F9bp alone 
(blue) and a 1:1 mixture with Δ65 (2 μM; red).  In both a and b, the fastest component of the luminescence 
decay, corresponding to wire bound to Δ65, which is irresolvable on this timescale.  The slower, visible, 
biexponential decay matches the biexponential decay of the wire alone in buffer (blue trace) and likely 
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Figure 6.9.  Semilog plot of luminescence at 560 nm vs. time for (a) ReC3F8imid alone (blue) and a 1:1 
mixture with Δ65 (red), and (b) ReC3F9bp alone (blue) and a 1:1 mixture with Δ65 (red).  The wire-only 
traces were fit to a bi-exponential decay with kem1 = 1.0(1) × 107 s-1 and kem2 = 1.35(5) × 106 s-1.  The protein 
plus wire traces were fit to three exponentials with kem1 and kem2 held constant at the values found for the 






Transient Absorbance.   
 
Transient absorbance measurements were conducted on both fluorine and 
imidazole-terminated wires the presence and absence of protein.  For both the fluorine 
terminated wires, no signal was detectable at any wavelengths (Figure 6.10).  The 
concentration of wire to protein was optimized such that no wire was free in solution, 
therefore there was no interference of Re(I)* absorbance signal.  Transient absorbance 
was probed in the Fe heme Soret region, and no Fe(II) growth or Fe(III) bleach was 
detected.  
Samples of imidazole-terminated wires in the presence and absence of protein 
were prepared, and transient absorbance spectra were measured.  The transient 
absorbance traces for ReF8bpimid wire in the presence of protein was generated in Figure 
6.11.  There is a bleach centered around 420 nm, assigned as the disappearance of six-
coordinate Fe(III) species, and an OD increase centered around 445 nm, assigned as the 
appearance of six-coordinate Fe(II).   
 Transient absorbance traces were measured for ReC3F8imid in the presence of 
protein (Figure 6.12).  The same negative and positive transient absorbance traces were 
observed.  Difference spectra were constructed from plotting the transient absorbance 
intensity against the probed wavelength to generate an absorbance curve for the transient 
species (Figure 6.13).  The difference spectra generated shows a clear decrease in signal 
at 420 nm and an increase in signal at 445 nm, indicative of Fe(III) disappearance and 




Figure 6.10.  Transient absorbance decay traces for fluorine terminated wires in the presence of protein 


























Figure 6.11.  Transient absorbance of a 1:1 mixture of ReF8bpimid and Δ65 (11 μM) showing the prompt 
formation and initial decay of six-coordinate, ferrous heme.  λex = 355 nm, λobs = 445 nm (red), λobs = 420 
nm (blue), bi-exponential fit (kb2 = 2.1(1) × 105 s-1, kb3 = 6(1) × 105 s-1, black).  Inset shows transient 
absorbance at 445 nm measured on a shorter timescale (red) fit to two exponentials (kb1 = 6(1) × 106 s-1, kb2 
= 2.5(4) × 107 s-1, black).  Taken together, these traces show that the Fe(II) signal has a complicated decay 
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Figure 6.12.  Transient absorbance of an approximate 1:1 mixture of ReC3F8bpimid and Δ65 (5 μM) 
showing the prompt formation and initial decay of Fe(II).  λex = 355 nm, λobs = 445 nm (red), λobs = 422 nm 




Figure 6.13.  Difference spectra of a 1:1 mixture of ReC3F8bpimid and Δ65 (5 μM, 80 ns after 355 nm 
excitation, blue squares) and a 1:1 mixture of ReF8bp and Δ65 (11 μM, 3 μs after 355 nm excitation, red 
triangles) showing a bleach of the 6-coordinate Fe(III) Soret (420 nm) and the appearance of the six-
coordinate Fe(II) Soret (445 nm).  Individual points were taken from single-wavelength transient 
absorbance traces.   
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For both imidazole-terminated wires, the photo-produced Fe(II) signal shows 
complicated, multi-exponential decay kinetics that consist of three dominant phases, kb1 = 
6(1) × 106 s-1, kb2 = 2.5(4) × 107 s-1, and kb3 = 6(1) × 105 s-1 (Figure 6.9).  Using Δε445 = 
59.6 mM-1cm-1 (see experimental), the calculated average yield of ferrous heme for both 
wires is 8 ± 2 %.   
Picosecond transient absorption was used to measure the rapid formation of Fe(II) 
in the presence of imidazole-terminated wires.  By pumping with 70 ps, 355 nm pulses 
and probing with the 441.6 nm line from a continuous wave He/Cd laser (as described in 
Experimentals), we were able to obtain transient absorbance traces which show the 
formation of the ferrous heme on a very short timescale (Figure 6.14).  The sample of 
protein in buffer did not show an increase in signal (Figure 6.14, blue trace), whereas the 
trace with ReF8bpimid in the presence of protein shows an increase in signal when 
probed at 441.6 nm, assigned as Fe(II) formation.  The trace was then fit to one 
exponential (eq 6.1) to give a rate of formation of Fe(II), kf = 7(3) × 1010 s-1.   
 A sample of ReC3F8bpimid and ReC3F9bp in the presence of protein was also 
measured by the same setup (Figure 6.15).  The lack of a signal in the sample containing 
ReC3F9bp plus protein trace (Figure 6.13, blue trace) confirms that there is no interfering 
Re(I)* signal nor are there any Fe(II) signals.  However, in the presence of ReC3F8bpimid 
wire, there is a huge signal observed which can indeed be attributed to Fe(II) and not to 
Re(I)*.  The signal generated here was also fit to a monoexponential decay and a faster 
























Figure 6.14.  Transient absorbance at 442 nm of Δ65 iNOSoxy alone (8μM, blue) and in the presence of 
excess ReF8bpimid (red) with λex = 355 nm.  The red trace shows the rapid formation of ferrous heme to fit 
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Figure 6.15.  Transient absorbance at 442 nm of Δ65 (16 μM) bound to approximately 1.5 equiv. 
ReC3F8bpimid (red) or ReC3F9bp (blue).  The red trace shows the rapid formation (kf  ≤ 3(1) × 1010 s-1) of 
heme Fe(II), while the blue trace shows no indication of Fe(II) formation.  λex = 355 nm. 
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6.4  DISCUSSION 
 
Luminescence Quenching and Electron Transfer.   
 
The luminescence intensity of Re(I)* of the fluorine terminated wires were 
quenched in the presence of protein compared to the luminescence intensity of wire alone 
in buffer.  This could be attributed to direct ET from the Re(I)* to the Fe heme, however, 
no electron transfer product was observed at any wavelengths by transient absorbance 
experiments.  Furthermore, Re(I)* does not have a high enough redox potential to drive 
efficient electron transfer at a fast timescale with the Fe heme at 18 Å away (Table 6.2).   
 
Table 6.2.  Reduction Potentials 




Low spin iNOSoxy (FeIII/II) -0.3512 
Low-spin P450cam (FeIII/II) ~-0.313,14 
 
Since the quenching cannot be attributed to electron transfer, this phenomenon is 
explained by Förster energy transfer to a nearby amino acid residue.  A model of the 
fluorine terminated long and short wires in the active was generated (Figure 6.16). 
In Chapter II, two tryptophan residues (Trp490 and Trp84) of full length iNOSoxy 
were proposed to quench the Re(I)* state; however, for Δ65 iNOSoxy, the Trp84 (Figure 
6.14, pink) is flipped away and no longer forms the opening of the active site channel.  
Trp490 still forms the opening of the channel and is within close proximity to the rhenium 
metal center of the short and long wires in this system.  The rate at which the Re(I)* state 
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is quenched is consistent with a Förster distance of 2 Å, the distance at which the wire is 
modeled to interact with Trp490.   
In the case of the imidazole-terminated wires, luminescence quenching is too 
rapid (≤ 200 ps) to be explained by Förster energy transfer.  The observation of Fe(II) by 
transient absorbance indicates that electron transfer must be involved in the luminescence 
quenching of the imidazole terminated wires; however, the rate of Fe(II) formation (~ 
300 – 700 ps) is too fast for electrons to travel at a distance of 18 Å.  A mechanism is 
proposed to explain the fast quenching and fast electron transfer (Scheme 6.7). 
After binding and photo-excitation of all of the wires in the presence of Δ65 
iNOSoxy, the nearby Trp490 can quench the excited state, reduce Re(I)* to Re(0), and itself 
get oxidized.  This quenching mechanism is too fast to be measured (< 200 ps).  For the 
fluorine terminated wires, the oxidized tryptophan and Re(0) recombine, and no Fe(II) 
was detected.  For the imidazole-terminated wires, a through bond pathway is present 
between the wire and the heme; therefore, electron transfer is facilitated between the wire 
and the Fe heme creating a six-coordinate Fe(II) species in 300 – 700 ps.  The Fe(II) 
species recombines with the oxidized tryptophan and returns to its resting state after two 











Figure 6.14.  Model of (a) ReF9bp and (b) ReC3F9bp in the active site of Δ65 iNOSoxy (PDB code 1DMV).  
The proposed Trp490 “quencher” is shown in blue.  Trp84 is highlighted in pink, a proposed quencher for a 





Scheme 6.7.  Proposed electron transfer kinetics.  The rhenium wires are promoted to its excited state by 
355 nm photo-excitation.  A nearby Trp quenches the excited state and reduced the Re(I)* to Re(0).  In the  
 
 
Trp490   ReI ----- FeIII
Trp490   ReI* ----- FeIII
Trp490* (H+)   Re0 ----- FeIII




(too fast to measure) 





6.5  CONCLUDING REMARKS 
  
Four new wires were synthesized based on the wires previously studied with Δ114 
iNOSoxy.  The two shorter wires, ReF9bp and ReF8bpimid, were synthesized first and 
exhibited fast quenching and electron transfer kinetics with Δ65 iNOSoxy.  Then, two 
longer wires were synthesized, ReC3F9bp and ReC3F8bpimid, with the initial purpose of 
slowing down the electron transfer rate for better characterization.  However, all four 
wires bind to Δ65 iNOSoxy with similar affinity and exhibit similar quenching rates (< 
200 ps) and electron transfer rates (kET < 700 ps for the imidazole terminated wires).  
After photo-excitation of the imidazole-terminated wires, a transient Fe(II) species was 
observed and characterized.  Longer wires with carbon linkers of 4, 6, and 8 carbons long 
were also synthesized; however, binding and electron kinetics were never studied.  A 
reasonable future direction for these 4 - 8 carbon long wires is to conduct similar 
inhibition and electron transfer studies with full length iNOSoxy, which is structurally and 
functionally similar to the full length enzyme, with the oxygenase and reductase domains 
intact.   
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THESIS SUMMARY, FUTURE DIRECTIONS, AND 



















 Future direction towards the characterization of the second turnover of the NOS 
catalytic cycle is proposed via an N-hydroxyarginine wire.  Design, synthesis, and 
postulated results were discussed.  The nitrogen source for nitric oxide can be confirmed 
by radiolabeling the nitrogen of the N-hydroxy moiety of the substrate during synthesis.  
Substituted N-hydroxyarginine substrate will aid in determining the hydrogen source 
during the hydrogen abstraction reaction of the second turnover.  Designing an N-
hydoxyarginine wire is critical for mechanistic characterization of the second turnover.  
 The ingenuity of the wires discussed in this thesis does not end at novel inhibitors 
of the heme enzyme catalytic cycle or electrochemical sensors for protein redox centers, 
but they can also serve as structural probes for protein crystallography.  Both channel and 
surface binding wires are proposed to stabilize heme enzyme active sites and domain 
interfaces, respectively, via increased hydrogen bonding, electrostatic interactions, and π-
stacking between the wire and the important residues of the protein.  Insights on heme 
enzyme function by structural determination and characterization can be accomplished by 








7.1.  THESIS SUMMARY  
 
 
 The original goal of the project, as with all other wires projects, was to design and 
synthesize sensitizer-linked substrates (wires) to probe the catalytic mechanism of iron 
(Fe) heme thiolate enzymes.  A rigid class of rhenium wires were designed and 
synthesized, initially based on previous cytochrome P450 wires.1  These first generation 
wires were found to bind to inducible nitric oxide synthase (iNOS) with high affinity.2  
The channel binding wires (Chapter I, wire D)2,3 consist of a rhenium metal center with 
ancilliary tricarbonyl and dimethylphenanthroline ligands.  The sixth rhenium 
coordination site comprises an imidazole moiety linked to a fluorinated biphenyl ring.  
The wire terminus was either a fluorine atom or substituted with an imidazole ligand to 
probe for different modes of binding to the Fe heme site.  These wires bind to iNOS with 
low micro molar dissociation constant.  This discovery was completely unexpected for a 
rigid non-substrate of NOS isoforms.  After photo-excitation of the rhenium center, a six-
coordinate Fe(II) species was generated in the absence of quencher.  This transient Fe(II) 
species was created between 300 – 700 ps, orders of magnitude faster than the naturally 
occurring electron transfer step from the reductase domain (kET = 0.9 - 1.5 s-1).4,5  
However, the generated Fe(II) species is fully coordinated; the catalytic mechanism shuts 
down; and subsequent transient species were unobserved.  A second class of wires was 
designed with hopes of generating a five-coordinate Fe(II) species for characterization of 
short-lived intermediates further down the NOS catalytic cycle.   
The second generation wires were then developed into arginine substrate-based 
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wires specifically for NOS enzymes (Chapter I, wire A-C).  The rhenium metal center 
was kept the same, varying only the length and the substrate terminus of the wire.  Nitro-
protected or fully deprotected arginine substrates were explored.  These arginine wires 
were observed to bind with high affinity to iNOSoxy.  After photo-excitation of the 
rhenium metal, electrons are injected into the Fe heme, facilitated by the presence of 
reductive quenchers.  The transient Fe(II) species was generated in less than 10 ns, the 
instrument response limit, resulting in a five-coordinate Fe(II) species.  The first electron 
transfer step of the catalytic cycle was again fully characterized.  However, a second 
electron injection was never observed.   
A novel surface binding wire was also explored (Chapter I, wire E).  The surface 
binding wire is ruthenium-based, instead of rhenium, with bulky ancilliary ligands linked 
to fluorinated biphenyl rings.2  This wire was designed to not fit in the substrate active 
site for explorations of alternative binding sites. It was discovered that the ruthenium wire 
interacts closely with the surface of the protein, presumably at the hydrophobic patch (or 
the back face of the Fe heme), where the FMN region was proposed to bind to the 
oxygenase domain during electron transfer processes.  After photo-excitation of the 
ruthenium center and in the presence of reductive quenchers, electron transfer was 
facilitated between the ruthenium metal center to the Fe heme, producing a five-
coordinate Fe(II) species in less than 10 ns.  An electron transfer pathway is proposed 
based on the postulated pathway of electrons traveling from the reductase domain to the 
back face of the Fe heme of the oxygenase domain.  An attempt of arginine turnover by 
photo-excitation of the surface binding wire in the presence of iNOSoxy was proven 
unsuccessful.  An alternative nitric oxide detection method was proposed in the presence 
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of a multi-electron donor source to facilitate two complete turnovers of NOS catalytic 
cycle.      
 The future direction for the iNOS wires project is for full characterization the 
second turnover of the catalytic cycle (Scheme 7.1).  The first turnover of NOS enzymes 
is postulated to be a typical heme-dependent hydroxylation process.6,7  The second 
turnover is more challenging, owing to very unstable short-lived intermediates, and is 
therefore interesting for the mechanistic chemist to endeavor.  The first half of the second 
turnover is postulated to be similar to the cytochrome P450 cycle; however, many aspects 
of the second turnover are still unknown.8  The third electron source, the role of all the 
cofactors and substrate,9-11 the hydroxyarginine hydroxylation mechanism,8 and the order 
of redox states, are all unknown,12,13 creating a plethora of mechanistic possibilities for 
the catalytic cycle and, subsequently, various approaches for researchers to unravel the 
true mechanism.  Utilizing the flash quench methodology (Chapter I) and based on the 
successes of the wire project, a design and synthesis of an N-hydroxyarginine wire is 
proposed to address these unknowns.   
 Aside from their use as mechanistic probes, roles as novel inhibitors of heme 
enzyme catalytic cycle or electrochemical sensors for protein redox centers, these wires 
can also serve as structural probes for protein crystallography.  Wires were previously 
shown to be useful as structural probes for both cytochrome P450 and amine 



































































First turnover Second turnover  
 
Scheme 7.1.  NOS catalytic cycle.  The first turnover is the oxidation of L-arginine to N-hydroxyarginine.  
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However, obtaining crystal structures of NOS isoforms have proven difficult, especially 
for the full length enzyme (with the oxygenase and reductase domains intact).  Both 
channel and surface binding wires are proposed to serve as structural probes for enzyme 
active sites and domain interfaces of iNOS and cytochrome P450 BM3 for structural 
characterization.   
  
 
7.2.  FUTURE DIRECTIONS FOR INOS:  PROBE THE SECOND TURNOVER  
  
 The detailed mechanism of nitric oxide synthase (NOS) enzymes still remains 
unclear.6,7  What is known is that N-hydroxyarginine is the intermediate during the 
catalysis of arginine to produce citrulline and nitric oxide (NO) through two P450-like 
catalytic cycles (Scheme 7.2).  The first turnover uses NADPH and dioxygen to oxidize 
arginine to N-hydroxyarginine by a two electron process.  The first turnover is analogous 
to cytochrome P450 catalytic cycle, a heme dependent hydroxylation process.  The 
second turnover uses half an equivalent of NADPH and another equivalent of dioxygen, 
but requires three electrons to oxidize N-hydroxyarginine to produce the products.  The 
second turnover is not analogous to any known heme catalytic mechanism and presents a 
great challenge for mechanistic research.  As a result, there are a number of postulations 
and possible mechanisms for the second turnover of NOS catalytic cycle.     
 Most of these postulations differ in the order of the redox events involved in the 
oxidation of N-hydroxyarginine.  Questions such as which hydrogen (the N-H or the O-
H) gets abstracted, when does the O-H bond gets cleaved, and what is the source of the 
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third electron, remain unanswered.  Schemes 7.3 - 7.6 summarize the differences between 
postulated mechanisms.  Scheme 7.3 proposes a mechanism where the ferric peroxy 
abstracts the proton from the O-H bond, creating a ferric hydroperoxy species.12  The 
oxygen from the peroxy Fe heme species attacks the center carbon and cyclizes to 
produce ferric hydroxyl, citrulline and NO. 
   Another postulation involves a hydrogen abstraction from the N-H bond (Scheme 
7.4).16,17  This proposal assumes that the O-H moiety swings further away from the Fe 
heme, bringing the N-H bond closer.  Evidence from ENDOR spectroscopy has shown 
that this is the case.  The ferric peroxy abstracts the hydrogen from the N-H bond, 
initiating the second turnover process.  The ferric hydroperoxy then attacks the center 
carbon, resulting in citrulline and NO products. 
 A rather interesting proposal is the mechanism involving N-hydroxyarginine as 
the third electron donor in the second turnover (Scheme 7.5).18  The N-hydroxyargine 
was proposed to swing close enough to the Fe heme to ligate the Fe through the N-O 
oxygen.  The N-hydroxyarginine reduces the Fe (III) to Fe(II) and then is released as an 
iminoxy radical.  Then, one molecule of oxygen binds to the ferrous heme, the oxygen 
attacks the center carbon, and then produces citrulline and NO as products. 
 Another postulated mechanism does not involve a hydrogen abstraction at all 
(Scheme 7.6).18,19  With the loss of water, a high-valent Fe(IV) oxo species is created, 
which reacts with the N-hydroxyarginine oxime to form an oxaziridine species.  The 
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Scheme 7.6.  The second turnover of NOS with the proposed high valent Fe(IV) mechanism. 
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Wire Design and Proposed Synthesis.  A variety of mechanistic postulations for 
the second turnover of the NOS catalytic cycle reveals what little knowledge we have on 
the mechanism.  Chemical reactions that can mimic the key steps in the N-
hydroxyarginine oxidation process will be a powerful tool in unraveling the mechanism. 
 Designing an N-hydroxyarginine wire will add to our efforts towards unraveling 
the NOS mechanistic puzzle.  Arginine wires described in the previous chapters have 
shown to be successful fluorescent probes for the NOS catalytic mechanism.  A major 
disadvantage these arginine wires have is that five electrons cannot be injected into the 
system for complete turnover of the wire by the protein.  Efforts are currently underway, 
probing a single turnover mechanism.  An advantage that N-hydroxyarginine wires will 
have over arginine wires is that they can specifically probe the second turnover process 
and only need 3 electrons to complete the cycle.  The proposed N-hydroxyarginine wire 
comprises (Figure 7.1) of a rhenium metal center with tricarbonyl and 
dimethylphenanthroline as  ancilliary ligands.  N-Hydroxyarginine is connected to a 
carbon linker by an amide bond.  This wire is designed similarly to previous arginine 
wires.  The carbon length can be altered during synthesis to optimize binding down the 
substrate channel.  A proposed synthetic scheme is shown in Scheme 7.7. 
Dual-protected ornithine is commercially available.  Nα-BOC-Nε-carboxybenzoyl 
ornithine was chosen as the starting material for selective deprotection.  An amide 
coupling reaction by DCC reagent with an aminoalkylimidazole will result in protected 
imidazolylalkylornithine (1).  The first deprotection reaction will be to remove the 
























































































































The deprotected primary amine can then be deprotonated in the presence on 
cyanobromide to induce a nucleophilic attack of the amine at the bromocarbon to result in 
cyano-ornithine derivative (3).  The cyanocarbon is then reactive towards hydroxylamine 
(or substituted hydroxylamine) to produce N-hydroxyarginine (NHA, 4).  The BOC is 
then deprotected with TFA to complete the ligand synthesis (5).  The wire is completed 
by a typical rhenium metalation reaction as described in previous chapters.  The 
ReC3NHA wire is complete in six synthetic steps. 
 The synthesis of this wire allows for easy alterations of the wire length for 
optimize binding, substitution at the hydroxyl end to probe for hydrogen atom 
abstraction, or even introduction of radiolabeled nitrogen for identification of the nitrogen 
source of the NO product. 
 
 Proposed Results.  ReC3NHA is predicted to probe the second turnover of the 
NOS catalytic cycle (Scheme 7.8).  ReC3NHA would most likely inject one electron, 
similar to previous arginine wires.  In the presence of a quencher, it is possible to inject a 
second electron to access the high valent Fe species.  With the help of other electron 
donors such as dithionite, the second turnover can be completed to produce NO.  
ReC3NHA will serve as a mechanistic inhibitor when employed under the right 
conditions. 
 ReC3NHA can be further substituted at the hydroxyl end with either a methyl, 
butyl, or hexyl group to test whether initial N-H or O-H cleavage occurs during the 
second turnover process (Scheme 7.9).  If the hydrogen atom abstraction occurs at the O-




















































































































Scheme 7.10.  Radiolabeling of the N-hydroxide nitrogen can identify the nitrogen source of NO. 
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However, if the abstraction occurs at the N-H bond, then the substituted group will 
decompose as a radical, allowing for complete turnover of the wire and produce citrulline 
and NO.  
 Radiolabeled nitrogen can be introduced in the wire synthesis to track the nitrogen 
source of the NO (Scheme 7.10).  The source is predicted to be the same N-hydroxy 





 Uncertainties and postulated mechanisms of the second turnover of the NOS 
catalytic cycle were summarized.  A design and synthesis of an N-hydroxyarginine wire 
(ReC3NHA) were proposed to better characterize the second turnover process.  Future 
directions for the wires project of iNOS remain interesting with many areas unexplored 










7.3.  FUTURE DIRECTIONS FOR CHANNEL AND SURFACE BINDING 
WIRES:  PROBE CYTPCHROME P450 BM3 AND NOS ACTIVE SITES AND 
DOMAIN INTERFACES†  
 
† This work will be done at the School of Molecular and Microbial Bioscience at the 
University of Sydney with J. Mitchell Guss.    
 
 
Introduction to Cytochrome P450 BM3 and NOS.   
 
The cytochrome P450s and nitric oxide synthases (NOS) have been extensively 
studied, owing to their involvement in a plethora of cellular processes.20,21  Both types of 
enzymes participate in hydroxylation of substrates; NOS oxidizes L-arginine to produce 
L-citrulline and nitric oxide (NO) via an N-hydroxyarginine intermediate; and 
cytochrome P450 BM3, for example, oxidizes fatty acids at the ω 1-3 carbon positions.  
Any malfunctions in the enzyme catalytic process will result in a host of diseases, 
resulting in a great interest in mechanistic and structural characterization of these 
enzymes.22,23  Both cytochrome P450 BM3 and NOS are unique heme thiolate enzymes 
in that they are mechanistically self sufficient24 and have a single polypeptide chain of a 
thiolate ligated heme.  The chain contains the oxygenase domain, which has binding sites 
for tetrahydrobiopterin (BH4) cofactor and substrate, fused with a reductase domain, 
containing FMN, FAD, and NADPH binding regions.25,26  The interface between the two 
domains consists of a binding region for calmodulin (CAM) which aids in catalytic 
activity.  Crystallization of full length P450 BM3 and NOS have been proven immensely 
difficult, owing to the multi-domain composition, the flexible linkers connecting the two 
domains, and the weak interactions at the interface.   
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One goal of the proposed research is to stabilize protein active sites and 
oxygenase-reductase domain interfaces by utilizing channel and surface binding 
sensitizer-linked substrates to increase chances of crystallization and structural 
determination, which in turn will lead to an in-depth mechanistic understanding of these 
important enzymes.   
 
Proposed structural stabilization of FMN domain and the heme domain.   
Cytochrome P450 BM326,27 and NOS oxygenase and reductase domains6 have 
been crystallized separately.  The only example of a complete complex is that of 
cytochrome P450 BM3 crystallized with a single mismatched FMN domain and two 
oxygenase domains.28  The key to understanding the mechanism and interactions of 
subunits in these heme thiolate enzymes is the structural characterization of both 
oxygenase and reductase domains together with the FMN / FAD / NADPH binding 
regions in an intact complex.  The FMN domain is proposed to dock in a hydrophobic 
depression of the oxygenase domain with weak interactions between the two domains, 
resulting in difficult crystal growth for both full length cytochrome P450 BM3 and NOS 
isoforms.28,29  Crystal structures of cytochrome P450 BM3 show that there are only two 
hydrogen bonding interactions and one salt bridge between the two domains, revealing a 
relatively large space at the interface (Figure 7.2A).28 
One aim of the proposed research is to stabilize the interface between the two 
domains by introduction of a small molecule surface inhibitor for co-crystallization with 
the protein complex without interrupting the existing interactions at the interface, such as 











Figure 7.2.  (a)  Crystal structure of the FMN domain in complex with the oxygenase domain of 
cytochrome P450 BM3; FMN is shown in green π-stacking with a tryptophan shown in pink. (b) 













The proposed small molecule is a surface binding sensitizer-linked substrate (Figure 
7.3A) consisting of an inorganic ruthenium center, which is known to crystallize easily; 
three phenanthroline moieties for π-stacking interactions with aromatic residues between 
the two domains and a third ligand of various compositions (hydrophobic 
decafluorobiphenyl, Figure 7.3A, or FMN derivatives, Figure 7.3C)  to enhance 
interactions between the two domains. 
A model of the sensitizer-linked substrate in complex with cytochrome P450 
BM3 is shown in Figure 7.2B.  The ruthenium complex fits snugly between the two 
domains, filling the empty space without interfering with existing hydrogen bonds or the 
salt bridge.  One of the phenanthroline moieties is shown to π-stack with the FMN 
complex, which will increase contacts between the domains and may increase stability 
and chances for crystallization.  
  The third ligand of the ruthenium metal can easily be altered to optimize binding 
in between the two domains.  Ligands based on the FMN flavin design are shown in 
Figure 7.3C.  Two alternative ligands are proposed which are structurally similar to the 
FMN cofactor and which may aid in specific binding at the interface.  Electrostatic 
interactions also need to be considered when designing wires for specific binding.  The 
electrostatic potential surfaces of the oxygenase and FMN domains are shown in Figure 
7.4.  The oxygenase domain has a more positive (blue) surface, while the FMN domain 
has a more negative surface (red).  The wire can be designed to contain one ligand that is 
electrostatically negative for favorable interactions with the oxygenase domain and 

































































Figure 7.3.  (A) Proposed ruthenium wire. (B) FMN cofactor. (C) Proposed ligands for the ruthenium wire. 
 
 
    
Figure 7.4.  (top) Crystal structure of cytochrome P450 BM3 oxygenase domain (blue) in complex with the 
FMN domain (tan).  (bottom) Potential surfaces of both oxygenase (a) and the FMN (b) domains are 
shown.  The oxygenase domain has a more positive (blue) potential surface than the FMN domain. 
A B 
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Proposed structural stabilization of protein active sites.   
 
As shown previously for substrate binding of cytochrome P450cam,14 similar 
open and closed conformational changes of the active site channel in both cytochrome 
P450 BM3 and NOS are expected to occur upon substrate binding but have never been 
confirmed by structural analysis.  Published crystal structures have shown an open and 
closed conformation for cytochrome P450 BM3 (Figure 7.5) with no obvious 
conformational intermediates.27,30   
Another aim of the proposed research is to employ a channel binding sensitizer-
linked substrate to probe active site conformational changes upon substrate binding to 
create a more accurate picture of the breathing motion of the protein channel.  The 
channel binding sensitizer is designed to have a smaller (rhenium) metal center with three 
carbonyls and a single phenanthroline moiety as the ancillary ligands (Figure 7.6).  The 
substrate linker is an analogue of the natural substrate with a substitution at the 
carboxylic acid end by an amide bond attached to an alkyl-imidazole chain.  These 
sensitizer-linked substrates of varying lengths are proposed to bind in the active site 
channel, leaving the rhenium at the mouth of the channel, thereby stabilizing any 
conformational intermediates as the protein surface opens and closes to allow for 
substrate binding.    
In the substrate bound form of cytochrome P450 BM3, the carboxylic end of the 
substrate is held at the mouth of the enzyme by electrostatic interactions and hydrogen 




Figure 7.5.  Crystal structures of cytochrome P450 BM3 (a) substrate free (open conformation) and (b) 










































Figure 7.7.  Model of the rhenium wire (orange) in the active site of cytochrome P450 BM3 overlay with 
N-palmitoylglycine (green), natural substrate. 
A B
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The remainder of the substrate binds down the channel and interacts with 
hydrophobic residues.  In order for the enzyme to hydroxylate the ω1-3 carbons during 
the catalytic cycle, the enzyme undergoes a conformational reorientation by a 
displacement of a Glu264 residue above the heme.27  There have been suggestions of an 
on/off equilibrium of the Glu264 residue when substrate is unbound; and when the 
substrate is bound, the equilibrium is shifted to the fully glutamate-ligated form.  
However, there is no evidence for both the “on and off” positions of the Glu264 residue 
with the substrate bound.32  This proposal has only been supported by crystal structures 
of proteins with mutations of the Glu264 residue; however, the mutation itself may alter 
the conformational equilibrium.27,32 
A specific aim is to use a sensitizer-linked substrate to probe the glutamate on/off 
equilibrium while substrate is bound.  By varying the length of the substrate and therefore 
altering the penetration distance of the substrate down the channel, it should be possible 
to access both glutamate on and off orientations while substrate is bound to the protein 
active site.  A model of the proposed sensitizer-linked substrate is shown in Figure 7.7 
overlapped with the natural substrate bound enzyme.  The necessary carboxylic acid 
interactions are retained, while the alkyl-imidazole chain allows the rhenium complex to 
occupy various positions in the channel, thereby probing open and closed conformations 
at the surface of the protein.   
In summary, both channel and surface binding sensitizer-linked substrates for 
both cytochrome P450 BM3 and NOS isoforms should aid in active site and domain 
interface stabilization to promote crystallization that will lead to structure determinations. 
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Surfactant film methodology was employed to confine iNOSoxy onto the surface 
of basal plane graphite electrode for characterization of FeIII/II and FeII/I couples, ET 
kinetics, axial ligand effects, catalytic reduction of dioxygen, and pH dependence.  A 



















A.1  INTRODUCTION 
 
 
 Iron heme containing proteins, such as cytochrome P450s and nitric oxide 
synthase (NOS) enzymes, are redox proteins that exhibit electron transfer kinetics during 
the catalytic cycle.  During electron transfer processes, the iron (Fe) heme group changes 
between various Fe redox states.  Although the Fe heme redox reaction center is similar 
in all cytochrome P450-type enzymes, the potential of these redox states vary according 
to stabilization of these states by the protein conformation and structure.  Many factors 
such as axial ligand, pH dependence, heme solvent exposure, surface and buried charged 
groups, and residue protonation abilities play important roles in these redox potentials.  
An interesting question to consider is whether electron transfer reaction is coupled with 
proton transfer reactions, which can be addressed by the pH dependence of the heme 
redox states.  Owing to the heme inability to be protonated, the important residues to 
consider are the axial ligands or the residues surrounding the Fe heme that may shift the 
potential of the Fe heme oxidation states.  
However, characterizing protein redox states are notoriously difficult owing to the 
disordered orientation of the protein on bare electrode surfaces, which may hinder the 
electron exchange and the distance between the electrode and the protein redox sites.  
Diffusion of the protein in solution does not allow for the protein to get close enough to 
the electrodes for good cyclic voltammogram (CV) signals.  A relatively new way of 
studying protein redox states utilizes water-soluble surfactants to immobilize proteins 
onto the surface of electrodes in an orderly manner.  The thin self-assembled surfactant 
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films provide a well-defined microenvironment for protein alignments in a highly ordered 
phase (bilayers or micelles), bringing the proteins closer to the surface of the electrode.   
This research has employed surfactant film methodology for the studies of inducible 
nitric oxide synthase (iNOS) redox potentials.  Didodecyldimethylammonium bromide 
(DDAB) was chosen as the surfactant deposited onto basal plane graphite electrodes for 
this system.  A pictorial depiction of the film is shown in Figure A.1.  
Interesting problems such as electron transfer versus proton transfer, axial ligand 
effects, pH dependence, and residue protonation abilities were studied against iNOS 
redox potentials.  Being able to study direct electron transfer between proteins and the 
electrodes can provide a model for the electron transfer exchanged between protein and 













A.2  EXPERIMENTALS 
 
General.  iNOSoxy expression and purification is described in Appendix B. 
Preparation of DDAB films.  Electrodes for cyclic voltammetry (0.07 cm2) were 
made using the basal plane of pyrolytic graphite.  The surfaces were prepared by sanding 
briefly with 600 - grid sandpaper, followed by polishing with 0.3 and 0.05 µm alumina 
slurries.  The electrodes were then sonicated and dried in air.  DDAB films were formed 
by placing 5 µL of 10 mM DDAB in water on the surface of the electrodes, followed by 
slow drying in air overnight.  iNOS was incorporated into the film by soaking the DDAB-
filmed electrode in a solution of enzyme (~ 20 µM in 50/50 mM KPi / KCl, pH = 7 
buffer) for 30 minutes, followed by gentle rinsing with ddH2O.   
 A CH Instruments Electrochemical Workstation system was used for the 
reactions.  Voltammetry experiments were performed in a 3-compartment cell, using a 
platinum wire auxiliary and a Ag/AgCl reference electrode (BAS).  All experiments were 
performed under argon in thoroughly degassed buffer (50/50 mM KPi / KCl, pH = 7) 
unless otherwise stated. 
Digital Simulations.  Simulations were performed with software from the CH 
Instruments Electrochemical Workstation, which utilizes a fast finite difference 


















Scheme A.1.  Square scheme used for the digital simulations. 
 
The ko and Eo for the five-coordinate Fe heme were experimentally determined to be 370 
s-1 and -150 mV.  For the six-coordinate Fe heme, ko and Eo were estimated to be 10 s-1 
(consistent with previous ET studies with NOS1 and -250 mV (based on Ep,c(2)).  A 
surface-confined system was modeled with the following parameters: capacitance = 4 μF, 
surface coverage = 5 x 10-11 mol/cm2, electrode area = 0.07 cm2.  Values for k1, k2, and 
k3 were entered into the simulator, which calculated a corresponding value for k4 and 
produced a simulated CV.  Values for k3 < 100 s-1 resulted in CVs that were irreversible 
for the five-coordinate Fe heme at all scan rates, thus setting a lower limit on this value.  
Using this procedure, values for k1, k2, and k3 of 1 s-1, 0.5 s-1, and > 100 s-1 were able to 
accurately model the voltammograms.  The simulated CVs were found to be very 
sensitive to variations for k1 and k2: approximately, k1 and k2 values greater than 5-fold 
different from 1 s-1 and 0.5 s-1 resulted in CVs that did not reproduce the experimental 
data.   
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A.3  RESULTS AND DISCUSSIONS 
 
DDAB films.  The films were made by depositing 5 μL of 10 mM of DDAB in 
water onto the surface of basal plane graphite (BPG, 0.07 cm2) electrodes, followed by 
slow drying overnight (12 hours).  A 50/50 mM KPi / KCl (pH = 7.0) buffer solution of 
20 μM iNOSoxy was incorporated into the films by soaking for 30 minutes.  A cyclic 
voltamogram of the iNOS incorporated film is measured immediately (Figure A.2).   
The E1 (-191 mV) peak and E2 (-1049 mV) were assigned to the FeIII/II and FeII/I 
couples, respectively, which is consistent with other studies of heme proteins in DDAB 
films.2-4  When Fe heme proteins bind to substrates, the redox potential of the resting 
state Fe heme will shift accordingly to the nature of the environment and the ligation of 
the ligand present.  To test for the E1 assignment, CO was added to the solution during 
CV measurements.  The E1 peak was observed to shift +62 mV, which is consistent with 
other studies of CO binding to heme proteins.5,6  The E2 peak was not observed in this 
case; presumably, the E2 peak is beyond the solvent window.  Besides CO, imidazole was 
also tested in this system, which shifted the heme potential +20 mV (Figure A.3).  With 
the addition of O2 into the system, there was a large catalytic reduction current at the 
onset of E1 as more O2 was added (Figure A.4).  As the amount of O2 is increased, so 
does the reduction peak, demonstrating that iNOS still retains catalytic activity within the 






Figure A.2.  Cyclic voltammogram of iNOSoxy in DDAB on BPG (0.07 cm2) at 200 mV/s in 50/50 mM 
KPi / KCl buffer at pH = 7.  The E1 (-191 mV) peak and E2 (-1049 mV) were assigned to the FeIII/II and 
FeII/I couples, respectively.  
 
 
Figure A.3.  Cyclic voltammogram of iNOSoxy in DDAB on BPG in 50/50 mM KPi / KCl at pH = 7 and 
500 mM imidazole at 1 V/s.  Note that only a single cathodic process shifted + 20 mV is observed.  
 
 
Figure A.4.  Cyclic voltammogram of iNOSoxy in DDAB on BPG at 200 mV/s in 50/50 mM KPi / KCl at 
pH = 7 and 94 µM O2.  A large catalytic reduction current is observed.   
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The peak current of E1 is linear with scan rates up to 16.7 V/s, which is indicative 
of surface-bound protein.  At scan rates greater than 16.7 V/s, peak current of E1 is linear 
with the square root of the scan rate, which is indicative of diffusion of the protein from 
the film into the solvent (Figure A.5).7  This behavior is characteristic of thin film 
electrochemistry.8  At higher scan rates the protein is dislodged from the film and enters 
the solvent.  The electrochemical connection between the electrode and the protein is lost.  
Therefore, at rates up to 16.7 V/s, the redox system is treated as surface-confined.   
 A rate constant was calculated for this system utilizing the trumpet plot.  The 
potential was plotted against the log of the rate, and a trumpet plot is generated, revealing 
an increase in peak separation with increasing scan rates (Figure A.6).  Using Laviron’s 
theory, ko was evaluated at 16.7 V/s (the max scan rate where the protein still behaves 
surface-bound) and calculated to be 370 ± 20 s-1 (ΔEp = 50 mV).9  The proposed first 
electron transfer step in iNOS catalytic cycle is between 0.9 – 1.5 s-1.10,11  The value 
calculated for this system is much faster than what is reported for NOS isoforms under 
physiological conditions.  This suggested that there is a well coupled pathway from the 
electrode to the Fe heme in this system.  Naturally, NOS may have interferences in the 
electron transfer pathway, owing to such factors as domain-domain interactions under 
biological conditions. 
 Owing to the broader E1 cathodic peak, a careful inspection was conducted at 
various scan rates (Figure A.7).  The single E1 cathodic peak was resolved to two distinct 
cathodic processes: Ep,c(1) and Ep,c(2).  At high and low scan rates, only one cathodic 
peak is present, either Ep,c(1) (Figure A.7, dotted line at 8 V/s) or Ep,c(2) (Figure A.7, 
solid black line at 0.05 V/s).  At an intermediate scan rate, both peaks were observed.  
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Figure A.5.  The current of E1 versus scan rate.  At rates up to 16.7 V/s, the protein remains surface-bound.   
At rates greater than 16.7 V/s, the protein dissociates from the film.  
 
 
Figure A.6.  Standard rate constant calculated from a trumpet plot. 
 
Figure A.7.  Cyclic voltammograms of iNOSoxy in DDAB on BPG in 50/50 mM KPi / KCl at 0.05 V/s 
(black), 1 V/s (gray), and 8 (dashed) V/s at pH = 7.  Two distinct peaks are observed. 
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These two new peaks were further studied by a pH dependence experiment at 
different scan rates.  At pH 5 and 1 V/s scan rate, only one cathodic peak (Ep,c(1)) was 
observed (Figure A.8).  At higher pH, Ep,c(2) dominates with the initial scan at 1 V/s, 
while subsequent cathodic sweeps of both Ep,c(1) and Ep,c(2) were observed.        
 This dependence on pH can be analyzed by plotting E1/2 versus pH.2  CVs were 
performed on iNOS samples at 200 mV/s.  The variations of E1/2 were plotted against pH 
(Figure A.9).  There is no obvious variation in E1/2 with pH < 5, indicative of a simple 
conversion of Fe(III) to Fe(II).  At pH > 7, E1/2 varies linearly with pH according to -53 
mV/pH units.  This phenomenon is often seen with Fe heme proteins.12,13 
 The pH and scan rate-dependence indicates that the iNOS Fe heme axial ligand 
may play a role in the potential equilibrium that gives rise to two cathodic peaks: Ep,c(1) 
and Ep,c(2).  A proposed schematic of water on and off rates including Fe potentials are 
proposed in Scheme A.2.  At pH 7 and at 1 V/s scan rate, the first cathodic peak results in 
only Ep,c(2) (Figure A.8).  This is proposed to correspond to the initial reduction of 
Fe(III) to Fe(II), with the sixth coordination site occupied with water (Scheme A.2).  The 
water ligand is reasonably labile, resulting in the loss of water for subsequent cathodic 
sweeps.  This creates a five-coordinate Fe(II) species.14,15  After the oxidation of Fe(II) to 
Fe(III), a second cathodic sweep at scan rate 1 V/s gives rise to two reduction peaks, 







Figure A.8.  Cyclic voltammograms of iNOS in DDAB on BPG in 50/50mM KPi/KCl at various pHs.  At 
pH = 5 (above), only one cathodic peak is observed.  At pH = 7 and 9 (bottom), Ep,c(2) dominates with the 
initial scan rate.  Subsequent cathodic sweeps revealed both Ep,c(1) and Ep,c(2) peaks. 
 
 
Figure A.9.  The dependence of E1/2 on pH.  At pH > 7, E1/2 varies linearly with pH. 
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Scheme A.2.  Scheme representing water on and off equilibrium. 
 
This proposal is further supported by the notable 133 ± 9 mV difference between Ep,c(1) 
and Ep,c(2) cathodic peaks, which is consistent with the potential difference between five- 
and six-coordinate iNOS Fe heme.16  Furthermore, at low pH only a single cathodic peak 
was observed, which is indicative of the water ligand taking on acidic characteristics 
(H3O+), creating a weaker interaction between the water ligand and the heme resulting in 
a preferred five-coordinate Fe heme species, Ep,c(1).  In contrast, at high pH, the water 
ligand takes on a basic characteristic (OH-), enhancing the attractive force between the 
ligand and the Fe heme, resulting in a six-coordinate Fe heme, Ep,c(2).  This theory was 
also tested in the presence of buffer alone and buffer containing imidazole (Figure A.10).  
In the presence of imidazole, a single cathodic peak is observed, which is consistent with 
constant Fe heme ligation as it cycles between oxidation states.   
 The dependence of the cathodic peak distribution on scan rates can be explained 
in a more complicated scheme (Scheme A.3).  At high scan rates, after oxidation of 
Fe(II), reduction of water-free Fe(III) is faster than water ligation to Fe(III), resulting in 
only one cathodic peak, Ep,c(1).  At low scan rates, the water ligand has time to ligate the 
heme before Fe(III) is reduced to Fe(II), resulting in a second cathodic peak, Ep,c(2).  This 
explains why at intermediate scan rates, there are two cathodic peaks observed.   
FeIII -OH2 FeII -OH2 FeII 












Figure A.10.  CV in the presence of iNOSoxy in buffer (top) and imidazole (bottom).  A single cathodic 








A digital simulation was conducted to effectively model the experimental results 
above.  From the simulation, values for k1, k2, and k3 in Scheme A.3 were estimated to be 
1 s-1, 0.5 s-1, and > 100 s-1 (Figure A.12).  As expected,14,15 water dissociation from the 
Fe(II) heme is rapid (k3), while the kinetics of the equilibrium of Fe(III) with water on 
and off rates appear slow (k1, k2).  The first electron transfer step in the catalytic cycle of 
NOS is proposed to occur at 1 s-1.11  This research has shown that electron transfer can 
occur at faster rates than what occurs naturally.  A proposed water gated mechanism 
could be an explanation for slow electron transfer pathways.  Although a new speculation 
for iNOS, water-gated electron transfer pathway is consistent with what is known for 






























Figure A.12.  Digitally simulated voltammograms at 0.05 V/s (black), 1 V/s (gray), and 8 V/s (dashed) for 
iNOSoxy in DDAB films.  Simulation details are listed in the experimental section (vide supra). 
 
 
A.4  CONCLUDING REMARKS 
CVs were successfully measured for iNOSoxy confined onto DDAB surfactant 
films that were deposited onto graphite electrodes.  FeIII/II and FeII/I couples were 
identified.  ET kinetics were studied in terms of pH dependence and ligand effects.  The 
observation of proton-coupled electron transfer, in a pH range where the Fe heme is 
water-ligated, further suggests that the Fe heme axial water ligand plays a role in iNOS 
electron transfer rates.  A water gated mechanism for iNOS catalytic cycle was proposed.  
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B.1  INOS cDNA.  
 
The pCW plasmid containing iNOS cDNA was a gift from Michael Marletta (UC 
Berkeley).  This heme domain construct includes 1 - 490 amino acids of iNOSoxy 
sequence with a C-terminal histidine tag (6 x His).  A picture of the plasmid is shown in 
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Figure B.1.  iNOSoxy plasmid construct. 
 
iNOSoxy was expressed in JM109 E.coli strains following literature procedures1,2 with a 
few alterations.  Cells expressing protein were subjected to two rounds of chemical lysis.  
Cell pellets were resuspended in 40 mL of B-PER lysis buffer (Pierce) with 10 μg/mL 
benzamidine, 5 μg/mL leupeptin, 1 μg/mL each pepstatin, antipain, and chymotrypsin, 
~500 μM Pefabloc (Roche), 100 μg/mL DNAse, 100 μg/mL RNAse, ~ 500 μg/mL 
lysozyme, and 20 mM imidazole per liter of cells and shaken for one hour at 4oC.  The 
lysate was then spun down, and the supernatant was loaded directly onto a nickel column 
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(5 mL HisTrap, Amersham).  The loaded column was washed with 20 column volumes of 
20 mM imidazole in 50 mM NaPi / 300 mM NaCl / pH 8.  The protein was eluted with 
150 mM imidazole, concentrated to ~ 3 mL over an Amicon Ultra filtration device 
(10,000 MWCO, Millipore), and loaded onto a gel filtration column as previously 
described.  The anion exchange column was omitted when ≥ 95% purity was confirmed 
by UV-visible spectroscopy and gel electrophoresis. 
 
 
B.2  INOSOXY EXPRESSION AND PURIFICATION PROTOCOL.   
 
Preparation of LB plates.  LB plates were made following standard procedures.  
250 mL mili-q water, 1 g bacto-tryptone, 1.3 mg bacto-yeast, 2.5 g NaCl, and 3.7 g agar 
were added to a flask and covered with foil and autoclave tape.  LB media with agar was 
autoclaved for 20 minutes.  Ampicillin stock was prepared (25 mg/mL).  2.5 g ampicillin 
was added to 100 mL mili-q water.  The solution was sterile-filtered and aliquotted into 
10 mL portions.  Any excess we stored at -20oC.  Once LB media with agar solution was 
cooled to the touch (about 20 minutes) before agar began to solidify, sterile techniques 
were followed as ampicillin was added into the LB/agar solution, for a 100 μg/mL total 
concentration of ampicillin. 25 mL of LB-agar-ampicillin solution were added into each 
plates, while avoiding bubbles and working near a flame.  Once agar solidified, each 
plate was turned upside down and allowed to sit at room temperature for 1 day.  The 
plates were stored upside down to avoid condensation and contamination for 1 - 2 days at 
4oC before using.  Plates can be stored at 4oC up to 1 month. 
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Transformation: Day 1 (~ 7pm).  1 μL plasmid (pCWori, C-term his-tagged 
heme domain, ampicillin resistant, tac-tac promoter) was added to 20 μL JM109 
competent cells in an ependorf tube and was placed on ice for 20 minutes.  The samples 
were heat-shocked at 42oC for 45 seconds and placed on ice for 2 minutes.  Either 80 μL 
SOC buffer or 200 μL NZY+ was added into each ependorf.  Samples were transferred 
into falcon tubes and incubated for 1 hour at 37oC in a shaker.  100 μL of cells were 
dripped into the center of two LB (100 μg / ml ampicillin) plates each and spread with 
beads until the entire plate is thinly covered with cells.  The two plates were stored upside 
down overnight (12 hours) in an incubator at 37oC.  Plates were stored at 4oC once 
colonies formed. 
Growth media and starter cultures: Day 2 (am).  Starter culture (4 x 100 mL 
flasks) containing 4.7 g terrific broth, 100 mL milli-q water, and 0.4 mL glycerol in each 
flask were prepared.  Growth media (6 x 1 L flasks) containing 47 g terrific broth, 1 L 
milli-q water, and 4 mL glycerol in each flask were prepared.  Each flask was covered 
with foil and autoclave tape and was autoclaved for 30 minutes.  IPTG solution 
containing 1 g IPTG and 10.5 mL mili-q water (400 mM solution) were prepared and 
stored at -80oC for later use.   
 Innoculation: Day 2 (pm).  800 μL ampicillin (25 μg/ml) was added into each 
starter culture flasks.  Only one colony from each plate of bacteria was picked with a 
toothpick and added into one starter culture flask (one colony per flask).  The starter 
culture flasks containing ampicillin and bacteria was place in a shaker overnight (12 
hours) at 37oC (rpm = 250). 
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Culture expression: Day 3 (6am).  Ampicillin stock was thawed on ice.  Each 
expression culture (6 L flasks) was added to 4 mL of ampicillin (50 μg/ml).  A small 
amount of expression culture was removed for a UV-Vis blank.  Out of the two starter 
culture flasks, the absorbance peak at λmax = 600 nm was checked for an optical density 
of 1.0 value.  The starter culture that is closest to the ideal value was picked for 
expression.  Expression culture was inoculated (1:100) by adding 10 mL of the preferred 
starter culture into each 1 L expression culture flask.  The absorbance at λmax = 600 nm 
was checked for time = 0 minutes.  Each expression culture was placed in a shaker at 
37oC for 3.5 hours.  The foil on top of each flask was left loose for air to get in.  Cells 
usually double in 30 minutes.  The absorbance at λmax = 600 nm was checked again at t = 
1.5 hours.  Target A600 = 0.5.  Once cells reach target absorbance at 0.5 OD, the heat was 
turned off, and the shaker lid was left open for continued shaking until flask was cooled 
to the touch.  IPTG was thawed on ice in the mean time.  The culture was induced by 
adding 1 mL of 400 mM IPTG to each expression culture.  Absorbance was checked 
again.  The ideal value is A600 = 0.6-0.7.  The flasks were left shaking at room 
temperature for 19 hours. 
 
Various buffer solutions were prepared for cell lysis and purification: 
Vol Buffer Na2HPO4 NaCl Imidazole Glycerol 
2L A 14.2g 35.06g 0 200ml 
2L B 14.2g 35.06g 1.36g 200ml 
 
Buffer C (2 L total volume) contained 6.3 g tris, 0.27 g imidazole, and 11.7 g NaCl        
All must buffers were prepared at pH = 8 and filtered through a 0.2 μm size filter.  
Buffers A and B are used for the nickel column, and buffer C is used for the gel filtration 
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column.  Buffers worked out to be 50 mM Na2HPO4 and 300 mM NaCl.  
Harvest cells: Day 4 (am).  The cells were taken out of the shaker and poured 
into centrifuge containers.  The cells were spun at 4oC in a Sorvall Superspeed RC2-B 
centrifuge (RPM = 5000, time = 9 minutes).  All of the cells in the expression culture 
were spun down to collect cell pellets.  The cell pellets were transferred into falcon tubes 
and kept on ice until resuspension.  Each cell pellet was resuspended in 240 mL B-Per 
lysis buffer, 10 μg/ml bezamidine, 5 μg/ml pefabloc or AEBSF, 1 μg/ml of pepstatin, 1 
μg/ml antipain, 1 μg/ml chymostatin, 1 μg/ml chymotrypsin, 100 μg/ml DNAse, 100 
μg/ml RNAse, 500 μg/ml lysozyme, and 20 mM imidazole.  The cell pellets were placed 
in a shaker at 4oC for one hour.  The cells were spun down again (RPM = 10000, time = 
20 minutes).  The supernatant was collected this time.  The color of the supernatant 
should be dark red.  A second round of cell lysis was conducted on the original cell 
pellets. 
First column purification: Hi-trap Ni-column.  The Ni-column was prepared 
by washing the column with distilled water (3 - 5 column volumes) and equilibrated with 
5 column volumes of buffer A at 1 mL/min.  The supernatant was loaded directly onto 
the column, and the protein was purified with a gradient of 2 % - 100 % of buffer B at 1 
mL/min.  Fractions were collected as 60% of buffer B was being used.  An absorbance 
for each fraction protein was measured.  Fractions that had an absorbance of A280/A428 < 
1.70 were collected.  When A280/A428 = 1.35, then it was concluded that the fraction was 
95% pure.  A gel was run to check for purity.  Fractions containing protein were 
concentrated to about 3 – 5 mL for a gel filtration column. 
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Second column purification: Gel filtration column.  The concentrated protein 
sample from Ni column was loaded onto gel filtration column.  The protein was purified 
with buffer C running at 1.5 mL/min.  Heavier molecular weight proteins came off first.  
These fractions were probably protein aggregates (brown fractions).  Red fractions 
containing protein were collected.  The purity of samples was confirmed by gels.  Protein 
samples were aliquotted into 100 μL ependorf tubes and stored at -80oC. 
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